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1. Introduction 
 
1.1. Anatomy of the orbit 
 
1.1.1. Bony Anatomy 
 
The orbits are bony cavities situated at either sides of the nasal fossa, 
between the anterior compartment of the base of the skull and the superior 
portion of the facial bones occupied by the maxillary sinuses. The orbit 
displays a pyramidal and irregular shape with a square base directed 
anteriorly, corresponding to the facial opening of the orbit. The orbital vertex  
is located in the posterior extreme of the orbit. The orbit represents an 
anatomical unit with an approximate volume of 30 cc. In it converge complex 
structures such as bones, muscles, sensory and motor nerves, vascular 
elements as well as fat and connective tissue, while the globe occupies a 
volume of approximately 7cc.  
The medial walls of the orbit are 2,5cm apart, roughly parallel, and 4,4cm to 
5cm long. The lateral walls are 4,5cm to 5cm long and lie at right angles to 
each other. The distance from the inferior orbital rim anteriorly to the 
infraorbital groove posteriorly is 2,5cm to 3cm. The depth of the temporalis 
fossa laterally is 2cm.  
Orbital roof: It is triangular. It is composed by the horizontal plate of the frontal 
bone anteriorly and the lesser wing of the sphenoid bone posteriorly. 
Orbital floor: It is triangular. Anteromedialy it is composed by the orbital plate 
of the pyramidal process of the maxillary bone. The horizontal portion of the 
orbital process of the zygomatic bone contributes anterolaterally. Its vertex is 
composed by the orbital process of the palatine bone. The inferior orbital wall 
is a thin bony wall that separates the orbit from the adjacent maxillary sinus. 
The infraorbital sulcus is a fissure located on the orbital plate of the maxillary 
bone that runs the orbital floor displaying a posteroanterior direction. After a 
2cm trajectory it transforms into the infraorbital canal and exits the orbit 
through the infraorbital foramen, located 5mm below the inferior orbital rim. 
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The maxillary sinus and often some of the ethmoid sinuses are immediately 
adjacent to the floor. 
Medial wall: It is the thinnest wall (0,2mm to 0,4mm) and is made of the 
maxillary, lacrimal, ethmoid and lesser wing of the sphenoid. About 20mm 
behind the anterior medial orbital margin is the anterior ethmoid foramen and 
12mm behind this the posterior ethmoid foramen, which is 5 to 8 mm from the 
optic canal. These foramina mark the horizontal level of the cribriform plate at 
the fronto-ethmoidal suture line. The ethmoid and frequently the sphenoid and 
maxillary sinuses form part of the medial wall.  
Lateral wall: It is composed by the greater wing of the sphenoid, frontal and 
zygomatic bones, and is at an angle of 45 degrees to the medial wall. It is the 
strongest orbital wall. Posteriorly it is separated from the roof by the superior 
orbital fissure, which is 2,2cm long, and from the floor by the inferior orbital 
fissure, which is 2cm long. Laterally it forms a portion of the temporalis fossa, 
which is thinnest at the suture line between the greater wing of the sphenoid 
and the zygomatic bone (where it can be fractured easily at surgery).  
Orbital apex: At the level of the orbital vertex there is a confluence of its walls. 
The orbital vertex is occupied by two important foramina containing all the 
elements that compose the orbital pedicle: 
 
a). Optic foramen: It constitutes the anterior boundary of the optic canal, 
through which the orbital cavity and the middle cranial fossa communicate. 
b). Sphenoidal or orbital fissure: This is the space between the lesser wing of 
the sphenoid bone superiorly and the medial border of the greater wing of the 
sphenoid inferiorly. 
The periorbita is a thin fibromuscular membrane that lines the orbital walls 
completely from the orbital vertex to the orbital rim, where the orbital septum 
is attached. Posteriorly it is continuous with the dura of the optic nerve and 
that surrounding the superior orbital fissure and anteriorly with the periosteum 
of the orbital margins. Thus surgery or trauma posteriorly may result in 
cerebrospinal fluid leaks.  
The table below indicates the anatomic structures which pass through the 
foramina mentioned above.  
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Table 1. The anatomic structures which pass through the foramina 
(Moreiras JVP, Prada MC Orbit: Examination, Diagnosis, Microsurgery, 
Pathology 2004, modified). 
Superior sphenoidal 
fissure 
Communicates with the 
cavernous sinus 
Cranial nerves III, IV, 
and VI. Superior 
ophthalmic vein. V1 
(frontal, lacrimal, and 
nasociliary nerves) 
Optic canal Communicates with the optic chiasm 
Optic nerve. Ophthalmic 
artery 
Inferior orbital fissure 
Communicates with 
inferiortemporal and 
pterygopalatine fossae, 
and foramen rotundum 
V2 (infraorbital nerve). 
Inferior ophthalmic vein. 
Anterior and posterior 
ethmoidal foramina 
Communicates with 
ethmoidal sinus mucosa 
Arteries, veins, and 
anterior and posterior 
ethmoidal nerves 
(respectively) 
Zygomaticofacial 
foramen 
Communicates with 
tissues from the inferior 
and lateral orbital rim 
Zygomaticofacial artery, 
vein, nerve. 
Zygomaticotemporal 
foramen 
Communicates with 
tissues of the superior 
and lateral orbital rim 
Zygomaticotemporal 
artery, vein, nerve. 
 
 
Anterior/posterior ethmoidal foramen 
 
Lamina papyracea of the ethmoidal 
bone 
 
Lacrimal bone 
 
Lacrimal fossa 
 
Orbital process of palatine bone 
 
Maxillary bone  
 
Frontal bone 
Lesser wing of 
sphenoid 
Inferior orbital fis. 
Optic foramen 
Greater wing of 
sphenoid 
Zygomatic bone 
Inferior orbital fis. 
Infraorbital sulcus 
 
Figure 1. The bony anatomy of the orbit (aspect 1). (Netter Atlas of   
Human Anatomy, 2nd Edition 1997). 
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Figure 2. The bony anatomy of the orbit (aspect 2). (Rootman J Diseases 
of the orbit 1988). 
 
 
 
 
 
 
 
 
 
Lacrimal 
Nasolacrimal fossa 
Ethmoid 
Maxilla 
Palatine 
Zygomatic 
 Inferior orbital fissure 
 Greater wing of sphenoid 
Pterygopalatinate fossa 
Lacrimal foramen  
(variable) 
Ethmoid sinuses 
ANTERIOR 
MIDDLE 
POSTERIOR 
Optic canal 
        Lesser wing of sphenoid 
   Hypopheseal fossa 
   Posterior clinoid process 
Lacerum Rotundum    Ovale Spinosum 
Figure 3. The bony anatomy of the orbit (aspect 3). (Rootman J 
Diseases of the orbit 1988). 
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1.1.2. Orbital spaces 
 
1. Subperiosteal space (virtual): located between the periosteum and the 
orbital portions of the orbital bones. 
2. Preseptal space: located outside the orbital septum, includes the 
eyelids, lacrimal drainage system, palpebral lobe of the lacrimal gland and 
preseptal fat.  
3. Tenon’s space (virtual): located between the Tenon capsule and the 
episclera. 
4. Intraconal space: located inside the muscular cone, it contains the optic 
nerve and intrakonal fat. 
5. Extraconal space: located on the outside of the muscular cone and 
extending to the periosteum. It contains the oblique muscles, orbital lacrimal 
gland and extrakonal fat.  
 
1.1.3. Orbital extraocular muscles 
 
The six striated extraocular muscles, including the four recti and two oblique 
muscles control eye movement. The recti arise from the annulus of Zinn at the 
apex, where it is continuous with the dural sheath of the optic nerve and 
periorbita. Because of this intimate relationship apical disease frequently 
affects all of these structures simultaneously. Anteriorly the recti insert into the 
globe 5mm to 7mm posterior to the limbus. The superior oblique originates 
just superior to the annulus, and passes forward through the trochlea (4mm to 
the orbital margin) from whence it extends in a slight posterolateral plane to 
insert on the superior aspect of the globe. The inferior oblique arises from the 
bone just posterolateral to the nasolacrimal fossa, then it extends in a slight 
posterolateral direction beneath the inferior rectus and inserts on the 
inferolateral aspect of the eye.  
Levator palpebrae/upper lid retractor muscle  
This muscle originates in the deeper portion of the orbit from the lesser wing 
of the sphenoid, posteriorly to the tendon of Zinn. It courses forward and is 
situated between the orbital roof and the rectus superior. At the level of 
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superior orbital rim it passes into the insertional aponeurosis that curves 
following a descending direction reaching the entire width of the upper lid. The 
insertional fibers of the levator are disposed in two superposed layers: one 
superficial of aponeurotic nature, and another deep layer composed by non-
striated muscle fibers. The superficial layer ends inserting on the anterior 
portion of the tarsus. The non-striated muscle fibers of the deep layer insert 
on the upper border of the tarsus and the upper fornix. These non-striated 
fibers are known as the upper lid muscle of Müller. The striated and non-
striated muscle fibres of the levator constitute the upper lid retractor muscle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
m. levator palpebrae 
m. obliquous superior 
m. rectus superior 
m. rectus medial 
optic nerve 
ophthalmic artery 
m. rectus inferior 
 
sup. orbital fis. 
lacrimal nerve  
frontal nerve 
trochlear nerve 
sup. ophth.vein 
m. rectus lateral 
occulomotor nerve 
upper branch 
abducens nerve 
nasociliary nerve 
 
 
occulomotor nerve lower branch 
Figure 4. Apical structures. (Netter Atlas of Human Anatomy, 2nd Edition 
1997). 
Optic nerve 
 
 
 
M. rectus lateral 
 
 
 
 
 
M. obliquous inferior 
M. rectus medial 
 
 
 
 
 
 
M. rectus lateral 
 
 
 
M. rectus inferior 
M. rectus superior 
M. levator 
palpebrae M. obliquous superior 
Figure 5. The muscles of the orbit (aspect 1). (Netter Atlas of Human 
Anatomy, 2nd Edition 1997). 
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superior  tarsus 
 
M. levator palpebrae 
 
 
 
 
 
M. rectus superior 
 
 
 
M. rectus lateral 
 
 
Optic nerve 
 
 
 
M. rectus superior 
 
 
 
 
 
 
 
 
 
     M. obliquous    
         superior 
 
 
M. rectus lateral 
 
 
M. rectus inferior 
 
 
 
 
 
   Annus of Zinn 
M. levator palpebrae 
 
Figure 6. The muscles of the orbit (aspect 2). (Netter Atlas of Human 
Anatomy, 2nd Edition 1997). 
 
 
 
1.1.4. Orbital arteries and orbital venous drainage 
 
1.1.4.1. Ophthalmic artery 
 
Orbital vascularisation depends on the ophthalmic artery system, which is a 
collateral branch of the internal carotid artery. The ophthalmic artery enters 
the orbit through the optic canal accompanying the optic nerve. The 
ophthalmic artery adopts a caudal position in relation to the optic nerve.  
In the orbit, the ophthalmic artery initially adopts a lateral position in relation to 
the optic nerve (laterooptical portion); after a short distance of approximately 
5mm, the artery traverses the superior side of the optic nerve (supraoptical 
portion), and then situates near the medial orbital wall, where it adopts an 
undulated trajectory while travelling forward between the superior oblique 
muscle above, and the medial rectus muscle below. The artery reaches the 
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anterior border of the orbit and perforates the broad upper lid ligament, 
between the trochlea of the superior oblique muscle above, and the medial 
check ligament, below. Finally, it reaches the base of the nose where it 
anastomoses with the angular artery, the terminal branch of the facial artery. 
 
Collateral branches of the ophthalmic artery 
The ophthalmic artery sends the following ten collateral branches along its 
intraorbital trajectory: 
 
Central retinal artery 
Initially it lies on the lateral side of the optic nerve, and then reaches its 
inferior side. it sends multiple branches to the optic nerve sheaths, and finally, 
approximately 1cm behind the eyeball, penetrates the optic nerve through its 
inferior portion. When it reaches the eyeball, it penetrates into it through the 
lamina cribrosa, traverses the optic papilla and then branches onto the retina. 
 
Lacrimal artery 
The lacrimal artery follows an anterior direction applied to the superior edge of 
the lateral rectus muscle, accompanied by the lacrimal nerve. Before it 
reaches the posterior portion of the lacrimal gland, the artery divides into 
several branches that irrigate the gland. 
  
Supraorbital or frontolateral artery 
This takes an ascendant direction and travels along the internal portion of the 
superior rectus and levator muscles. It exits the orbit through the supraorbital 
foramen, and ends innervating the frontal region and upper lid. 
 
Posterior ciliary arteries 
Initially they are composed of two or three branches that immediately send 
new branches. They follow the direction of the optic nerve, following an 
undulated trajectory until they reach the posterior pole of the globe. They 
penetrate the sclera around the optic nerve and distribute some branches on 
the sclera, but fundamentally into the choroid. 
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Long ciliary arteries 
These are two arteries, one medial and the other lateral, that lie medially and 
laterally to the optic nerve respectively. When these arteries reach the eyeball 
they penetrate the sclera and reach the suprachoroidal space where they 
travel (without sending branches) along the nasal and temporal meridians of 
the globe accompanied by branches of the long ciliary nerves. 
 
Posterior and anterior ethmoidal artery 
They penetrate the anterior and posterior ethmoid foramina.  
 
Medial Palpebral arteries 
These two arteries, one the superior palpebral and the other the inferior 
palpebral, originate from the ophthalmic artery through a common trunk below 
the trochlea of the superior oblique muscle. They traverse the broad palpebral 
ligament and situate between the tarsus and the orbicularis muscle, parallel to 
the free margin of the corresponding lid. 
 
Internal frontal artery 
Originates from the ophthalmic artery in the vicinity of the trochlea of the 
superior oblique muscle, traverses the broad upper lid ligament and exits the 
orbit accompanying the internal frontal nerve 
 
Terminal branch of the ophthalmic artery 
After sending all its collateral branches, the ophthalmic artery lies in the 
superomedial orbital angle and traverses the broad upper lid ligament, 
between the internal frontal artery inwards, and the superior palpebral artery 
outwards. Once it exits the orbit, the ophthalmic artery displays an oblique, 
downward and outward trajectory following the base of the nose. It traverses 
the angular vein and ends anastomosing to the angular artery, the terminal 
branch of the facial artery. 
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1.1.4.2. Orbital venous drainage 
 
The orbital veins are valveless, the superior ophthalmic draining into the 
cavernous sinus by the superior orbital fissure, and the inferior into the 
superior ophthalmic vein and the pterygoid plexus. The superior is larger, and 
is formed by the confluence of the angular, nasofrontal and supraorbital veins. 
It has three sections, the first extending posterolaterally to the medial border 
of the superior rectus in the anterior third of the orbit. The second section of 
the superior ophthalmic vein enters the muscle cone, passing to the lateral 
orbit beneath the superior rectus muscle. The third section extends 
posteromedially along the lateral border of the superior rectus into the 
superior orbital fissure, where it drains into the cavernous sinus. The more 
variable inferior ophthalmic vein forms inferolaterally as a plexus, and passes 
posteriorly 
adjacent to the inferior rectus muscle. It anastomoses with the superior 
ophthalmic vein, and has a similar branch that connects with the pterygoid 
plexus through the inferior orbital fissure. The tributaries are muscular, medial 
collateral, vortex, and lateral collateral. 
Anterior venous drainage may be through the facial by means of the angular 
vein medially, and a plexus from the inferior ophthalmic to the facial vein 
laterally. 
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         Internal frontal a. 
        Terminal branch  
     of the ophthalmic a. 
   Anterior meningeal a. 
    Anterior ethmoidal a.  
   Posterior ethmoidal a. 
               Ophthalmic a.   
         Muscle collateral 
               Ophthalmic a. 
. 
 
 
Lateral palpebral a.  
 
 
Lacrimal gland 
 
Supraorbital a. 
 
 
Zygomatic collaterals 
 
Ciliary a. 
 
Muscle collateral 
Lacrimal a. 
 
Central retinal artery 
 
Medial palpebral a. 
 
Figure 7. The arteries of the orbit (aspect 1). (Netter Atlas of Human 
Anatomy, 2nd Edition 1997). 
 
Supraorbital a. 
 
Internal frontal a. 
 
Terminal branch of ophthalmic a. 
Internal palpebral a. 
 
Angular a. 
 
Internal palpebral a. 
 
Palpebral a. 
 
 
Facial a. 
 
         
         
        Frontal collateral 
         of A. temporalis 
    Lateral palpebral a. 
 
    Lateral palpebral a. 
 
 Zygomatic branch of  
              A. temporalis  
                      Facial a. 
 
Infraorbital a. 
 
Figure 8. The arteries of the orbit (aspect 2). (Netter Atlas of Human 
Anatomy, 2nd Edition 1997). 
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Nasofrontal v. 
 
Angular v. 
 
Vortex v. 
 
 
 
Facial v. 
 
 
 
 
 
deep Facial v.  
                      
 
 
                                   Supraorbital v. 
 
 
           Superior ophthalmic v. 
                      Cavernous sinus 
                   Inferior   
           ophthalmic v. 
                Pterygoid 
                    plexus 
          Mandibular v. 
   Posterior facial v. 
 
Figure 9. Orbital vein drainage. (Netter Atlas of Human Anatomy, 2nd 
Edition 1997). 
 
 
1.1.5. Orbital nerves 
 
Optic Nerve 
The optic nerve is a nerve fiber tract, 4,5cm to 5 cm long and about 4mm in 
diameter, that extends from the globe to the chiasm. It is divided into four 
portions: intraocular (1mm), intraorbital (3cm), intracanalicular (5mm to 6mm) 
and intracranial (1cm). Because the distance from the globe to the apex is 
20mm the intraorbital portion has an S-shaped configuration. The 
subarachnoid space and meningeal linings sheathe the nerve and extend 
from the canal forward to the globe.  
 
Peripheral nerves 
The sensory nerves of the orbit are branches of the ophthalmic and maxillary 
nerves which are the first 2 terminal branches of the trigeminal nerve. The 
ophthalmic nerve through its three terminal branches (frontal, nasal and 
lacrimal nerve) innervates the skin of the frontal region, upper lid, interciliar 
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region, the root of the nose, the lacrimal gland and it also contains 
postganglionic fibres for pupil dilatation. The sensory innervation of the 
lacrimal gland is provided by the lacrimal nerve but the secretory innervation 
(parasympathetic) is provided by an anastomotic branch of the zygomatic 
nerve, which is a branch of the maxillary nerve.  The maxillary nerve has also 
three terminal branches (infraorbital, zygomatic and sphenopalatine nerve). 
From these only the first two have an intraorbital trajectory. These provide 
sensory innervation to the lower lid, superior lip, nose, lacrimal drainage 
system, skin of the zygomatic region and secretory innervation (as mentioned 
above) to the lacrimal gland. The ciliary ganglion constitutes a neural ganglion 
of parasympathetic importance and it is located at the lateral side of the optic 
nerve. It receives afferent branches from the long or sensory nerve (sensory 
branches for the eyeball and sympathetic fibres for iris dilatation), short or 
motor branch (ciliary muscle and pupillary sphincter muscle) and sympathetic 
branch (vasomotor function). The efferent branches are represented by the 
short ciliary nerves, which are variable in number and run along the optic 
nerve until reaching the dorsal extremity of the eyeball. 
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Figure 10. The nerves of the orbit (also see Table 2.). (Rootman J 
Diseases of the Orbit 1988) 
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Table 2. The nerves of the orbit. (Rootman J Diseases of the Orbit 1988) 
 
 
 
1.2. Classification of orbital disease 
 
The orbital diseases account for approximately 1% of all ophthalmic diseases. 
Five types of processes can occur in the orbit: inflammation, including 
endocrine orbitopathy and other inflammations, neoplasia, structural 
abnormality, vascular lesions and degenerative conditions. The 
frequency of each process is different in different age groups. In the first two 
decades of life neoplasia and structural lesions are the most common 
pathology (Rootmann 2002, Deconcilis 1996). The adult middle life is 
dominated by the endocrine orbitopathy which is responsible for 42% of all 
pathology in the age group of 17 to 64 years  (Rootman 2002). In the late 
adult life thyroid orbitopathy is still the most common process accounting for 
39,3% and neoplasia is the second accounting for 31,4% of the pathology in 
the age group of >64 years  (Rootman 2002), while according to other authors 
Sensory nerves 
1. Trigeminal (Gasserian) ganglion 
2. Ophthalmic (first) division 
3. Maxillary (second) division 
4. Mandibular (third) division 
5. Meningeal branch 
6. Frontal 
7. Supraorbital 
8. Supratrochlear 
9. Nasociliary 
10. Sensory (long) posterior ciliary 
11. Posterior ethmoidal 
12. Anterior ethmoidal 
13. Infratrochlear 
14. External nasal 
15. Lacrimal 
16. Zygomaticotemporal 
17. Zygomaticofacial 
18. Anastomosis with lacrimal 
19. Lateral palpebral 
20. Medial palpebral 
21. Pterygopalatine ganglion 
22. Zygomatic 
23. Infraorbital 
24. Superior labial branches 
25. Iferior palpebral branches 
26. Lateral nasal branch 
27. Otic ganglion 
Motor nerves 
28. Oculomotor (III) 
29. Trochlear (IV) 
30. Abducent (VI) 
31. Carotid plexus (sympathetic) 
32. Oculomotor, upper division 
33. Oculomotor, lower division 
 
Ciliary ganglion 
34. Sympathetic root from carotid plexus 
35. Ciliary ganglion 
36. Parasympathetic root to inferior division 
of oculomotor nerve 
37. Short posterior ciliary 
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(Perez Moreiras 1986) neoplasia dominates in this age group with 50 % of all 
cases, carotid cavernous fistulas are the second most common process  with 
12,1% of all cases and the thyroid orbitopathy is seen in 4,8% of patients of 
this group. De Concilis (De Concilis 1996) estimates that in this age group 
neoplasia is responsible for 38,4% of the pathology, endocrine orbitopathy 
accounts for 10,4% and vascular lesions for 5,3% of the pathology.  
The neoplastic disease can be classified on the basis of the tissue of origin as 
follows (Rootman 1988, Jacobiec, Font 1986): 
 
 Neurogenic:  
     a)  Tumors of the optic nerve: pilocytic( juvenile) astrocytoma, malignant 
optic     
           glioma ( glioblastoma) of the adulthood 
     b)  Menigioma: Optic nerve, sphenoid wing, other location. 
     c)  Tumors of the peripheral nerve sheath: Neurofibroma, Schwannoma 
     d) Other secondary and metastatic optic nerve tumors: Retinoblastoma,                                
          melanoma, leukaemia, primary neoplasia of the central nervous 
system. 
 
 Lymphoproliferative, leukaemic and histiocytoses: reactive 
lymphoid hyperplasia, atypical lymphoid hyperplasia, non-Hodgkin 
Lymphoma, plasma-cell tumors, leukaemia, Hodgkin disease, histiocytosis-X. 
 
 Vascular: capillary haemangioma, cavernous haemangioma, 
lymphangioma, hemangiopericytoma. 
 
 Mesenchymal: 
a) Osseous and cartilagous lesions: osteoma, osteosarcoma, chondroma, 
Ewing’s sarcoma, reactive tumors of bone like aneurismal bone cyst. 
b) Fibro-osteoid lesions: fibrous dysplasia 
c) Tumors of adipose tissue: lipoma, liposarcoma 
d) Tumors of muscular tissue: rhabdomyoma, rhabdomyosarcoma, 
leioma, leiomyosarcoma 
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 Lacrimal: pleomorphic adenoma, adenoid-cystical carcinoma, 
adenocarcinoma 
 
 Metastatic: carcinomas (breast, prostate, gastrointestinal, lung, 
others), sarcomas 
 
 Secondary tumors: From neighbouring structures like lid, 
nasopharynx, globe, conjuctiva. 
 
The structural lesions   include congenital or acquired lesions like mucocele, 
microphthalmos with cyst, orbital cephalocele, bony anomalies, mucocele, 
orbital trauma. 
 
The inflammatory disease includes:  
 
 Infectious inflammation 
 
 Non/specific Inflammation:  
a) Acute and subacute idiopathic inflammation 
b) Sclerosing inflammation 
c) Granulomatous inflammation 
 
 Specific inflammation: sarcoidose, vasculitis in connective tissue 
disorders like SLE, Wegener’s granulomatosis, orbital vasculitis, Cogan’s 
syndrome, Sjögren’s syndrome. 
 
The vascular pathology except for the vascular tumors which belong to the 
neoplastic category includes   arteriovenous shunts like arteriovenous 
malformations and carotid-sinous cavernous fistulas and venous anomalies 
like orbital varix.  
 
 
 23 
1.3. Pathophysiological and anatomical patterns of orbital 
disease  
 
Apart from endocrine orbitopathy the symptomatic of orbital disease is not 
specific. From the clinical point of view the effect of orbital disease is 
influenced by the primary nature of the process (pathophysiology) and the 
anatomic pattern of involvement. 
A pathopysiological categorization, which is very helpful in the clinical praxis, 
was proposed by Guthoff (1999): 
 
 Expansive lesions: they are well circumscribed and produce mainly a 
mass effect in the form of axial exophthalmos, globe displacement or both, 
with or without signs of involvement of sensory and oculomotor structures. A 
typical example of this category is the cavernous haemangioma of the orbit. 
This type of lesions can be surgically excised and a total healing can be 
achieved. 
 
 Infiltrative lesions: they cause destruction, entrapement or both, 
resulting in disturbance of ocular movement or neurosensory dysfunction 
(diplopia, optic neuropathy, pain, parasthesia). These lesions cannot be totally 
removed by surgery. The therapeutical procedure includes biopsy and (where 
applicable) surgical debulking. After the establishment of the definite 
diagnosis the therapeutical alternatives are generally planned on a 
multidisciplinary basis. The differential diagnosis includes cellulitis, non-
specific or specific inflammation, neoplasia such as lymphoma or metastasis. 
 
 Vascular lesions: an underlying vascular pathology is responsible for 
orbital manifestations. To this category belong arteriovenous fistulas, orbital 
varices, thrombosis of the ophthalmic superior vein and/or cavernous sinus 
involvement. 
 
 Myopathic: The involvement of the orbital muscles is the dominant 
feature. The main symptom is painful or painless ocular motility disorders with 
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diplopia. The differential diagnosis includes endocrine orbitopathy, idiopathic 
non-specific myositis, metastasis, arteriovenous fistulas, and neoplasia.  
 
The anatomic pattern of involvement is the second major factor affecting the 
clinical presentation of the disease. Rootman (1988) and Moreiras (2003) 
proposed the following categorization on the basis of the anatomical location 
of orbital lesions: 
 
 Anterior: the process is situated in the anterior orbit adjacent to and 
affecting the globe. Typical symptoms are proptosis, lid swelling, lid injection, 
injection of conjuctiva, possible retinal venous dilatation or uveitis. 
 
 Diffuse: It is similar to anterior but more severe. It is more frequently 
associated with optic neuropathy or motor and sensory deficits. The process 
occupies the preseptal, extraconal and intraconal spaces.  
 
 Apical: It causes less proptosis but is associated with early optic 
neuropathy or motor and sensory symptoms. In the superior orbital fissure 
vascular congestion can be caused by obstruction of the ophthalmic veins. 
The typical symptoms include pain, limitation of movement and visual deficits 
named as orbital apex syndrome.  
 
 Lacrimal: Typical symptoms are localized pain, injection of the 
temporal lid and fornix, palpable lacrimal gland, S-shaped lid deformity, 
conjuctival injection.  
 
 Intraconal: These lesions produce axial displacement, optic 
neuropathy, oculomotor disorders. 
 
 Optic nerve: The symptoms depend on whether or not the lesion is 
intrinsic to the nerve or affects the nerve sheath.  
 
 Periorbital: Diseases originating from the sinuses, face and 
intracranial cavity may extend into and affect the orbit. 
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 The categorization on the basis of the anatomical pattern was originally 
proposed for inflammatory disease. However it can be useful for the 
evaluation of non-inflammatory orbital lesions, as well.  
 
1.4. Examination 
 
1.4.1 Clinical examination of the orbital patient 
 
The clinical examination of the orbital patient includes the recording of 
following parameters: 
 
1. Visual acuity/Refraction 
2. Pupil reactions/Relative afferent papillary deficit 
3. Analysis of the ocular motility and exact recording of ductions 
4. Cover tests & Maddox rod testing in the presence of manifest 
deviations 
5. Visual field 
6. Color vision 
7. Orbital palpation  
8. Measuring of the lid fissure width and function of the levator 
9. Corneal sensibility 
10. Exophthalmometry/Recording of vertical or horizontal displacement 
11. Tonometry 
12. Biomicroscopy/ Fundus examination 
 
The evaluation of these clinical parameters additionally to a careful medical 
history helps the clinician proceed to the management of the patient. The 
application of modern diagnostic imaging methods (CT/MRI) can further 
contribute to the elucidation of distinct questions arising from the clinical 
examination.  
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1.4.2. Orbital imaging techniques 
 
1.4.2.1. Ultrasonography  
 
Computer tomography and magnetic resonance imaging have gained a 
privileged place in orbital exploration over the past years relegating the orbital 
sonography in a second place. The B-mode-sonography is most commonly 
used in the clinical praxis and an examination performed by a trained 
specialist can provide useful information regarding the pathological process 
(Guthoff 1991, Moreiras 2004, Dibernardo 2006), including: 
 
1. Topographical anatomy:  distinction between intraconal and 
extraconal lesions, relationship to adjacent tissues such as globe, optic nerve, 
lacrimal gland, muscles. 
2. Pathophysiology: expansive, infiltrative, myogenic and vascular 
lesions 
3. Internal structure: homogenous-heterogenous, hyporeflectivity- 
hyperferlectivity, cystic-solid pathology. 
 
A synopsis of the sonographic characteristics of orbital lesions is shown in the 
following table. 
 
Table 3. Sonographic characteristics of orbital lesions (Moreiras JVP, 
Prada MC Orbit: Examination, Diagnosis, Microsurgery, Pathology 2004, 
modified). 
Well-defined, regular lesion 
Homogenous Heterogenous 
Medium-low 
reflectivity 
Low reflectivity 
Medium-high 
reflectivity 
Medium 
reflectivity 
Lymphoma 
(lympoid lesions) 
Schwannoma 
Glioma (optic 
nerve) 
Hemorrhage 
Subperiosteal 
cyst 
Varix (Valsava’s 
maneuver) 
Cavernous 
hemangioma 
(intraconal, orbital 
floor) 
Hemangiopericytoma 
Lacrimal gland 
mixed tumor 
Dermoid cyst 
(high lipid 
content) 
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Meningioma 
(optic nerve) 
Metastasis 
Myositis (non-
specific 
inflammation) 
Mucocele 
Dermoid cyst 
 
Abscess 
(cellulitis) 
Cavernous 
lymphangioma 
Lacrimal gland 
adenoma 
Dermoid cyst 
Cholesterol 
grannuloma 
  
Ill-defined, irregular lesion 
Homogenous Heterogenous 
Infiltrating tumors 
(rhabdomyosarcoma, metastases, 
diffuse pseudotumor) 
Sclerosing non-specific inflammation 
Diffuse capillary hemangioma 
Cellulitis (increased volume) 
Carcinoma 
 
 
1.4.2.2. Computed tomography (CT) 
 
This examination has become an extremely useful diagnostic tool offering a 
wide range of information regarding the anatomy and pathophysiology of the 
orbital lesions. The main advantage of this method (in comparison to the MRI) 
is that it can be used for the evaluation of the bony pathology and it has a very 
good resolution for lesions affecting or arising from bone. It is also helpful for 
the evaluation of tumor limits and extension before surgery. The morphology 
of the orbital structures tissues depends on the plane of the section. A 
complete study requires two orthogonal incidences: axial and coronal. The 
axial view is superior for demonstrating the lateral and medial bony margins, 
the superior orbital fissure and the optic canal. Coronal views are best for 
assessing the floor and roof. The lacrimal sac and nasolacrimal duct as well 
as the inferior orbital fissure and infraorbital canal are equally well seen on 
axial and coronal images. The majority of cases are studied using a plane of 
section including lens, optic nerve and optic canal. If this plane is correctly 
attained, the orbits will appear symmetrical, and structures, such as medial 
and lateral rectus muscles, optic canal and bony walls will also be visualized.  
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1.4.2.3. Magnetic Resonance Imaging (MRI) 
 
Magnetic resonance imaging (MRI) is a technique that provides high 
resolution images of orbital disorders. Although CT scan is more useful for 
evaluation of bone structures, MRI is superior to CT in a number of other 
cases (Atlas Scott 1988), such as:  
 Lesions of the orbital apex, sphenoidal  fissure, optic canal. 
 Differentiation between optic nerve and periorbital lesions. 
 Differentiation between inflammatory pseudotumor and other malignant 
neoplastic processes with similar clinical presentation. 
 Detection of neoplastic lesions with hemorrhagic foci or other 
paramagnetic materials (melanin). 
 Evaluation of posterior extension in optic gliomas. 
 Detection of anomalous flow in vascular structures. 
Every patient must be carefully studied and prepared for this examination. 
The examination is absolutely contraindicated in the presence of magnetic 
foreign bodies in the orbit or periorbital soft tissues, in patients with 
pacemakers and magnetic vascular clips or other magnetic prostheses. 
Proton density, T1- and T2-relaxation times are characteristic and different for 
each tissue. Rapid sequences, such as “turbo spin-echo” or “fast spin-echo”, 
although similar to conventional techniques, have remarkably reduced the 
examination time and improved the image quality by reducing movement 
artifacts. T1- weighed spin-echo sequences are useful for estimation of the 
volume and extension of lesions, whereas T2-weighed turbo spin-echo 
sequences obtain a better lesion characterization by signal intensity. Fat 
suppression techniques, also called STIR and FAT SAT, increase the ability 
to visualize lesions with similar behavior to fat. The use of paramagnetic 
contrast injection of gadolinium-dimeglumine-gadopentate (DTPA) in T1-
weighed sequences with fat suppression can be very useful in distinguishing 
neoplastic tissues capturing contrast, which may be otherwise confused with 
fat. Some authors (Link TM et al 1995) suggest that the fat-suppression 
technique is superior to the conventional technique in respect to the 
visualisation of extraocular muscles and the optic nerve. Moreover 
pathological conditions of the orbit (optic glioma and neuritis, spread of local 
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tumors to the orbit) were better visualised using the fat suppression 
technique. The appearance of orbital tissues in different MRI sequences is 
shown on the following table.     
 
Table 4. Appearance of orbital tissues in MRI sequences (Moreiras JVP, 
Prada MC Orbit: Examination, Diagnosis, Microsurgery, Pathology 2004). 
 
Sequences T1 Proton 
density 
T2 
Cortical bone 
Retroorbital fat 
Extraocular muscles 
Vitreous 
Anterior chamber 
Lens 
No signal 
Hypersignal 
Isosignal 
Hyposignal 
Hyposignal 
Hypersignal 
No signal 
Hypersignal 
Isosignal 
Hypersignal 
Hypersignal 
Hypersignal 
No signal 
Hypersignal 
Isosignal 
Hypersignal 
Hypersignal 
Hyposignal 
 
 
1.5. Orbital surgery 
 
The development of modern imaging techniques has allowed for a more 
targeted and less invasive surgical approach, which has reduced 
postoperative complications. Dependent on the nature and the anatomic and 
pathophysiological patterns of the lesion following surgical procedures can be 
performed: 
1. Incisional biopsy for infiltrative disease to establish a histological diagnosis. 
2. Total excision of an expansive/ well circumscribed lesion. 
3. Exenteration, when malignant disease processes originate within the orbit 
and threaten to extend beyond it.  
 
The routes used in orbitotomy are: 
 Anterior: It can be carried out through an anterior incision in skin or 
conjuctiva. There is no opening of the periosteum or bony structures of the 
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orbit. This approach is used for incisional biopsy or removal of well defined 
anteriorly located or even some deeper intraconal lesions.  
 Lateral: The removal of the lateral wall allows for a clear access to the 
orbital contents. The amount of bony excision can be customised to include 
more of the superolateral rim and if necessary even the zygomatic arch, 
depending on the size and location of the lesion. Most retrobulbar or 
parabulbar lesions can be handled by an anterior or lateral orbitotomy alone 
ore in combination. 
 Superior: This approach is conducted either by a transfrontal or by 
temporofrontal (panoramic) incision. The cooperation of ophthalmologists and 
neurosurgeons is needed. This approach is conducted in case of compound 
trauma of the orbit or intracranial cavity, as well as for decompression of the 
optic canal or removal of apical or combined apical and intracranial lesions. 
 Medial: This approach facilitates the intraoperative palpation of the 
lesion, which was of high significance before the development of modern 
orbital imaging techniques. Due to the possible development of convergent 
strabismus resulting from manipulation of the medial rectus muscle, this 
approach is nowadays rarely used.   
 
All of the approaches mentioned above can be used in combinations or with 
variations in order to gain access to any of the surgical spaces of the orbit.  
The total removal of the orbital contents (exenteration) is indicated when 
malignant procedures originate within the orbit and have reached the bone or 
threaten to extend beyond it. The operation includes removal of the orbit and 
periorbital contents. The exenteration can be either total or subtotal when the 
lids are not included. Depending on the process soft tissue can be left in the 
orbital apex, which serves as starting point of the granulomatous procedure. 
The cosmetic result is usually satisfactory and a flat cavity forms, which can 
be covered with a bone-anchored epithesis.   
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2. Material and methods 
 
2.1. Patients 
This retrospective study includes 132 cases of patients with orbital disease 
who were treated from the year 1993 to the year 2008 in the University Clinic 
of Ophthalmology Rostock. All individuals were inpatients. The vast majority 
of the patients came from northern Germany and was referred to our clinic 
from private ophthalmology practices. A minority of patients were referred to 
our clinic from other German ophthalmology clinics. 
 
2.2. Exclusion criteria 
Patients with endocrine orbitopathy were excluded from this study. Also 
patients with orbital cellulitis were excluded. These patients are treated in-
patiently or operated in the University Clinic of Otolaryngology Rostock and 
are examined by ophthalmology consultants only on an outpatient basis. 
There were no exclusion criteria regarding age, race, sex or presence of 
systemic disease. 
 
2.3. Data 
The data of this study was obtained from patient’s archives of the University 
Clinic of Ophthalmology Rostock. Postoperative follow-up examinations have 
taken place mainly in the University Clinic of Ophthalmology Rostock. The 
rest of the patients were examined postoperatively by ophthalmologists in 
private practices. Information about the postoperative course for these 
patients was collected by questionnaires which were sent to and filled out by 
private ophthalmologists. 
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Aim 
 
Purpose of this study is to propose a practical pathophysiological and 
anatomical categorization of orbital disease, excluding endocrine orbitopathy, 
on the basis of clinical manifestations and characteristics in orbital imaging 
techniques, and to discuss treatment options. This sort of categorization could 
serve as a guideline in the management of orbital patients for clinical 
ophthalmologists. 
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3. Results 
 
3.1. Epidemiologic characteristics 
 
3.1.1. Distribution of lesions by age and histological correlations 
 
The patients were distributed to the following age groups: 0-20 years (10 
patients, 8%), 20-60 years (70 patients, 53%) , > 60 years (52 patients, 39%).  
0-20
8%
20-60
53%
>60
39%
0-20
20-60
>60
 
Figure 11. Distribution by age. 
 
Out of the 132 patients, 98 (74,2%) had benign disease and 34 (25,8%) had 
malignant disease. Histologically our series comprised 48 (36%) cases of 
inflammatory disease, 59 (45%) cases of neoplastic disease, 19 (14 %) cases 
of vascular pathology (tumors excluded) and 6 (5%) cases of structural and 
degenerative lesions. The inflammatory disease included 44 cases of non-
specific inflammation and 4 cases of specific inflammation (2 sarcoidose, 2 
Wegener granulomatosis). 
In the age group of 0-20 years 8 patients (80%) had inflammatory disease, 1 
patient (10%) had neoplasia and 1 patient (10%) had a structural lesion. In the 
age group of 20-60 years 28 patients (39%) had inflammatory disease, 27 
patients (39%) had neoplasia, 11 patients (16%) had vascular disease and 4 
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patients (6%) had a structural lesion. In the age group of > 60 years 12 
patients (23%) had inflammatory disease, 31 patients (60%) had neoplasia, 8 
patients (15%) had vascular disease and 1 patient (2%) had structural lesion.  
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6%
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60%
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Neoplasia
Vascular disease
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All age groups
36%
45%
14%
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Figure 12. Distribution by histological group and age group. 
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3.1.2. Distribution of lesions by pathophysiological mechanism 
 
We observed 43 expansive, 60 infiltrative, 10 myopathic and 19 vascular 
lesions (vascular tumors excluded).  
 
45%
8%
14%
33%
expansive
infiltrative
myopathic
vascular
 
Figure 13. Distribution by pathophysiological mechanism. 
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3.1.3. Distribution of lesions by anatomical pattern 
 
The anatomical pattern of involvement for the expansive and infiltrative 
lesions (103 patients) was the following: 32 (31%) intraconal, 32 (31%) 
lacrimal, 27 (26%) anterior, 7 (7%) diffuse, 3 (3%) periorbital and 2 (2 %) 
apical.  
 
31%
31%
26%
7%
3%
2%
intraconal lacrimal anterior diffuse periorbital apical   
Figure 14. Anatomic site of involvement for expansive and infiltrative 
lesions. 
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3.1.4. Histology of neoplastic lesions 
 
The neoplastic category included 25 (42%) benign and 34 malignant tumors 
(58%). The benign tumors comprised: 
 16 vascular tumors: 14 cavernous haemangiomas, 1 lymphangioma 
and 1 angiomyoma. 
 6 lacrimal tumors: all of them were pleomorphic adenomas. 
 3 neurogenic tumors: 2 neurinomas, and 1 neurofibroma. 
The malignant tumors comprised: 
 22 tumors of haemopoietic system: 18 lymphomas, 2 cases of 
Langerhans-cell Histiocytosis (LCH), 1 chloroma, 1 case of Erdheim-Chester-
Disease (ECD) 
 3 lacrimal tumors: all of them were adenoid cystic carcinomas. 
 5 mesenchymal tumors: 2 liposarcomas, 1 malignant fibrous 
histiocytoma, 1 malignant fibrous solitary tumor, 1 rhabdomyosarcoma. 
 3 metastatic tumors: 1 neuroendocrine tumor, 1 prostate 
adenocarcinoma, 1 mammal carcinoma. 
 1 case of basosquamous carcinoma of the canaliculi.   
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Figure 15. Malignant tumors by origin. 
 
 
 38 
3.1.5. Histology of lacrimal gland lesions 
 
The lacrimal gland along with the intraconal space was found to be the most 
common anatomical site of disease. We examined 32 patients with lacrimal 
gland disease. 20 of these cases were non-specific inflammations (NSI), 10 
cases were neoplastic (6 benign and 4 malignant) and 2 cases were 
sarcoidose with bilateral involvement of the lacrimal gland.  
 
63%9%
19%
3% 6%
NSI
carcinoma
pleomorphic adenoma
lymphoma
sarcoidosis
 
Figure 16. Distribution of lacrimal lesions by histology. 
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3.2. Clinical presentation and treatment of disease on the 
basis of histology and pathophysiology 
 
The major symptoms and the therapeutical procedures are presented 
seperately for inflammatory, neoplastic, vascular (tumors excluded) and 
structural/ degenerative lesions.  
 
3.2.1 Inflammatory disease 
 
Our series included 48 patients with inflammatory disease. 44 of these 
patients had non-specific orbital inflammation (orbital pseudotumor) and 4 
patients had a specific inflammatory infiltrate (2 with sarcoidose and 2 with 
Wegener granulomatosis). In all of these patients the anatomic pattern of 
involvement was studied by means of orbital CT or MRI scans and the 
diagnosis was confirmed by biopsy of the lesion.  
As to the group of non-specific inflammation the following anatomical patterns 
were observed: 
 
 Anterior (7 patients): lesion situated in the anterior 1/3 of the orbit, 
parabulbar or retrobulbar, with or without involvement of the eyelids and the 
anterior portion of the external muscles. 
 Intraconal (5 patients): lesion situated within the muscle cone. 
 Diffuse (1 patient): lesion extending from the extraconal space to the 
intraconal space and from the anterior to the posterior orbit. 
 Apical (2 patients): lesion situated in the orbital apex.  
 Lacrimal (20 patients): the inflammatory process affects primarily the 
lacrimal gland and can extend to the surrounding extraconal space, periorbital 
skin with or without involvement of the lateral rectus muscle or the superior 
rectus muscle. 
 Myositis (9 patients): the inflammatory process affects primarily one 
external muscle. 
 
 40 
8 patients were 0-20 years of age, 25 patients were 20-40 years of age and 
11 patients were older than 60 years of age. 
 
16%
11%
2%
5%
46%
20%
anterior
intraconal
diffuse
apical
lacrimal
myositis
 
Figure 17. Anatomical site of involvement in non-specific inflammation. 
 
Anterior: All the patients with anterior inflammation had lid swelling and 
moderate to severe lid injection. In one patient exophthalmos (8 mm 
difference in Hertel exophthalmometry) was the main symptom as the 
inflammatory process was situated in the anterior 1/3 of the orbit directly 
retrobulbar with additional involvement of the lacrimal gland and the anterior 
portion of the rectus superior and rectus lateral muscle. The other patients 
had no or minimal exophthalmos (up to 3 mm difference in Hertel 
exophthalmometry). The ocular motility was normal in 3 patients, 4 patients 
had restriction in ocular motility in at least one direction of gaze. No patient 
had an optic nerve compression.  
Orbital biopsy was performed in all of the patients. Histologically 4 patients 
had a florid inflammatory infiltrate (inflammatory pseudotumor) and 3 patients 
had a chronic inflammatory infiltrate with less cellular component and variable 
degree of fibrosis. 5 patients were treated with systemic prednisolon (3 with 
inflammatory pseudotumor) and a complete remission was observed in 4 of 
them. In one patient with florid inflammation and exophthalmos of 8 mm the 
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systemic prednisolon resulted in a complete regression of lid injection and lid 
swelling but the exophthalmos was persistent 2 years after initial diagnosis. A 
deficit in down gaze was also present with subsequent diplopia in the same 
patient but no further treatment occurred, as the patient was not severely 
disturbed in daily life. In one patient corticosteroids were contraindicated and 
this patient was treated with systemic ibuprofen with complete regression. In 
one female patient after histological exclusion of malignity no further treatment 
occurred and the clinical course is unknown to us.  
Intraconal: In the group with intraconal involvement exophthalmos was the 
main symptom in all of the 5 patients. All patients had restriction in ocular 
motility in at least one direction of gaze with subsequent diplopia. No patient 
had clinically or radiographically compression of the optic nerve. Biopsy of the 
lesion was performed in each patient. 3 patients had histologically no or 
minimal amount of fibrosis and were initially treated with systemic 
prednisolon. In one patient even if a clinical improvement was observed the 
therapy was stopped due to side effects. The other two patients had no 
clinical improvement and subsequently each of these three patients 
underwent orbital radiotherapy with complete regression of the inflammatory 
process. However, one patient had persistent diplopia in abduction, which 
nevertheless was not disturbing in daily life. 2 patients had a chronic 
inflammatory infiltrate with severe amount of fibrosis (sclerosing 
pseudotumor). In one of them prednisolon and methotrexate had been 
systemically administered ex domo without any success. At the time of first 
examination in our clinic this patient had an exophthalmos (5 mm difference in 
Hertel exophthalmometry) and restriction of abduction with subsequent 
diplopia. The inflammatory process was in the intraconal space with extension 
in the ethmoid cells and infiltration of the medial rectus muscle. Medial 
orbitotomy with evacuation of the ethmoid cells was performed and 3 months 
postoperatively this patient had no exophthalmos, but only a minimal 
restriction in adduction without diplopia was observed. The second patient 
received no therapy after initial diagnosis because of mild exophthalmos and 
minimal restriction in ocular motility; one year after surgery no progression 
was observed. 
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Diffuse: 1 patient presented with bilateral exophthalmos. The patient had no 
diplopia, but ocular motility was restricted in all directions of gaze on both 
eyes. Visual acuity was normal and there were no signs of optic nerve 
compression.  As previous steroid therapy had been without any success, we 
performed bilateral lateral orbital decompression with surgical dekulking. We 
achieved reduction of exophthalmos (7 mm on the right side and 8 mm on the 
left side), but postoperative diplopia occurred and strabismus surgery 
followed.   
Apical: Two patients in our series had an apical involvement. One of them 
reported severe decrease in visual acuity; on first presentation he was only 
able to perceive hand movements. This patient had mild exophthalmos (3 mm 
difference in Hertel exophthalmometry) with paresis of the III and VI cranial 
nerves. In MRI scan optic nerve compression in the apex was observed. 
Despite immediate orbital decompression no improvement of visual acuity 
was achieved and no further therapy occurred. Histologically, a sclerosing 
orbital inflammation was observed. The second patient had restriction of 
ocular motility without any exophthalmos or optic compression. After 
treatment with systemic prednisolon complete regression was observed, 
ocular motility returned to normal and no diplopia was present any more. 
Lacrimal: The lacrimal gland was the most common site of involvement in our 
series. All of the 20 patients underwent an orbital biopsy. Histologically, non-
specific inflammatory infiltrates (lymphocytes, plasmocytes, granulocytes, 
epitheloid cells) with variable amount of fibrosis were observed. 7 patients had 
severe fibrosis in terms of a sclerosing inflammation. Clinically lid swelling 
with variable amount of lid injection was present in 18 patients, 5 patients had 
indolent palpable mass, 4 patients had ptosis, 4 patients had restriction in up 
gaze with subsequent diplopia and 10 patients had exophthalmos.   
5 patients had a well circumscribed process (3 out of them with sclerosing 
inflammation). All lesions were treated as expansive with en-block resection of 
the lacrimal gland region. In three of these patients no further treatment was 
necessary as they were free of symptoms after surgery. One patient had 
persistent diplopia in abduction and strabismus surgery was subsequently 
performed. In one patient the clinical course is not known.  
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Among the remaining 15 patients there were 4 patients with sclerosing 
inflammation. 8 patients out of them (3 with sclerosing inflammation) were 
treated with systemic prednisolon. In 5 patients, all of them without sclerosing 
inflammation, complete or partial clinical improvement was observed. 1 of the 
patients with sclerosing inflammation had only partial improvement and 1 
patient had no improvement. Orbital radiotherapy was recommended to this 
patient; the further clinical course is not known to us. The other patient with 
sclerosing inflammation had initially a very good response to therapy, but 
reported severe loss of visual acuity 1 month after initial regression of 
disease. The visual acuity was hand movement perception; the patient had 
mild exophthalmos with restriction in ocular motility. In MRI-scan an 
inflammatory process located in the apex and causing optic nerve 
compression, was shown. Despite immediate endonasal and lateral 
decompression the visual acuity failed to improve. The clinical course in the 
remaining 7 patients is not known. 
Myositis: All the patients with myositis had acute painful restriction in ocular 
motility. 6 out of them had lid swelling. The rectus superior muscle was the 
muscle most frequently involved. Diagnosis was established by clinical 
examination and sonography, which showed enlargement of muscle with 
involvement of the tendon. The inflammation responded rapidly to 
corticosteroid treatment. 3 patients (33%) had a recurrence of the myositis, 
which also responded to corticosteroids.  
The group with specific inflammation included 2 patients who presented with a 
dacryoadenitis due to sarcoidose. The first patient was female, 40 years of 
age and presented with a unilateral palpable mass of the temporal upper lid. 
Visual acuity and ocular motility were normal. In CT scans an enlarged 
lacrimal gland was seen. Biopsy and further diagnostic evaluation through the 
internists confirmed the diagnosis of sarcoidose without any lung involvement. 
Under steroid therapy there was a complete regression of ocular symptoms. 
The second patient was female, 50 years of age and presented with a 
bilateral lid swelling with normal visual acuity and ocular motility. This patient 
had a known systemic sarcoidose. In CT scans bilateral enlargement of the 
lacrimal gland was seen. Therapy with corticosteroids was recommended. 
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2 of our patients had Wegener granulomatosis of the orbit. The first patient 
was female, 74 years of age and presented with subacute exophthalmos (8 
mm difference in Hertel exophthalmometry) and motility restriction in all 
directions of gaze. Visual acuity was 40/100 on both eyes due to cataract 
formation. In MRI scans we saw an infiltrative process with an intraconal and 
an extraconal component. The lesion was in contact with the medial orbital 
wall and caused downward and lateral globe displacement. The lesion had an 
intense gadolinium uptake. In the contralateral inflammatory infiltrates taking 
up gadolinium were seen, as well. There was a great deformity of nasal sinus 
and the paranasal sinuses; the ethmoid cells and sphenoid sinus were not 
definable from the nasal sinus. Orbital biopsy confirmed the diagnosis of 
orbital Wegener granulomatosis. The disease was limited to the orbit and 
paranasal sinuses without any other systemic involvement. cANCA antibodies 
were negative. A systemic therapy with cyclophosphamide followed and a 
complete regression of the exophthalmos was achieved. 
The second patient was female, 38 years of age, and had a known systemic 
Wegener granulomatosis with kidney and lung involvement. Over the past 8 
years she had been suffering bilateral vision loss due to optic atrophy caused 
by a pituitary adenoma. The patient was referred to us due to unilateral 
subacute painful exophthalmos with lid swelling, lid and conjuctival injection.  
At first presentation the visual acuity was no light perception on both eyes. In 
funduscopy bilateral optic nerve atrophy was seen. There were restrictions in 
ocular motility on both eyes.  MRI scans showed a bilateral diffuse infiltrative 
orbital process (on the left more pronounced) with intracranial extension. 
Biopsy confirmed the diagnosis. Therapy with cyclophosphamide followed; 
however, only minimal reduction of the exophthalmos was achieved.    
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3.2.2. Neoplasia 
 
Our series included 59 cases of neoplastic disease (34 malignant, 25 benign). 
These cases were categorized according to the tissue of origin. 
 
3.2.2.1. Malignant tumors 
 
1). Neoplasia of haemopoietic system (22 cases): 18 patients with orbital 
lymphoma, 3 patients with histiocytosis (2 Langerhans cell histiocytosis, 1 
Erdheim-Chester disease) and 1 patient with a myeloblastoma (chloroma).  
 
Lymphoma 
 
3 patients (16%) had bilateral disease. 4 patients (22%) had systemic stadium 
IV disease with involvement of the bone marrow in 3 patients, the lymph 
nodes in 2 patients, tonsils in 1 patient, bones in 1 patient and of lungs in 2 
patients. In all of these patients the ocular symptoms were the first symptoms 
of the disease. In one patient the orbital lymphoma was a relapse of a 
systemic lymphoma treated with chemotherapy seven years before. 
Histologically, 12 (66,7%) were MALT-lymphomas of low malignity, 2 were 
follicular (centroblastic-centrocytic) of low malignity, 2 were 
lymphoplasmocytic immunocytomas of low malignity, 1 was chronic lymphoid 
leucaemia, and 1 was diffuse lymphoma of large B-cells (centroblastic-
immunoblastic) of high malignity. 
Out of the 18 cases of orbital lymphomas, 11 lesions were situated exclusively 
in the anterior orbit forming 61% of all observed lymphomas. 
Pathophysiologically, 2 cases presented as expansive, 1 case as myogenic, 
and 15 cases as infiltrative lesions.  
In both cases which presented as expansive, the lesions were situated in the 
anterior orbit extraconally and were well circumscribed. Both of them had lid 
swelling and a palpable orbital mass. The histological examination showed a 
low malignant orbital lymphoma of MALT-Type in both cases.  
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In the case with the myogenic pattern the superior rectus muscle was the only 
anatomical site of involvent. This patient presented with progressive ptosis as 
unique symptom. Biopsy showed a low-malignity MALT-Lymphoma. 
The remaining 15 lesions which presented as infiltrative, exhibited following 
anatomic patterns: 
 Anterior: The anterior orbit was the most common site of anatomical 
involvement (9 patients). Lid swelling was the most common symptom and 
was found in 6 patients. 4 patients had restriction of ocular motility with 
subsequent diplopia, 5 patients had moderate exophthalmos (4 monolateral 
up to 4 mm difference in Hertel exophthalmometry, one bilateral) and one 
patient had a palpable indolent orbital mass. One patient had visual acuity 
deterioration with choroidal folds in funduscopy.  
 Diffuse: All 4 patients had slow progressive moderate to severe 
exophthalmos (5 to 11 mm difference in Hertel exophthalmometry) with 
restriction in ocular motility and diplopia. No patient had bone destruction in 
orbital imaging. One patient had visual acuity deterioration because of optic 
nerve compression and one patient had a palpable indolent orbital mass. 
 Intraconal: 2 patients with intraconal lymphoma were treated. Both of 
them had exophthalmos (11 mm and 7 mm difference in Hertel 
exophthalmometry) and motility restriction in more than one direction of gaze 
with diplopia. No patient had lid swelling. One patient had visual acuity 
deterioration due to optic nerve compression. 
 Lacrimal: One patient with lymphoma had exclusively a bilateral 
infiltration of the lacrimal gland with lid swelling. A diagnosis of dacryoadenitis 
had been made ex domo and the patient had been treated with systemic 
corticosteroids without any success. Orbital biopsy established the diagnosis 
of a bilateral low malignity MALT-lymphoma.  
 
The patients were treated as follows: 
  
9 patients were initially treated exclusively with orbital radiotherapy (3 patients 
with bilateral lymphoma/ bilateral dose 36 Gy and 6 patients with unilateral 
lymphoma/ dose 40 Gy). 7 patients had a low malignity MALT-Lymphoma, 
one of them bilateral, 1 patient had a bilateral low malignity 
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lymphoplasmocytic immunocytoma and 1 patient had a bilateral relapse of a 
low malignity systemic follicular (centroblastic-centrocytic) lymphoma treated 
with chemotherapy 7 years before. 8 of them had localized disease; one 
patient with a low malignity MALT-lymphoma had an involvement of bone 
marrow and lungs, as well. 1 to 2 years after initial treatment, 7 patients were 
completely free of disease clinically and in orbital MRI scans. However, 
occlusive radiation retinopathy with cystoid macular oedema developed in one 
patient. Final visual acuity was 1/15 despite panretinal laser coagulation and 
intravitreal injection of triamcinolon. The patient with the bilateral relapse of 
the centroblastic-centrocytic lymphoma had a distinct decrease of tumor mass 
in orbital MRI scans; tumor rest was however present 6 months after initial 
treatment. The further clinical course in this patient is not known. In one 
patient with a unilateral MALT-lymphoma an increase in tumor mass was 
diagnosed 3 months after radiotherapy. This patient was therefore additionally 
treated with chemotherapeutical schema in an oncology centre (CHOP/ 
Rituximab/ Bendamustin/ Interferon) and was completely free of disease 
clinically and in orbital MRI scans 2 years after chemotherapy. 
One patient with a low malignity MALT-lymphoma stadium IV and involvement 
of bone marrow, lymph nodes and tonsils, was initially treated with a 
combination of orbital radiotherapy with a dose of 36 Gy and chemotherapy 
schema in an oncology centre (MCP/Interferon). This patient was clinically 
free of orbital disease one year after treatment, but the systemic clinical status 
is not known to us. 
One patient with a high malignity centroblastic- immunoblastic lymphoma 
stadium IV and bone marrow involvement was exclusively treated with a 
chemotherapy schema (Prednisolon/Vincristin) in an oncology centre. This 
patient was clinically free of orbital disease 1 year after treatment; the further 
clinical course is not known. 
Two patients with well-circumscribed tumor without systemic involvement 
were initially treated with surgical tumor excision alone. Both of them had a 
low malignity MALT-lymphoma. In one of them a recurrence of the lymphoma 
was observed 2 years after surgery. An orbital radiotherapy with a dose of 36 
Gy was subsequently performed and the patient was free of disease clinically 
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and in MRI scans 2 years after treatment. The clinical course of the second 
patient is not known to us.  
One patient with a MALT-lymphoma with involvement of lymph nodes, bones 
and lungs, died 4 months after diagnosis before completion of the planned 
treatment.  
In the rest of the patients the treatment and clinical course are not known to 
us.  
 
The following table summarizes the therapeutical steps chosen for each of our 
patients with lymphoma.  
 
Table 5. Therapeutical strategy in patients with lymphoma. 
 
Patient Histology Systemic involvement 
Initial 
treatment Clinical course 
1 
Lympho-
plasmocytic- 
immuncytoma 
(bilateral) 
no 
radiotherapy  
36 Gy 
(bilateral) 
in 1 year complete 
regression (clinical, 
MRI) 
2 MALT no radiotherapy  40 Gy 
in one year complete 
regression (clinical, 
MRI) 
3 MALT no radiotherapy  40 Gy 
in two years complete 
regression (clinical, 
MRI) 
4 
MALT  
(bilateral, 
lacrimal 
gland) 
no 
radiotherapy  
36 Gy 
(bilateral) 
in one year complete 
regression (clinical, 
MRI) 
5 MALT 
bones, lungs, 
mediastinal 
lymph nodes 
Stadium IV) 
 died 4 months after diagnosis 
6  
relapse of a 
follicular 
systemic 
lymphoma 
(bilateral) 
no 
radiotherapy  
36 Gy 
(bilateral) 
distinct decrease in 
tumor mass 6 months 
after radiotherapy 
(MRI) 
7 MALT no radiotherapy 40 Gy 
in two years complete 
regression (clinical, 
MRI) 
8 MALT 
bone marrow, 
lungs 
(Stadium IV) 
radiotherapy 
40 Gy 
in two years complete 
regression (clinical, 
MRI) 
occlusive radiation 
retinopathy  
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systemic status 
unknown 
9 MALT no radiotherapy  40 Gy 
increase of tumor 3 
months after initial 
treatment. 
chemotherapy (CHOP, 
Rituximab, 
Bendamustin, INF) : in 
two years complete 
regression (clinical, 
MRI) 
10 
Diffuse 
lymphoma of 
large B-cells 
(centroblastic- 
Immuno-
blastic) 
bone marrow 
(Stadium IV) 
chemotherapy 
(Prednisolon, 
Vincristin) 
in one year clinically 
free of orbital disease,  
systemic status not 
known 
11 
chronic 
lymphoid 
leucaemia 
No Not known Not known 
12 MALT 
bone marrow, 
tonsils, lymph 
nodes 
(Stadium IV) 
radiotherapy 
36 Gy 
chemotherapy 
( MCP, INF) 
in one year clinically 
free of orbital disease, 
systemic status not 
known  
13 MALT (expansive) no 
surgical 
excision 
relapse two years after 
initial treatment 
radiotherapy 36 Gy : in 
two years complete 
regression (clinical, 
MRI) 
14 MALT no radiotherapy 40 Gy 
in one year complete 
regression (clinical, 
MRI) 
15  MALT no not known not known 
16 follicular no not known not known 
17 
Lymphoplasm
ocytic 
immuno-
cytoma 
no not known not known 
18 MALT (expansive) no 
surgical 
excision  not known 
 
 
Histiocytosis 
 
3 of our patients had a histiocytosis. All of them were male. Two of them had 
a Langerhans-cell-histiocytosis LCH). The first patient was 24 years of age 
and had unilateral painless lid swelling. The neoplastic process was situated 
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in the anterior orbit and caused bone destruction with infiltration of the 
frontobasal dura, and displacement of the rectus superior muscle and 
obliquous superior muscle without infiltrating them. The second patient was 
27 years of age and had exophthalmos caused by an expansive intraconal 
tumor situated in the great wing of the sphenoid bone. The tumor destroyed 
the bone and infiltrated the dura. Both tumors showed an intense gadolinium 
uptake in MRI-scans and had a central necrotic zone. Other bone or systemic 
involvement was excluded. The diagnosis was confirmed by orbital biopsy. 
The first patient was treated with total tumor extirpation in a neurosurgery 
clinic and was free of disease clinically and in MRI- scans one year after the 
operation. The clinical course of the second patient is not known to us.  
One patient had an Erdheim-Chester-disease (ECD). This patient was 60 
years of age and presented with bilateral exophthalmos and progressive 
visual acuity deterioration of the left eye. The MRI showed a bilateral 
intraconal tumor surrounding the optic nerve. In funduscopy bilateral choroidal 
and retinal folds were seen. Orbital biopsy established the diagnosis. Further 
examinations revealed retroperitoneal fibrosis; other systemic involvement 
was excluded. A clinical deterioration was observed despite systemic 
Interferon-α therapy and bilateral orbital decompression was performed. A 
decrease of exophthalmos and an improvement of the visual acuity of the left 
eye were achieved and the further treatment regarding other therapeutical 
options was undertaken by oncologists.  
 
 
Finally, one of our patients presented with unilateral exophthalmos caused by 
an intraconal infiltration of an acute myeloid leucaemia. The exophthalmos 
was the first sign of the disease. The patient died 5 months after diagnosis.  
 
 
2). Mesenchymal tumors (5 cases):  1 patient with malignant fibrous 
histiocytoma, 2 patients with liposarcoma, 1 patient with malignant solitary 
fibrous tumor, 1 patient with rhabdomyosarcoma. 
The first patient was male, 68 years of age and presented with a progredient 
exophthalmos. Orbital biopsy performed ex domo established the diagnosis of 
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an orbital pseudotumor. Systemic therapy with corticosteroids and 
methotrexate had not been successful. In orbital MRI a relatively well 
circumscribed intraconal tumor with high gadolinium uptake was shown. An 
orbitotomy with partial tumor excision and biopsy established the diagnosis of 
a malignant fibrous histiocytoma. Metastases were excluded. An exenteration 
and subsequent orbital radiotherapy with a dose of 60 Gy followed. Two years 
after there were no signs of tumor rest in orbital MRI. 
The second patient was female, 53 years of age and presented with lid 
swelling and a palpable mass of the medial lid of her last eye. The other eye 
had been enucleated in the childhood after a perforating injury. In funduscopy 
choroidal and retinal folds were seen. The orbital MRI showed an intraconal 
well circumscribed tumor with high gadolinium uptake causing displacement 
of the rectus inferior muscle, the rectus medial muscle, the optic nerve and 
the globe, without infiltrating them. The tumor was high vascularised in the 
angiography of the carotid internal artery. Orbitotomy with biopsy was 
performed and the initial histological diagnosis was haemangiopericytoma, 
however a giant cell angiofibroma could not be excluded.  A radical tumor 
excision was recomended by the pathologists. A second orbitotomy with 
tumor excision was performed and the final histological diagnosis was that of 
a solitary fibrous tumor with focal sarcomatous (malignant) transformation. 
Metastases were excluded. The patient was free of disease both clinically and 
in MRI scans two years after the operation. Three years after the operation 
new tumor growth with high gadolinium uptake and infiltration of the rectus 
superior muscle and levator palpebral muscle was shown in MRI. Orbitotomy 
with tumor excision was again performed and the histological examination 
showed this time a sarcomatous transformation of the whole tumor with 
infiltration of the excision margins. Radiotherapy with a dose of 60 Gy 
followed and the patient was free of tumor in MRI scans one year after. 
The third patient was male 40 years of age and presented with exophthalmos 
and lid swelling caused by a relatively well circumscribed tumor of the anterior 
orbit, as shown in MRI. The tumor showed a high gadolinium uptake, as well.  
Orbitotomy with local excision and biopsy was performed, and a well 
differentiated liposarcoma was diagnosed. Metastases were excluded. No 
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other therapy followed. The patient was free of disease both clinically and in 
MRI scans one year after surgery.  
The fourth patient was female, 26 years of age and presented with ocular 
motility restriction and diplopia. The MRI showed a tumor situated in the 
anterior orbit infiltrating the rectus superior muscle and the lacrimal gland. 
Orbitotomy with partial tumor excision and biopsy was performed and the 
initial diagnosis was that of a dermoid. Five months after the operation 
increase of lid swelling was observed and the MRI showed new tumor growth 
and infiltration of the bony orbit and intraconal extension. A new orbitotomy 
was performed and the final diagnosis was that of a liposarcoma (myxoid 
type). Metastases were excluded. Exenteration followed and the patient was 
free of disease clinically and in MRI scans seven months after the operation. 
The further clinical course is not known to us. 
The fifth patient was male, 17 years of age and presented with rapidly 
increasing exophthalmos and lid swelling. The orbital CT scan showed a 
tumor of the maxillar sinus with bone destructions and extension in the nasal 
cavity, the ethmoid cells, epipharynx, sphenoid sinus and orbit. The lymph 
nodes of the neck region were also involved. Biopsy established the diagnosis 
of an alveolar rhabdomyosarcoma. Metastases were excluded. 
Chemotherapy according to CWS-protocol and radiotherapy with a dose of 30 
Gy were administered. The initial response was very good, since no residual 
tumor was evident clinically and in MRI 7 months. However, 8 months after 
end of therapy new tumor growth was observed in the medial lid. Biopsy 
confirmed a relapse of the rhabdomyosarcoma and chemotherapy according 
to CWS-protocol was again performed. Metastases were once more 
excluded. 4 months later residual tumor was present in orbital MRI scans, 
which increased in size 1 month later. Tumor excision with partial excision of 
the medial rectus muscle and brachytherapy with a dose of 20 Gy followed. 1 
month after treatment the visual acuity was 0,8 and the patient had diplopia in 
all directions of gaze, which could not be compensated with prisms.  The 
further clinical course is not known to us. 
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Table 6. Findings, treatment and clinical course in 5 patients with 
malignant mesenchymal tumors. 
 
Patients: 
Sex, age 
Histology Symptoms Orbital imaging Initial therapy 
Clinical course – 
Last follow-up 
Male, 68 
Malignant 
fibrous 
histiocytoma 
Slowly 
progredient 
exophthalmos 
MRI: well-
circuscribed 
intraconal 
tumor, high 
gadolinium 
uptake 
Exenteration, 
radiotherapy 60 
Gy 
Free of disease 2 
years after 
treatment 
Female, 
53 
Malignant 
solitary fibrous 
tumor 
Lid swelling, 
palpable mass 
MRI: well-
circuscribed 
intraconal 
tumor, high 
gadolinium 
uptake 
Local excision 
Relapse 3 years 
after primary 
surgery – subtotal 
excision, 
radiotherapy 60 Gy, 
free of disease 1 
year after second 
treatment 
Male, 40 
Well 
differentiated 
liposarcoma 
Slowly 
progredient 
exophthalmos, 
lid swelling 
MRI: well-
circuscribed 
tumor, 
anterior orbit, 
high 
gadolinium 
uptake 
Total local 
excision 
Free of disease 1 
year after treatment 
Female, 
26 
Liposarcoma 
(myxoid type) Diplopia 
MRI: 
infiltrative 
tumor, 
anterior orbit 
Exenteration 
Free of disease 7 
months after 
treatment 
Male, 16 
Alveolar 
rhabdomyosar
coma 
Rapidly 
progressive 
exophthalmos, 
lid swelling 
MRI/CT: 
infiltrative 
mass, 
paranasal 
sinuses, orbit, 
nasal cavity, 
bone 
distruction 
Chemotherapy, 
Radiotherapy 30 
Gy 
Initial resolution, 
but later relapse – 
New chemotherapy 
course/partial 
excision/ 
brachytherapy 20 
Gy – Outcome of 
last treatment not 
known 
 
3). Lacrimal gland tumors (3 cases): All of them were adenoid cystic 
carcinomas. The patients were 47, 65 and 70 years of age, two female and 
one male. 
The first patient presented with lid swelling and ptosis without pain. There was 
a restriction of up gaze. The orbital MRI showed a tumor in the lacrimal fossa 
with intraconal extension to the apex and gadolinium uptake. Bone erosion 
could not be radiographically excluded. Metastases were excluded. Biopsy 
established the diagnosis of an adenoid cystic carcinoma and exenteration 
with subsequent radiotherapy with a dose of 63 Gy followed. The patient was 
free of disease clinically and in MRI scans 4,5 years after radiotherapy.  
The second patient presented with lid swelling and ptosis without pain. There 
was restriction in up gaze. The orbital CT showed a tumor in the lacrimal 
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fossa with calcification, bone erosion and infiltration of the rectus superior 
muscle and the Levator palpebrae muscle. Orbital biopsy showed an adenoid 
cystic carcinoma and the same treatment as in the first patient was 
performed. The clinical course is not known to us. 
The third patient presented with rapid progressive exophthalmos and visual 
acuity deterioration of the left eye. In funduscopy optic disc swelling and 
choroidal and retinal folds were seen. The orbital MRI showed an infiltrative 
intraconal and extraconal tumor with optic nerve compression and intracranial 
and miningeal extension. In CT scans the sphenoid bone and the lateral 
orbital wall were eroded. Biopsy showed an adenoid cystic carcinoma. 
Exenteration with dura excision and treatment of the infiltrated bone with the 
CO2 laser as well as radiotherapy with a dose of 62 Gy were performed. Ten 
months after initial treatment the patient presented with visual acuity 
deterioration of the right eye. The MRI showed intracranial growth, infiltration 
of the scull base, frontal sinus, ethmoid cells and chiasm. Pterional 
craniotomy with optic nerve decompression was performed without any other 
adjuvant therapy. This patient succumbed 14 months after the initial 
diagnosis.  
 
4). Orbital metastases (3 cases): The first patient had a prostate carcinoma 
which had been diagnosed 3 months before and had already been under 
chemotherapy treatment. He had no ocular symptoms, but in the bone 
scintigraphy and in orbital CT scans an osteosclerotic metastasis was 
suspected in the great wing of the sphenoid. Orbital biopsy confirmed the 
diagnosis of a metastasis. One year later the patient continued to have no 
ocular symptoms, the further clinical course is not known to us. The second 
patient had undergone radical prostatectomy 11 years and extirpation of an 
endocrine tumor of the heart 7 years before reference to us. This patient had 
no ocular symptoms. In an MRI scan performed due to chronic headaches, an 
extraconal circumscribed tumor was found in the anterior orbit with contact to 
the obliquous superior muscle without infiltrating the muscle. The tumor was 
excised and the histological examination confirmed an orbital metastasis of 
the neuroendocrine tumor. 4 months later the patient was free of symptoms. 
The third patient had had a surgical excision of a breast carcinoma 5 years 
 55 
before reference to us. The patient presented with lid swelling and diplopia 
due to ocular motility restriction. There was no exophthalmos.  The orbital MRI 
showed an intraconal infiltrative tumor with contrast medium uptake. Biopsy 
confirmed a metastasis of the breast carcinoma and the patient died of 
metastatic disease 2 years after.   
 
Our series also included one patient with a basosquamous carcinoma of the 
canaliculi. The patient was 59 years of age and presented with a palpable 
tumor of the medial lid without pain. The CT showed a subcutaneous tumor of 
the medial lid with contrast medium enhancement, without infiltration of the 
nasal cavity and paranasal sinuses. Biopsy established the diagnosis and 
resection of the tumor, canaliculi, lacrimal sack and ethmoidal region was 
performed, followed by radiotherapy with a dose of 60 Gy. Metastases were 
excluded. One year after treatment a new tumor growth was observed. New 
orbitotomy and tumor excision along with the adjacent periost took place. The 
histological examination confirmed a tumor recurrence and the excision 
margins were free of tumor. Metastases were once more excluded. The 
further clinical course is not known to us.  
 
3.2.2.2. Benign tumors 
 
1). Vascular tumors (16 cases): 14 patients with cavernous haemangioma, 1 
patient with lymphangioma and 1 patient with an angiomyoma.  
The cavernous haemangiomas were in their vast majority intraconal (13 
cases) lesions. 1 was situated extraconally in the anterior orbit. The patients 
were 29 to 78 years of age (mean age 54,5 years). 7 patients were male and 
7 patients were female. 11 patients (78%) had moderate to severe 
exophthalmos. 5 patients (36%) had  optic disc swelling and choroidal and 
retinal folds, with 3 of them having a visual acuity deterioration and 1 of them 
having localized visual field defects due to optic compression by apical tumor. 
3 patients (21%) had ocular motility constriction with subsequent diplopia. In 2 
patients the tumor was a coincidence finding in MRI scans performed for other 
reasons. In all patients orbitotomy with tumor excision was performed. In 12 
patients (86%) the tumor was completely excised and the postoperative 
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course was without any complications. In one patient with severe 
exophthalmos (14 mm difference in Hertel exophthalmometry) the tumor could 
not be completely excised due to close contact to the optic nerve. 
Exophthalmos was persistent (9 mm difference in Hertel exophthalmometry), 
but since the visual acuity remained normal, no other treatment followed. One 
patient presented with exophthalmos (11 mm difference in Hertel 
exophthalmometry), motility restriction in all directions of gaze, optic disc 
swelling and retinal and choroidal folds caused by a cavernous haemangioma 
with thromboses and phleboliths in close contact to the optic nerve, as shown 
in CT scan. The tumor was only partially excised and the patient suffered 
vision loss directly after the operation due to central retinal artery occlusion. 
The visual acuity failed to recover.  
1 patient presented with exophthalmos (7 mm difference in Hertel 
exophthalmometry) caused by an expansive intraconal tumor with contrast 
medium uptake, as shown in MRI scan. The tumor was in close contact to the 
optic nerve and only partially definable from it. We performed a partial tumor 
excision and histological examination showed an angiomyoma. The patient 
had a postoperative keratopathy with persistent corneal erosion due to 
incomplete lid closure caused by oculomotor nerve paresis. Despite twice 
performed amnion membrane transplantation, a perforating corneal ulcus 
developed. Keratoplasty followed, but transplant rejection occurred, and final 
visual acuity was as a result only light perception.  
1 22 years old patient presented with exophthalmos caused by a known 
lymphangioma which was twice operated ex domo. At first presentation the 
patient had severe exophthalmos (15 mm difference in Hertel 
exophthalmometry), visual acuity deterioration (50/100) with a relative afferent 
pupil defect and choroidal and retinal folds in funduscopy. Ocular motility was 
restricted in all directions of gaze.  In MRI scans an intraconal relatively well 
circumscribed tumor, was seen, which was homogenous and hyperintense in 
T1 and T2 weighed images and showed a moderate gadolinium uptake. The 
apex was free of tumor. The optic nerve was displaced. Lateral orbitotomy 
with partial tumor excision was performed. Histological examination showed a 
cavernous lymphangioma (mixed venous-lymphatic malformation). The visual 
acuity was postoperatively stable, but the exophthalmos persisted. The 
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patient presented 18 months later with unaltered exophthalmos (15 mm 
difference in Hertel exophthalmometry). Visual acuity and ocular motility were 
unaltered, as well. We advised the patient against a new operation due to 
high risk of postoperative complications including postoperative hemorrhage, 
cyst formation, recurrence with increase of the vascular component of the 
haemangioma and visual loss. The patient demanded emphatically a re-
operation and unfortunately suffered total visual loss due to apical 
hemorrhage with optic nerve compression on the first postoperative day. 
Enucleation was subsequently performed.  
 
2). Neoplasia of the lacrimal gland (6 cases): Histologically, all of them 
were pleomorphic adenomas. The patients were between 40 and 70 years of 
age, 3 male and 3 female. 
3 patients presented with exophthalmos and inward and downward 
displacement of the globe without any motility restriction or diplopia. 1 patient 
presented with lid swelling, normal ocular motility and no exophthalmos.  The 
orbital MRI showed in all of them a well circumscribed tumor with medium 
gadolinium uptake causing globe displacement. In CT scans no bone erosion 
was found. In 2 of these patients the tumor had a slightly nodular 
configuration. Lateral orbitotomy with tumor extirpation (3 complete, 1 
incomplete) was performed and established the diagnosis of a pleomorphic 
adenoma. In the case with incomplete excision recurrence of the tumor with 
diplopia was observed 3 years after the initial operation. Surgery was again 
performed and the patient was free of disease 2 years after second surgery. 
2 patients presented with a relapse of a pleomorphic adenoma operated ex 
domo. The first of them had motility restriction with diplopia in up gaze. This 
patient had undergone an incomplete tumor excision 5 years before reference 
to us. An extraconal multinodular tumor was shown in MRI scans. New 
orbitotomy followed and histology excluded malignant transformation. 1 month 
postoperatively a small rest was found to be present in MRI scan without any 
progression 3 years later. The second patient had been operated 23 years 
before reference to us, had no ocular symptoms and the tumor relapse was 
coincidentally discovered in an MRI performed for other reason. Orbitotomy 
with total tumor excision followed. Histological examination excluded 
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malignant transformation. Postoperatively, esophoria with diplopia occurred 
and strabismus surgery was performed 6 months after the operation. The 
further clinical course is not known to us. 
 
3). Neurogenic neoplasia (3 cases): 2 patients with a neurinoma 
(schwannoma) and 1 patient with a neurofibroma. 
The first patient was 72 years of age, male and presented with a slowly 
progredient exophthalmos over the past 20 years (difference of 8 mm in the 
Hertel exophthalmometry). There was a hypotropia with restriction of ocular 
motility in up gaze. MRI scan showed a well circumscribed tumor with contact 
to the orbital roof causing bone expansion but no bone erosion. The tumor 
had a cystic part extending intraconaly. The tumor was excised and 
histological examination showed a neurinoma without signs of malignity. 
Postoperatively, no other signs or symptoms were present except for a very 
mild exophthalmos (3 mm difference in Hertel exophthalmometry). 
The second patient was 73 years of age, female and presented with slowly 
progredient exophthalmos (difference of 14 mm in the Hertel 
exophthalmometry), downward globe displacement and motility restriction in 
all directions of gaze. The tumor was well circumscribed and in contact to the 
orbital roof causing bone expansion but no bone erosion, consisting of a 
cystic and a solid part, as seen in MRI scan. Orbitotomy with partial tumor 
excision was performed. The diagnosis was that of a neurinoma without any 
signs of malignity. The postoperative exophthalmos was 8 mm in Hertel 
exophthalmometry and further clinical course was uneventful.  
The third patient was 30 years of age, male and presented with bilateral 
exophthalmos with normal motility. In orbital CT and MRI we saw a bilateral 
well circumscribed tumor of the upper orbit causing bone expansion. The 
tumor showed only a peripheral contrast medium enhancement. Excisional 
biopsy was unilaterally performed and the diagnosis was that of a 
neurofibroma. This patient was referred to a dermatology clinic where 
neurofibromatosis was confirmed. Three years after the operation the patient 
had a slight bilateral constriction of adduction without diplopia and no other 
treatment was performed.  
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3.2.3. Vascular lesions 
 
Our series included 19 patients with vascular pathology other than vascular 
tumors. 9 patients had an arteriovenous fistula, 6 patients had a venous 
malformation, 2 patients had a thrombosis of the ophthalmic superior vein and 
2 patients had a haematic cyst.  
 
1). Arteriovenous fistulas (9 cases): 3 patients were male and 6 female. 
The patients’ ages were between 53 and 82 years. 2 patients with an indirect 
dural fistula between the external carotid artery (ECA) and the cavernous 
sinus (CS) , 2 patients with an indirect dural fistula between the internal 
carotid artery (ICA) and the CS, 1 patient with a complex direct and indirect 
fistula between ICA and ECA and the CS, 1 patient with a direct traumatic 
fistula between the ICA and the CS, 1 patient with a fistula between the ECA 
and the superior ophthalmic vein (SOV), 1 patient with a fistula between the 
ophthalmic artery (OA) and the SOV and 1 patient with a complex fistula 
between the ECA and OA and the CS. 8 patients (89 %) had dilated 
conjuctival and episcleral vessels, 2  patients (22%) ptosis, 3 patients (33%)  
visual acuity deterioration with 2 of them having a relative afferent pupil 
defect, 4  patients (44%) abnormal findings in funduscopy such as papillary 
edema, venous engorgement and retinal hemorrhages, 3 patients (33%) 
abnormal intraocular pressure. All patients had exophthalmos (moderate to 
severe) and ocular motility restriction in at least one direction of gaze. 1 
patient with minimal symptoms (exophthalmos of 2 mm difference in Hertel 
exophthalmometry and abduction deficit with diplopia in extreme gaze) due to 
an indirect ECA and CS fistula received no treatment. In 5 patients the fistula 
was embolised by a neuroradiologist: 1 patient had a fistula between the ACE 
and SOV, 1 patient had an indirect dural fistula between the ECA and the CS, 
1 patient had a direct fistula between the ICA and CS and 2 patients had an 
indirect dural fistula between the ICA and SC (1 of them with drainage by the 
contralateral SOV). In 3 of them there was a complete regression of the 
symptoms postoperatively. In 2 of them recanalisation of the fistula occurred: 
1 of them received a second embolisation with complete regression of 
symptoms; the other had a minimal arterial flow after recanalisation and the 
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symptoms resolved due to thrombosis of the junction between the superior 
ophthalmic vein and the angular vein, and therefore no further embolisation 
was performed. 3 of the patients were treated in a neurosurgery clinic; 1 of 
them had a complex indirect and direct fistula between the ICA and ECA and 
CS and only the ECA component could be embolised, but the patient had full 
recovery from symptoms and no retrograde flow in the orbit was shown in the 
postoperative angiography. The clinical course in the rest of the patients is not 
known to us. 
 
2). Thrombosis of the superior ophthalmic vein (SOV) (2 cases): The first 
patient was male, 39 years of age and presented with acute visual acuity 
deterioration, massive chemosis and conjuctival injection and exophthalmos 
of 8 mm difference in Hertel exophthalmometry. The patient had no pain. The 
visual acuity was no light perception. Sonographically, an intensely dilated 
SOV was seen. In CT scans a completely thrombosed SOV and partially 
thrombosed (cavernous sinus) CS and superior and inferior petrous sinuses 
were evident. The patient had a known mutation of the V Leyden factor. 
Immediate orbital decompression was performed but visual acuity failed to 
recover. The second patient was female, 71 years of age and presented with 
visual acuity deterioration, chemosis and conjuctival injection, exophthalmos 
(3 mm difference in Hertel exophthalmometry) and painful restriction of 
abduction. In funduscopy choroidal detachment and macular edema were 
seen. Angiographically a thrombosis of the inferior petrous sinus, the CS and 
the adjacent part of the SOV was shown. Anticoagulant therapy followed and 
symptoms regressed.   
 
3). Venous malformation (6 cases): 4 patients had a non-distensible venous 
malformation. 2 of them had a palpable indolent mass in the nasal lid. CT 
scans revealed in both patients a well circumscribed mass with minimal 
contrast medium uptake. MRI was additionally performed in one patient. The 
process was isointens in T1 weighed and hyperintens in T2 weighed scans, 
with inhomogenous gadolinium uptake. Anterior orbitotomy with excision of 
the lesion followed and postoperatively no complications occurred. 1 patient 
had axial exophthalmos and restrictions in ocular motility with diplopia. The 
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process was situated intraconaly, displacing the medial rectus muscle and the 
optic nerve and had isointens signal in T1-weighed and heterogenous signal 
(isointens with hyperintens areas) in T2-weighed. The hyperintens part of the 
lesion showed minimal and the rest of the lesion showed medium gadolinium 
uptake. Lateral orbitotomy with total excision was performed and histological 
examination showed a partially thrombosed venous malformation. 
Postoperatively the patient had no exophthalmos, but diplopia was still 
present 7 months after the operation. The further clinical course is not known 
to us. 1 patient presented with visual filed defects and ocular motility 
restriction with diplopia. Visual acuity was normal in both eyes. A CT scan 
was performed and showed a well circumscribed apical mass with minimal 
contrast medium uptake. Lateral orbitotomy with total excision was performed 
and histological examination showed a thrombosed venous malformation with 
benign reactive intravascular endothelial hyperplasia. Since ocular motility 
restriction persisted after surgery, strabismus surgery followed and the patient 
was free of symptoms thereafter.  
2 patients presented with intermittent exophthalmos after Valsalva maneuver. 
Visual acuity and ocular motility were normal. MRI scans showed an 
intraconal process in the first case and an extraconal lesion with intraconal 
component in the second case. Both lesions were isointens in T1 weighed 
and moderately hyperintens in T2 weighed images and showed marked 
gadolinium uptake. No surgical treatment was performed.  
 
 
 
Table 7. Findings and treatment in 6 patients with orbital venous 
malformations 
Patients Symptoms Orbital imaging Therapy Diagnosis 
 
Clinical 
course – 
Last follow-
up 
1 Palpable mass 
CT: well-
circumscribed 
lesion, 
minimum 
contrast 
medium uptake, 
anterior orbit 
Anterior 
orbitotomy, 
excision 
Non-
distensible 
venous 
malformation 
(histology) 
Free of 
symptoms, no 
complications 
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2 Palpable mass 
CT: well-
circumscribed 
lesion, 
minimum 
contrast uptake, 
anterior orbit 
MRI: 
T1:isointens, 
T2:hypeintens, 
inhomogenous 
contrast 
medium uptake 
Anterior 
orbitotomy, 
excision 
Non-
distensible 
venous 
malformation 
(histology) 
Free of 
symptoms, no 
complications 
3 
Visual field 
defects, 
diplopia 
CT: well-
circumscribed 
apical lesion, 
minimal 
contrast 
medium uptake 
Lateral 
orbitotomy, 
excision 
Thrombosed 
non-
distensible 
venous 
malformation 
(histology) 
Persistent 
diplopia – 
Strabismus 
surgery 
Free of 
symptoms 
4 
Axial 
exophthalmos, 
diplopia 
MRI: well-
circumscribed 
lesion, 
intraconal, 
T1:isointens, 
T2:isointens 
with 
hyperintens 
areas, 
inhomogenous 
contrast 
medium uptake 
Lateral 
orbitotomy, 
excision 
Thrombosed 
non-
distensible 
venous 
malformation 
(histology) 
Persistent 
diplopia, no 
complications 
5 
Intermittent 
exophthalmos, 
increase with 
Valsava 
maneuver 
MRI: well-
circumscribed 
intraconal 
lesion, 
T1:isointens, 
T2:moderately 
hyperintens, 
marked contrast 
medium uptake 
Observation 
Distensible 
venous 
malformation 
No 
complications 
6 
Intermittent 
exophthalmos, 
increase with 
Valsava 
maneuver 
MRI: well-
circumscribed 
intraconal 
lesion, 
T1:isointens, 
T2:moderately 
hyperintens, 
marked contrast 
medium uptake 
Observation 
Distensible 
venous 
malformation 
No 
complications 
 
4). Haematic cyst (2 cases): The first patient was male, 56 years of age and 
had no symptoms. The lesion was coincidentally discovered in an MRI scan 
performed due to chronic headaches. Clinical examination revealed 
exophthalmos (3 mm difference in Hertel exopthalmometry) and downward 
globe displacement. MRI scans showed a well circumscribed intraconal 
encapsulated process situated above the optic nerve. Only the capsule was 
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enhanced by gadolinium. Surgery with extirpation of the lesion was 
performed. Biopsy showed an organizing hematoma, fibrous tissue, histiocytic 
inflammatory cells and hemosiderin and hematoidin deposits without epithelial 
or endothelial lining, and established the diagnosis of an orbital hematic cyst.  
The second patient was male, 49 years of age and presented with acute 
exophthalmos, lid swelling and hypotropia after nausea with intense vomiting. 
MRI scans showed a subperiostal well circumscribed encapsulated process 
which was hypointense in T1 weighed and had hypointense and hyperintense 
areas in T2 weighed images corresponding to an acute bleeding in a 
haematic cyst. Only the capsule showed gadolinium uptake. No further 
therapy followed. The patient had only minimal exophthalmos (2 mm 
difference in Hertel exophthalmometry) 1 month after first examination. The 
patient refused an operation and he was advised to avoid Valsalva maneuver. 
 
3.2.4. Structural and degenerative lesions 
 
This last group of patients included 4 patients with an orbital dermoid, 1 
patient with an orbital amyloid and 1 patient with a mucopyocele. 3 patients 
with orbital dermoid presented with upper lid swelling (2 laterally and 1 
medially) and 1 patient presented with axial exophthalmos. In all of them the 
lesions had been known since childhood and were situated in the anterior 
orbit. In MRI scans (performed in 2 patients) we saw well circumscribed orbital 
process with relatively high signal in T1 weighed and T2 weighed images. 
Only the capsule enhanced with  gadolinium. In CT (perfrormed in 2 patients) 
the tumor was hypodense without bone infiltration or erosion or contrast 
capture. Τumor excision was performed in all of them and there were no 
postoperative complications.  
1 patient presented with an infiltrative anterior orbital process causing bilateral 
indolent lid swelling. The lesion showed moderate contrast capture in orbital 
CT scans. The conjuctiva showed a yellowish infiltration. Biopsy was 
performed and confirmed the diagnosis of an amyloid. Systemic amyloidose 
was excluded. 
1 patient presented with an indolent palpable soft orbital mass and hypotropia 
of the right eye. CT scans showed an expansion of the frontal sinus, a 
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destruction of the floor of the frontal sinus and the frontoethmoidal region and 
a displacement of the lateral rectus muscle and globe. The diagnosis of a 
mucopyocele was made and further treatment was undertaken by ENT 
specialists.  
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4. Discussion 
 
4.1. Inflammatory disease 
 
4.1.1. Non-specific inflammation (NSI) 
 
In our series the lacrimal gland region was found to be the most common site 
of location of non-specific inflammation (NSI), accounting for 45% of all cases. 
In a series of 90 cases with idiopathic orbital inflammation (Yuen et al 2003) 
the lacrimal gland region was also found to be the most common site of 
involvement. In order to establish the diagnosis, we performed an orbital 
biopsy in all patients independent of the site of involvement. Many authors, 
though, suggest sparing an orbital biopsy in the presence of typical symptoms 
and signs (clinically and in orbital imaging), and perform it only when steroid 
treatment has no or minimal effect. It is our tactic to perform a biopsy before 
initiating a therapy, because lymphoproliferative lesions including lymphomas 
can also have an initial positive response to steroid therapy and the diagnosis 
of such lesion could be delayed. When acute symptoms, such as pain, 
erythema and proptosis, dominate the clinical picture, the presence of an 
acute inflammation is highly likely. In that case, an initial treatment with 
steroids without first performing a biopsy could be considered. However 
presentation of NSI can be variable and subacute, and chronic cases of NSI 
lacking a history of pain are not uncommon (Cytrin et al 1997). Several CT 
and MRI features such as site, shape, CT-attenuation, contrast enhancement 
and signal intensity in T2-weighed images, have been used to differentiate 
between NSI and lymphoma in the orbit (Weber et al 1996, 1999, Gufler et al 
1997, Won-Jin-Moon et al 2003). However, in many cases the radiological 
characteristics overlap, and only orbital biopsy can establish the right 
diagnosis. According to Rootman (Rootman 1998) the diagnosis of NSI 
should be made extremely cautiously and may more often require biopsy 
because of the risk of misdiagnosis, especially when two locations are 
affected: the apex and the lacrimal gland. According to the same author 
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lacrimal lesions are associated with a systemic disorder in 50% of the cases, 
while processes localised in the apex are very frequently misdiagnosed. In our 
series, however, only 2 of 22 (9%) patients with lacrimal inflammation were 
found to have systemic disease. Among 44 patients with NSI in our series 10 
of them had severe degree of fibrosis in biopsy specimens in terms of a 
sclerosing non-specific orbital inflammation (SNSI). 7 patients (70%) had 
lacrimal involvement, 2 patients (20%) had intraconal involvement and 1 
patient (10%) had apical involvement. As by other authors reported (Hsuan et 
al 2006), we found a predilection for the lateral orbit, as well. It is postulated 
that the lacrimal gland is prone to involvement because it is the only orbital 
site which normally contains lymphoid tissue (Garner 1992). It has been 
suggested that lymphocytes play a critical role in the development of fibrosis 
(Mc Carthy et al 1993).  
The clinical course in 8 patients of our series (1 with sclerosing inflammation) 
is not known to us.  
1 patient with intraconal SNSI and diplopia, who was not severely disturbed in 
daily life, refused therapy after exclusion of malignancy. One year later no 
progression was observed.  
The follow-up period of the rest of the patients varied between 2 months and 
24 months. 15 patients of the group of NSI, excluding myositis, were initially 
treated with systemic steroids; 11 out of them (73,3%) had complete 
regression of symptoms, 1 (6,6%) had partial regression with persistent 
exophthalmos and minimal ocular motility restriction with diplopia, and 3 
(20%) had no improvement of symptoms. 2 of the latter patients underwent 
orbital radiation therapy; complete regression occurred in one patient and 
partial regression occurred in the other one (persistent diplopia). The third 
patient who had no improvement after steroid therapy, underwent bilateral 
orbital debulking surgery due to bilateral exophthalmos with ocular motility 
restriction in all directions of gaze. Bilateral reduction of exophthalmos was 
achieved, but postoperatively diplopia persisted and strabismus surgery 
followed.  
1 patient was treated with ibuprofen with complete regression of the disease. 
Systemic steroid therapy is the established first-line treatment for NSI of the 
orbit. NSI is exquisitely sensitive to systemic steroids, however some authors 
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(Yuen S.J.Y, Rubin P.A.D 2003) found that a considerable number of patients 
had unsatisfactory outcomes. According to the same authors steroid 
dependence with recurrence or increase of symptoms during or after steroid 
taper has also occurred in patients with good initial response to therapy. A 
very low cure rate of only 37% and high recurrence rate of 52% after systemic 
steroid administration along with considerable adverse effects, were reported 
in other retrospective studies, as well (Mombaerts et al 1996). In order to 
minimize systemic side effects, the intraorbital injection of steroids (20 to 
40mg/ml triamcinolon acetonide intralesionally or perilesionally) has 
alternatively been proposed. In a series of 10 patients with anterior 
inflammatory process (7 with NSI and 3 with SNSI) receiving intraorbital 
steroid injections, 9 patients had very good response with regression of 
disease (Leibovitch et al 2007). 5 of these 9 patients responded after only one 
injection, while in 4 patients repeated injections had been necessary. The 
authors concluded that steroid injections could be an alternative in steroid 
responsive but steroid intolerant patients with anterior NSI; moreover, 
periocular injections may need to be repeated until the desired therapeutical 
effect is achieved. The same authors claimed that patients with resistance to 
periocular steroid treatment were unlikely to respond to systemic steroid 
therapy. However, as the dose equivalent between steroid injections and 
systemic steroids is not known, the authors suggested that a trial of high-dose 
steroid treatment should be done in all cases, before immunosuppressive 
agents or radiotherapy are considered. Intraoperative injection of triamcinolon 
has also been considered as effective in cases of SNSI (Harris 2005). 
Because there are only few reports on this type of treatment and additionally 
multiple complications of orbital steroid injections (even if not usually) have 
occured (skin depigmentation, intractable elevated intraocular pressure, 
ptosis, globe perforation, corneoscleral or conjuctival melting, retinal artery 
occlusion from embolisation, pressure-induced optic compression, proptosis 
and fat atrophy), we have not used intraorbital steroids for the treatment of our 
patients with NSI. In our cases of NSI where steroids had not been effective 
or well-tolerated, we considered the alternative of orbital radiotherapy (2 
patients) or debulking surgery (1 patient). Orbital radiotherapy has been 
reported to be successful in the treatment of upto 70-75% of cases with NSI 
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(Orcutt et al 1983, Sergott et al 1981). This percentage includes patients with 
complete resolution or patients with partial resolution with significant 
improvement without the need of steroids. The response to steroid treatment 
may be a predictor factor for the response to radiotherapy. In a study (Orcutt 
et al 1983) including 22 patients receiving orbital radiotherapy due to NSI, 12 
out of 13 patients (93%) with initial good response to steroids showed 
subsequent good response to radiotherapy. However only 2 (33%) out of 6 
patients with no response to steroids showed response to radiotherapy. Since 
the patients who responded to radiotherapy, had not suffered any recurrence 
of their disease in a mean follow-up time of 22,3 months, response to 
radiotherapy might present a permanent cure. In the same study, the average 
time for response to occur, was 3,2 months for full responders and 7,9 months 
for partial responders. The authors concluded that radiotherapy should be 
considered as a treatment option in patients with NSI who show an initial 
steroid response but relapse after steroid tapering, or for those cases where 
steroids have adverse effects or are contraindicated. However, findings of 
other authors (Sergott et al 1981) failed to prove a correlation between steroid 
and radiotherapy response. The histological composition of the inflammatory 
lesion may also predict the response to radiotherapy. It has been postulated 
that the dominance of lymphocytes can predict a favorable outcome of the 
therapy (Kim, Roth 1978, Kennerdell et al 1979, Sergott et al 1981, Orcut et al 
1983). The presence of eosinophils could generally imply a poor response to 
radiotherapy, however not all authors agreed on this. The presence of fibrosis 
has not been shown to be a predictor factor of effectiveness.  Moreover, small 
discrete masses may respond better than large diffuse masses (Orcut et al 
1983). 
As reported above, 3 of our patients with NSI underwent radiotherapy: 2 of 
them had had no response to previous steroid administartion, and one of 
them had had good initial response to steroids, but the administration of 
steroids had to be stopped due to severe side effects. The latter patient as 
well as one of the patients with no response to steroids, showed a complete 
regression, whereas the other patient only partial. Our results agree with 
those of Sergott, and we think that orbital radiotherapy should be tried 
independent of initial response to steroids.  
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10 of our 44 patients with NSI had SNSI. In 1 of them steroid treatment was 
recommended after the diagnosis had been established, but the further 
clinical course is not known to us. 1 patient received no therapy and no 
progression was observed 1 year later. 1 patient had apical involvement with 
visual acuity of hand movement perception. Despite immediate 
decompression, visual acuity failed to improve and no further treatment 
occurred. 
4 patients with SNSI were initially treated with steroids: 1 of them (25%) had 
partial response, while 2 others (50%) had no response. Only 1 of them 
(25%), who had SNSI of the lacrimal gland, had very good initial response; 
yet, relapse occurred 5 months after initial diagnosis with apical involvement 
and visual acuity of hand movement perception. Despite immediate 
decompression visual acuity failed to improve. In the first patient without 
response to steroids, orbital radiotherapy was recommended; the further 
clinical course is not known to us.  The second patient without any response 
to steroids had intraconal involvement and received methotrexate, which also 
proved ineffective. Surgical debulking was subsequently performed with 
reduction of his exophthalmos and only minimal restriction in ocular motility 
remained.  
3 patients with well circumscribed lacrimal SNSI were operated with en-block 
resection of the lacrimal gland region. 2 of them were completely free of 
symptoms and no further treatment occurred. In 1 of them the clinical course 
is not known to us.  
The treatment of SNSI has been controversial. Most studies included few 
patients, and there have been no randomized or controlled trials. No 
treatment can be expected to reverse established fibrosis. Steroids continue 
to be the first line therapy although results have been in many cases 
disappointing. In the largest retrospective review published on this subject, 
including 31 patients from 5 orbital centers, 27 patients were initially treated 
with steroids. Only 9 (33%) had good response and 11 (40%) had partial 
response (Hsuan et al 2006). Steroids were found to be more effective in 
patients with shorter duration of disease. Other authors also suggest early 
and aggressive treatment with steroids should be considered in cases with 
short duration of disease (Brannan et al 2006). It has been suggested that 
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SNSI should be separated from NSI leaving the former as an independent 
entity among orbital inflammations. Idiopathic sclerosing inflammation of the 
orbit is considered as a unique clinicopathologic entity, similar to 
retroperitoneal fibrosis, which is characterized by primary, chronic, and 
immunologically mediated fibrosis. As a matter of fact only poor response to 
corticosteroid treatment or radiotherapy is generally to be expected, and early 
and aggressive immunosuppressive therapy seems to be justified (Rootmann 
et al 1994). The partial effectiveness of immunosuppressants, such as 
cyclophosphamide and azathioprime, has been reported in the literature in 
isolated cases. Cyclophosphamide was found to be effective in a case of 
SNSI in combination with steroids (Uy et al 2001). Cyclophosphamide 
prescribed to 3 patients with partial or no response to steroids, achieved 
partial resolution in only 1 patient (Hsuan et al 2006). The use of stereotactic 
radiotherapy in combination with the immunosuppressant rituximab achieved 
complete remission in a case of SNSI without response to high dose systemic 
steroids (On et al 2006). Another therapeutical alternative for SNSI is surgical 
debulking (Mombaerts et al 1996, Moreiras 2004). Moreiras favors surgery for 
sclerosing dacryoadenitis, even if this does not always guarantee reduction or 
disappearance of pain. Out of 7 patients with sclerosing dacryoadenitis he 
operated, 4 patients had complete resolution, while 3 patients had persistent 
fibrosis because the lesion had not been completely excised. According to the 
same author surgery could also be considered for intraconal sclerosing 
inflammations simulating neoplasia, as radical as possible. Kennerdell 
(Kennerdell 1991) also reported good results after surgical excision of lesions 
with severe and established fibrosis. He recommended complete surgical 
removal for local lesions and debulking surgery with or without steroid 
treatment, followed by radiation therapy for diffuse lesions. Hsuan (Hsuan et 
al 2006) reported good results after surgical debulking, as well. In his series of 
31 patients, 4 patients underwent surgical debulking with 2 of them having 
complete and 1 of them partial resolution.  
We operated 4 patients with SNSI. 3 of them (1 with intraconal lesion and 2 
with dacryoadenitis) had complete or almost complete resolution; in 1 of them 
the clinical course is not known. Considering the high failure rate of steroids 
and radiotherapy and the potential adverse effects of immunosuppessants, 
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which might not always lead to regression of disease,  we favor surgical 
treatment especially in cases with relatively well circumscribed lesion and 
involvement of the lacrimal gland. Cases with intraconal involvement could 
also benefit from partial surgical excision if other therapeutical alternatives fail 
and reduction of exophthalmos is aimed.  
Besides, we performed debulking surgery in further 3 patients with NSI: 2 of 
them had lacrimal gland involvement and 1 bilateral diffuse involvement.  1 of 
the first two patients was free of symptoms, whereas the other one had 
diplopia after the operation, so that strabismus surgery was performed. The 
patient with the diffuse inflammation had formerly been treated with steroids 
due to exophthalmos without any success; we performed bilateral lateral 
orbitotomy achieving distinct reduction of exophthalmos. Postoperative 
diplopia demanded, however, subsequent strabismus surgery.  
In our opinion, systemic steroids should be the first line therapy for NSI and 
SNSI. If treatment fails, orbital radiotherapy should be tried, especially in 
cases of NSI. In sclerosing inflammation, especially when the lesion is 
relatively well circumscribed and involves the lacrimal gland, surgical removal 
should be seriously considered, given that: i.) steroids and radiotherapy have 
high failure rate, ii.) steroids can be associated with adverse effects, and iii.) 
the efficacy of immunossuppressants is controversial.  
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Figure 18. Treatment of non-specific orbital inflammation. 
 
 
4.1.2. Specific inflammation 
 
Our series included 2 patients with Wegener granulomatosis. Both of them 
were female. 1 of them had a known systemic disease, and additionally 
bilateral blindness due to optic nerve atrophy caused by a pituitary adenoma. 
This patient presented with a subacute painful exophthalmos with 
inflammatory signs. Treatment with cyclophosphamide led only to partial 
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reduction of exophthalmos. The second patient had subacute exophthalmos 
and ocular motility restriction with diplopia. The disease was limited to the 
orbit and paranasal sinuses without any other systemic involvement. 
Cyclophosphamide led to complete resolution. Wegener granulomatosis is a 
necrotizing granulomatous inflammation which occurs in two forms, localized 
and generalized. In the localized form there is no renal involvement and 
prognosis is better (Stavrou et al 1993, Cassan et al 1970). Ocular and orbital 
involvement is seen in up to 50% of cases of Wegener granulomatosis 
(Rootman 2001). In the localized form orbital involvement tends to be more 
indolent, whereas in the generalized disorder orbital disease may follow a 
course from rapid progression to long-term intermittent activity. Wegener 
granulomatosis may only present as an orbital mass without upper respiratory 
or systemic features at the beginning of disease. However, ear, nose and 
throat features tend to become universal during the follow-up period (Perry et 
al 1997). Main ocular symptoms are decreased vision, redness, and ocular 
pain; main findings are proptosis, scleritis, and lid inflammation. The diagnosis 
might be difficult to establish especially in localized forms of disease. This 
happens due to the fact that up to 50% of orbital biopsies for suspected 
Wegener granulomatosis are nonconclusive (Woo et al 2001). Accurate 
interpretation of biopsies is essential. In a study of 13 orbital biopsies of 
patients with well documented Wegener granulomatosis (Kalina et al 1992) 
only in 7 (53%) the classic triad of vasculitis, tissue necrosis and 
granulomatous inflammation was seen. In 4 biopsies (31%) vasculitis was 
seen, and in further 2 biopsies (16%) only perivascular infiltrates were seen. 
Moreover, ANCA antibody testing is often negative in cases of localized 
disease, with false negative results being as high as 68% (Woo et al 2001). 
Thus, the diagnosis of orbital Wegener disease should be based on a 
constellation of clinical, radiological, and pathologic features. The most 
important clinical features that should raise an index of suspicion are 
bilaterality, involvement of the respiratory tract or sinuses including the 
mastoids (which are often missed), scleritis at the time of onset, particularly 
when associated with the classical features of limbal corneal infiltrates, and 
systemic associations (Austin et al 1978). Comparison of orbital and 
extraocular biopsies (when available) is also recommended (Kalina et al 
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1992). The disease can affect a wide age range (Ziakas et al 2004).  In our 
patient with localised disease ANCA antibodies were negative; this correlates 
with the references mentioned above. In the second patient with known 
generalised disease ANCA antibodies were not examined. Orbital biopsy was 
diagnostic for both patients. Classic treatment of Wegener granulomatosis is 
with a combination of cyclophosphamide and steroids. This therapy achieves 
remission in up to 90% of cases (Fauci et al 1983, Rootman 1988). Nowdays 
cyclophosphamide is used to induce remission of disease and its use rarely 
exceeds 6 months. After remission, other less toxic agents, such as 
azathioprime, methotrexate or leflunomide, are administered, with various 
relapse rates reported in the literature. However proptosis and subglottic 
stenosis might be sometimes refractory to treatment (Hoffman et al 1992). In 
case of refractory disease therapy with the monoclonal antibody rituximab has 
been proposed (Seo et al 2008). This agent was used in 8 patients who had 
failed therapy with immunossuppressants and achieved disease remission in 
all of them (Seo et al 2008). In general, collaboration with rheumatologists 
who have experience with the use of immunosuppressive drugs, guarantees 
the optimal management of such patients. The ophthalmologist should be 
aware of cases with limited disease which may initially present with solely 
ocular findings and establish timely the diagnosis based on clinical, 
radiological and histological findings, because early treatment can be 
dramatically effective with prevention of adverse local or systemic outcome.   
 
4.2. Neoplasia 
 
4.2.1. Malignant tumors 
 
4.2.1.1. Neoplasia of the haemopoietic system 
 
4.2.1.1.1. Orbital lymphomas 
  
Orbital lymphomas are unusual neoplasms, constituting less than 1 % of all 
nodal and extranodal lymphomas (Keleti et al 1992, Calle et al 1975). Orbital 
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lymphoma is the most common primary orbital malignancy (Adam et al 1971, 
Rosenberg et al 1961). In our series orbital lymphomas were responsible for 
30% of all neoplastic diseases, a percentage however much higher than the 
10% reported in the literature (Reese 1976). They belong to the spectrum of 
orbital lymphoproliferative disorders. Orbital lymphoproliferative disorders 
include mainly lymphoid hyperplasia (LH) and orbital lymphoma. However 
there are lymphoproliferative lesions which defy categorization to one of the 
groups mentioned above. It has been suggested that lymphoproliferative 
disorders represent a continuous spectrum of disease which is not separable 
in a conceptual sense. This means that all pure lymphoproliferative lesions of 
the orbit can be considered as malignant or pre-malignant disease and LH 
could be the one end of the natural history of disease and the pure malignant 
variants the other (Garner 1992). In other words a neoplastic proliferation 
could supervene in an initially reactive disorder, in which case the two 
processes would be operating together for a time. Examples of this concept 
are extranodal lymphomas of the bronchus and the lacrimal gland and the 
same could be true for the orbit as well (Benerjee et al 1982, Schmid et al 
1982). The differentiation between LH and orbital lymphoma is generally 
clinically and radiographically impossible. LH responds generally well to 
steroids, but orbital lymphomas can also show a partial initial regression after 
corticosteroid therapy, and thus response to anti-inflammatory treatment is not 
reliable for differentiation. The histological features of the lesion are the 
decisive criteria, but there are also lesions which cannot be categorized after 
biopsy. Germinal centers have usually been considered as one of the most 
reliable indicators of LH (Chavis et al 1978), but they are far from being an 
infallible guide (Garner 1992). Prominence of interstitial capillaries and 
presence of plasma cells and histiocytes support the diagnosis of LH. 
Evidence of monoclonality or even oligoglonality is a reliable index of 
neoplastic behavior. In our series MALT-Lymphomas composed 71 % of all 
primary localized orbital lymphomas (10 out of 14 cases). Histologically, the 
majority of orbital lymphomas are of the MALT-type. The percentage of 
MALT-type in primary localized lymphomas in the literature ranges from 30% 
to 100% (Smitt et al 1993, Chao et al 1995, Galieni et al 1997).  This could be 
due to the fact that many low-grade MALT-lymphomas of the REAL-
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classification were categorized as intermediate grade before introduction of 
this classification. 76% of our patients with primary orbital lymphoma had 
localized disease (Stage IE) and the rest had disseminated disease. 75 % of 
primary orbital lymphomas have been reported to be of Stage IE at the time of 
diagnosis (Jakobiec et al 1989), whereas other authors report a considerably 
lower percentage (49%) in a series of 59 patients (Polito et al 1996). Orbital 
lymphomas are confined in the orbit for long periods before metastasing. 
Different explanations exist. It is believed that they share a feature common 
among other types of extranodal lymphomas, namely homing back to their 
tissue of origin if they enter the general circulation (Issacson et al 1994). The 
absence of orbital lymphatic vessels could also play a role (Garner 1994). 
Bilaterality was observed in 11,7% of our patients with primary lymphoma. In 
a series of 63 patients (Polito et al 1996) bilateral involvement was found to 
be present in up to 19% of cases. Moreiras (2003) reports 15% bilaterality in 
83 patients with lymphoproliferative orbital disease (LH included). The anterior 
orbit is the most frequent site of involvement (Rootman 1988).  
The lesions are almost always infiltrative and surgical therapy is almost 
always impossible without any severe functional deficit. However, 2 of our 
patients with low malignity Stage IE MALT-lymphoma and well circumscribed 
lesion were initially treated with surgical excision alone. The first patient 
suffered a recurrence 2 years after surgery and 36 Gy radiotherapy followed 
achieving complete regression. The clinical course of the second patient is not 
known to us.  
Radiotherapy is the first line therapy for primary localized orbital lymphomas 
of low malignancy. In our series 6 of 7 patients (86%) with primary Stage IE 
low malignancy lymphoma treated with radiotherapy exhibited complete 
remission 1-2 years after initial diagnosis. The dose was 36 Gy for bilateral 
disease or 40 Gy for unilateral disease. In one patient increase of the tumor 
mass was observed so that additional chemotherapy followed with complete 
regression of the tumor. Radiation therapy has been very effective in 
providing local control and cure in orbital lymphomas especially of low 
malignity; reported success rates have been > 90% (Reddy et al 1988, 
Letschert et al 1991, Galieni et al 1997, Lee et al 2002). Radiotherapy has 
also been proved effective in achieving complete remission in cases of local 
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relapse formerly treated with chemotherapy or surgical excision (Galieni et al 
1997). In 1 of our patients, as mentioned above, relapse was observed 2 
years after surgical excision of a well circumscribed low malignity Stage IE 
MALT lymphoma. Subsequent radiotherapy in this patient led to complete 
remission of disease. However, some studies reported systemic progression 
of the lymphoma even after successful primary local control with radiotherapy 
(Kim et al 1976, Letschert et al 1991). In their clinicopathologic study Knowles 
and Jakobiec (1980) found that the single most important feature determining 
the development of systemic disease and hence the prognosis, was the 
degree of cytologic differentiation. In a study of 18 patients, complete 
response to radiotherapy was observed in 100% of patients with low grade 
and 85% of patients with intermediate grade lymphoma (Lee et al 2002). The 
invasion of orbital walls is a negative prognostic factor for the efficacy of 
treatment, and the survival rate in such patients is generally poor (Bennet et al 
1986, Lee et al 2002). The suggested dose of radiotherapy varies. Some 
authors propose a dose of 30 Gy for low malignity tumors (Letschert et al 
1991, Lee et al 2002), whereas others propose a higher dose of 30-35 Gy 
(Smitt et al 1993) or even 36-40 Gy (Galieni et al 1997). We prefer a dose of 
40 Gy for unilateral and 36 Gy for bilateral lesions, because complications at 
dose levels of less or equal to 40 Gy are to our knowledge extremely rare. In 
our case series, however, 1 patient developed occlusive radiation retinopathy 
with macular oedema and a final visual acuity of 1/15 after radiotherapy of 40 
Gy. Serious complications of radiotherapy occur generally with dose levels 
higher than 40Gy and include radiation retinopathy, optic neuropathy and 
cataract formation. Contrary to low malignity lymphoma, in which radiation 
alone has a very high success rate, in intermediate or high malignancy 
lymphomas combination radiochemotherapy is needed, even in cases of 
localized Stage IE disease (Lee et al 2002, Moreiras 2004). There are some 
authors who suggest that radiotherapy alone in higher dose could be sufficient 
for orbital lymphoma of intermediate or higher malignancy (Letschert et al 
1991), taking into account that orbital lymphoma is a disease with a peak 
incidence in the sixth and seventh decade of life and the results on 10 years 
survival equal the survival of a normal population of the same age distribution. 
Since, however, relapse-free survival might be improved by adjuvant 
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chemotherapy in patients with stage IE primary orbital lymphoma and 
unfavorable histology (Monfardini et al 1980, Nissen et al 1983, Somers et al 
1987), the decision to perform adjuvant chemotherapy should be 
individualized and made after careful balancing against side effects of 
treatment.  
In patients with disseminated disease chemotherapy is the first line therapy. In 
this study 4 patients had systemic Stage IV disease. 3 had low malignity and 
1 high malignity lymphoma. 1 died 4 months after diagnosis. 1 was treated 
with chemotherapy alone, 1 received radiotherapy and chemotherapy and 1 
received initially only radiotherapy. In all patients local remission was 
achieved, but the systemic status thereafter is not known to us. Although 
radiation therapy has been very effective especially in cases of localized 
lesions of low malignity, there are problematic cases, in which local or 
systemic relapse occurs despite initial control of the disease. MALT-
lymphomas have a more favorable prognosis than other lymphoid 
proliferations (Jakobiec et al 1986, White et al 2006), but long term follow-up 
has shown that extraorbital recurrence and death can occur occasionally in 
cases of MALT-lymphomas and more frequently in other forms of orbital 
lymphoma (Jenkins et al 2000, Auw-Haedrich et al 2001). Furthermore, some 
patients have already disseminated disease at first presentation or secondary 
orbital involvement of a systemic lymphoma. In such cases where 
chemotherapy and radiotherapy protocols fail to control the neoplastic 
disease, the use of the monoclonal antibody rituximab has been proposed 
(Esmaeli et al 2002, Sullivan et al 2004). Clinical trials established the efficacy 
of rituximab in the treatment of both low-grade and more aggressive 
lymphomas. Other authors have studied the efficacy of the combination of this 
agent with standard chemotherapy (Coiffier et al 2002) or the efficacy of the 
linking antibodies with radioisotopes (Knox et al 1996) in cases of relapsed or 
aggressive lymphoma. In one of our patients with low malignity lymphoma and 
no response to radiotherapy this agent was used in combination with 
chemotherapy and complete remission was achieved. Sullivan et al (2004) 
reported good response in 6 of 7 patients with orbital lymphoma and systemic 
disease with complete or partial resolution. The authors concluded that 
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rituximab could be a treatment modality with low side effects available for 
repeated use in local and systemic relapses.  
In conclusion, we think that radiotherapy alone is the first line therapy for 
patients with orbital lymphomas, since the vast majority of them have 
localized Stage IE disease and lesions of low malignity, as shown in our 
series and in series of other authors. We recommend a dose of 40 Gy for 
unilateral and 36 Gy for bilateral involvement because serious ocular 
complications are very rare with dose equal or less of 40 Gy. In patients with 
localized disease and high malignity lymphoma adjuvant chemotherapy 
should be seriously considered, especially in patients with good systemic 
status, since histology has been proven to be a very significant risk factor for 
local or systemic relapse. In cases with systemic disease chemotherapy is the 
treatment of choice, whereas in patients with refractory disease or relapse 
after initial control the use of the monoclonal antibody rituximab in 
combination with chemotherapy could be an alternative. Relapse duration is 
generally less than 24 months (Foster et al 1971, Lee et al 2002), but can be 
more than 5 years. Lymphoma-associated deaths can occur many years after 
diagnosis and the proportion of patients who died of lymphoma at 5 years was 
found to be 12% for MALT-lymphoma, 19% for lymphoplasmocytic 
immunocytoma, 22% for follicular lymphoma and 48% for diffuse large cell 
lymphoma in a series of 192 patients (Jenkins et al 2000). Therefore, even 
after good initial response all patients should be ophthalmologically and 
systemically evaluated for a long period, especially if histology is not 
favorable.  
 
4.2.1.1.2. Histiocytosis 
 
2 of our patients were diagnosed with Langerhans-Cell-Histiocytosis (LCH). 
Both of them were male and had unifocal bone lesion of the orbit, without any 
evidence of other involvement. LCH is an uncommon disease with a clinical 
spectrum that includes benign unifocal disease (eosinophilic granuloma), 
chronic multifocal disease (Hans-Schuller-Christian disease) and acute or 
subacute fatal disseminated disease (Letterer-Siwe disease). It accounts for 
1% of biopsied orbital tumors (Henderson 1980). When it occurs in the orbit it 
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is almost always unilateral and localized. However, bilateral orbital disease 
has also been reported (Demirci et al 2002). The disease is generally 
diagnosed in children and young adults, and has a predilection for males 
(Shields et al 1999). Histopathology shows a proliferation of large histiocytic 
cells, which under the electron microscope exhibit characteristic cytoplasmic 
granules (Birbeck granules). Moreover, a various number of eosinophils, 
plasma cells, lymphocytes and multinucleated giant cells can be seen. 
Histiocytic cells show positive reaction for S-100 protein and CD1 antigen. 
The pathogenesis of the disease is not clear. A disorder of immune regulation 
has been postulated (Egeler et al 2004), but given the monoclonality of the 
Langerhans-cell histiocytes a neoplastic process cannot be ruled out 
(Leonidas et al 2003). The orbital lesions of LCH are usually situated in the 
superior lateral orbit, are typically osteolytic and have irregular margins, which 
can be sclerotic. MRI imaging may be useful in order to determine the extent 
of intracranial involvement (Stromberg et al 1995, Azouz et al 2005). 
Differential diagnosis in the orbit includes dermoid cyst, lacrimal gland tumor, 
primary bone tumors, such as osteosarcoma, aneurysmal bone cyst, fibrous 
dysplasia and Ewing sarcoma, and metastasis of neuroblasoma. Diagnosis is 
made by biopsy (Moreiras 2004, Binning et al 2008). The natural history of 
LCH is poorly understood. Systemic forms with involvement of vital organs are 
usually seen in younger children and carry a bad prognosis with mortality rate 
of 55 % to 60% (Rootman 1988). On the contrary, local disease limited to 
bone carries a very good prognosis. In a review of 348 cases treated in 
pediatric hematology/oncology centres the survival rate was 96% to 100% for 
LCH limited to bone (The French Langerhans’ Cell Histiocytosis Study Group 
1996), although considerable case-to-case variation does exist. Treatment of 
unifocal lesions of the skull typically consists of surgical curettage, which may 
necessitate an interdisciplinary approach depending on the extent of lesion 
(Binning et al 2008). Additional low dose radiotherapy can follow (Harris 
2003). That was also the case in one of our patients with intracranial 
extension, who was treated in a neurosurgery clinic. Local recurrence rate is 
6% and new lesions present in 22% of patients according to some authors 
(Stromberg et al 1995). Spontaneous regression following biopsy has also 
been reported (Glover et al 1987, Demirci et al 2002, Harris et al 2003, Key et 
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al 2004, Harzallah et al 2005). Another treatment option in cases of localized 
LCH is the intralesional injection of steroids. In a series of 3 patients with 
localized bone involvement of the mandibulla treated with intralesional 
steroids alone, no evidence of residual disease was present one year after 
treatment (Putters et al 2005). Intralesional steroids in combination with 
surgery have been used in orbital involvement with good results, as well 
(Kindy-Degnan et al 1991, Harris et al 2003). Patients with multiple lesions, 
organ system involvement, those who are younger than 2 years, and patients 
with recurrent or progressive disease need chemotherapy (Jubran et al 2005).  
In our series, one patient was treated with tumor excision alone in a 
neurosurgery clinic; 2 years later he was free of disease. The clinical course 
of the second patient after establishment of the diagnosis is not known to us. 
Erdheim-Chester-Disease (ECD) is a non-Langerhans-cell-histiocytosis. The 
differential diagnosis from LCH is based on the age of manifestation, with the 
ECD affecting older individuals and the LCH being mainly a disease of the 
childhood, the pattern of bone lesions (typically osteosclerotic, symmetric 
involvement of the long bones in ECD and typically osteolytic involvement of 
the axial skeleton in LCH) and immunohistological criteria. Orbital involvement 
is very rare and was found in only 25 of approximately 250 published cases of 
ECD. The therapy of patients with ECD is generally individualized, as the 
disease is rare and no randomized controlled studies are available.  INF-α 
could be a first-line long time therapy in ECD.  Haroche et al   (Haroche at al 
2006) evaluated INF-α as a first-line therapy for ECD in eight patients. 
Xanthelasma, exophthalmos and retroperitoneal fibrosis completely 
regressed, whereas cardiovascular manifestations in the severe multisystemic 
forms of ECD responded to the therapy with varying results. The use of the 
purine-analogue Cladribine is reported to have led to complete regression of 
exophthalmos and to normal ocular motility, as well as improvement of the 
lung function in a case of ECD causing bilateral exophthalmos, 
ophthalmoplegia and lung disease (Myra et al 2004).  Another patient, though, 
with bilateral ECD orbital involvement, who was treated with the same 
medicament, suffered toxic optic neuropathy with bilateral blindness. If 
treatment with Cladribine is instituted for orbital disease, careful monitoring of 
the optic nerve function is mandatory.  Local radiotherapy to the orbits has 
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also been used, achieving only a short time improvement with high rate of 
recurrence (Miller al 2006). Regression of the exophthalmos was achieved by 
double autologous stem-cell transplantation in a case of orbital ECD, in which 
INF-α had been proven ineffective (Boissel et al 2001). In patients with orbital 
disease who develop signs of compression neuropathy despite conservative 
therapy, orbital decompression should be seriously considered, as shown in 
one of our patients, as well. 
 
4.2.1.2. Mesenchymal tumors 
 
Liposarcoma 
2 patients of our series had a liposarcoma (1 myxoid and 1 well-
differentiated). The histological subtypes mentioned above are based on the 
classification of Enziger and Weiss, which is the classification used by almost 
all authors in the literature (Enzinger, Weiss 1988). The histological subtype 
has a very important role for the prognosis. Well differentiated and myxoid 
liposarcomas have a relatively indolent course, whereas round cell and 
pleomorphic variants usually behave aggressively (Brennan et al 1997). Most 
of the cases described in the literature belong to the myxoid subtype. 
Liposarcomas represent 16% to 18 % of all malignant soft tissue tumors 
(Enzinger 1988) with the thigh and retroperitoneum being the most common 
sites. The orbit is a very rare site of primary involvement. Metastases of 
liposarcoma to the orbit have also been reported and are even rarer (Fezza et 
al 1997, Tehrani et al 2003). The most common symptoms are painless 
proptosis in a quiet eye and ocular motility restrictions with diplopia. Both of 
our patients had exophthalmos at first presentation. In one of our patients the 
main symptom was diplopia with motility restriction in up gaze. The tumor was 
situated between the rectus superior and the levator palpebral muscle with 
infiltration of the rectus superior, extraconal fat and lacrimal gland, as shown 
in MRI scan. Enlarged rectus superior muscle with contrast medium 
enhancement as restricted manifestation of primary orbital liposarcoma has 
been reported (Monteiro 2002). Computer tomography tends to reveal a well 
circumscribed lesion with faint internal radiodensities; a pseudocystic 
appearance may be present with borders of apparent pseudocapsulation 
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(Cockerham et al 1998). CT findings can vary from well defined homogenous 
lesions of soft tissue density, not evidently fatty (Naeser et al 1982), to 
heterogenous lesions containing fat (Lane et al 1988). In cases, in which 
computer tomography failed to reveal an identifiable tumor, abnormal signal 
from part of orbital fat in MRI, indicated presence of pathology in these 
patients (Lane at al 1988). MRI usually shows a relatively hypointense mass 
on both T1- and T2-weighed images (Cockerham et al 1998), but spin 
characteristics not typical for fat containing tumor have also been seen by 
some authors (Lane et al 1988). Signal hyperintensity in T2-weighed images 
can also be encountered (Costas et al 2001). The different intensities which 
appear in CT and MRI are due to the different proportion of fat existing in this 
kind of tumor. Both patients in this study were examined with MRI, none with 
CT. The lesions were hypointense in T2-weighed and hypo- or isointens in 
T1-weighed images and showed marked gadolinium uptake.  One of the 
patients had a well circumscribed; the other had an infiltrative lesion. Because 
of the rarity of this tumor, the lack of specific findings in CT and MRI, and the 
commonly encountered well defined and encapsulated appearance without 
signs of malignancy in orbital imaging, the diagnosis is always established 
after surgery. In many cases biopsy can be initially misinterpreted (Lane et al 
1988, Jakobiec et al 1989, Cockerham et al 1998), and therefore all 
suspected cases should be reviewed by experienced experts to avoid delay in 
definitive care. Misdiagnosis occurred in one of our patients, in whom the 
initial diagnosis was that of a dermoid. Although tumors appear well-
encapsulated during surgery, in fact no true capsule exists. The “capsule” 
seen represents compressed orbital tissues, and this is evident on histological 
examination.  
Local wide excision of liposarcoma occurring elsewhere in the body is 
advocated by most authors (Enterline et al 1960, Spittle et al 1970, Kinne et al 
1973). Surgery with ample margins is generally considered as fundamental, 
since it admittedly improves survival and local control. In case of orbital 
involvement this usually means performing an orbital exenteration or even 
midfacial resection with or without subsequent radiotherapy. However, in a 
series of studies surgery plus radiotherapy were proven to have better results 
as compared to surgery alone (Saab et al 1996). Enterline (Enterline et al 
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1960) found that myxoid tumors are more sensitive to radiotherapy, whereas 
Spittle (Spittle et al 1970) reported surprisingly high response of poorly 
differentiated tumors. On the contrary, radiotherapy alone is not effective in 
achieving local control (Tran et al 1992). In a review of 29 orbital 
liposarcomas, 2 were pleomorphic and 1 was round cell. Most of the other 
cases were of myxoid type (Costas et al 2001). There were only 4 deaths 
among these patients. In 3 out of the 15 best documented cases (20%) there 
was a tumor relapse. The 2 of these patients underwent simple excisions and 
radiotherapy and the other one underwent radiotherapy alone. The remaining 
12 cases included 2 simple resections, 1 simple resection with radiotherapy, 1 
craniofacial resection, 2 craniofacial resections with radiotherapy, and 6 
exenterations. Survival was 94% in patients with a follow-up ranging from 2 
months to 4,5 years (Costas et al 2001). In cases with subtotal excision, 
radiotherapy has been reported to significantly decrease the risk of recurrence 
and is always recommended.  Most of the tumors relapse within the first year, 
although relapse has been reported even 5 years after diagnosis despite 
radical excision, subsequent radiation and favorable location and histology 
(Cockerham et al 1998).   
In our series, 1 patient with myxoid liposarcoma involving bone was treated 
with exenteration alone and 1 patient with well differentiated tumor was 
treated with total excision. In both patients no relapse was observed clinically 
and in MRI scans during a follow-up period of 7-12 months. None of our 
patients had metastasis on diagnosis or in the follow-up period. Therefore 
wide local excision seems to be the rational approach for this kind of tumor. 
As histology is the most important prognostic factor for survival (Kindblom et 
al 1975), the decision to perform additional radiotherapy should be based on 
histology, provided that total excision has formerly been conducted.  In any 
case of subtotal excision or in cases, in which uncertainty regarding the 
radicality of excision exists, subsequent radiotherapy should be the rule. In 
patients with well-differentiated and well-circumscribed lesions, however, local 
excision with or without radiotherapy is justified, provided that close follow-up 
will be performed.  
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Malignant fibrous histiocytoma 
This study included 1 male patient with a malignant fibrous histiocytoma (FH).  
The patient presented with exophthalmos of very slow evolution (4 years). An 
ex domo performed biopsy had established the diagnosis of non-specific 
inflammation; repeated therapy with corticosteroids and immunosuppressive 
medicaments, however, achieved no clinical improvement. The tumor was 
relatively well circumscribed and situated mainly intraconaly. It enhanced 
contrast medium intensively. Excisional biopsy was performed and 
histological examination showed a malignant fibrous histiocytoma. 
Exenteration with subsequent radiotherapy followed with the patient being 
free of disease 2 years after treatment.   
FH constitute 1% of all orbital tumors, and are considered the commonest 
primary mesenchymal tumors of the orbit in adults (Ulloa et al 1999). It is 
believed to be of histiocytic (Kempson et al 1972) or primitive mesenchymal 
cell origin (Fu et al 1975, Weiss et al 1978). In the greatest review of orbital 
FH in the literature including 150 cases (Font et al 1982) tumors were 
classified according to histological criteria in 3 groups: benign (94 cases), 
locally aggressive (39 cases) and malignant (17 cases). Benign FH are well 
circumscribed and some of them encapsulated, whereas local aggressive and 
malignant lesions display infiltrating margins. The duration of symptoms and 
size of the tumor were found to correlate with the possibility of malignity. 
Small lesions with a duration of several years were most likely benign (Font et 
al 1982). In the same study, almost 30% of the lesions showed foci of 
increased vascular proliferation and many irregularly dilated capillaries. Some 
of them had been initially misdiagnosed as hemangiopericytoma, 
haemangioendothelioma or angiosarcoma. Jakobiec (1978) hypothesized that 
FH and hemangiopericytoma probably arise from the same primitive 
mesenchymal cell, which may differentiate either to fibroblast/ histiocyte or to 
pericyte. In the series of Font et al (1982) various treatment modalities were 
performed, such as in toto excision, incomplete excision, piecemeal removal, 
exenteration, enucleation and craniotomy. The authors, however, provided no 
exact data of treatment modalities applied to each histological category 
mentioned. The incidence of local recurrence was 31% in the benign group, 
57% in the locally aggressive group and 64% in the malignant group. 9 
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patients died of tumor, either due to local invasion or due to metastatic 
disease. All patients with metastases belonged to the malignant category. 
Recurrence of tumor was sometimes combined with more aggressive clinical 
and histological characteristics. Radical tumor excision is the treatment of 
choice for malignant FH and for locally aggressive tumors, especially if they 
recur. A recurrence rate of 51% of patients with malignant FH despite total 
removal of the tumor has been reported by some authors (Kearny et al 1980); 
radical surgery was found by the same authors to improve the survival rate to 
68% after 5 years. In the study of Font et al (1982), the 10 year survival rate 
was 100% in benign, 92% in locally aggressive and only 23% in malignant 
FH. In case of orbital involvement, radical excision usually means 
exenteration, unless the tumor is small. Benign tumors can be treated with 
total excision. We performed exenteration with additional radiotherapy. No 
relapse was noted clinically and in MRI two years after treatment.  
Radiation therapy for the treatment of FH is controversial. Font et al (1982) 
report low tumor sensitivity to radiation therapy, since 13 of 18 patients 
treated with radiotherapy (72%) for whom follow-up information was obtained 
developed recurrence. Other authors however state that radiotherapy as well 
as chemotherapy may be useful for patients with surgical risk or more than 2 
lesions, and could also be used in addition to surgery (Hirano et al 1996). The 
decision to perform chemotherapy should be individualized by oncologists 
dealing with sarcomas after consideration of possible side effects and general 
health of the patient.  
 
Malignant solitary fibrous tumor 
Solitary fibrous tumor (SFT) is a rare spindle-cell neoplasm, which most 
commonly arises from the serosal surface of the pleura. However it has been 
encountered in many other sites including the orbit. Its intense 
immunoreacivity for CD34 and the fibroblastic nature of tumor cells on 
electron microscopy have definitely demonstrated their mesenchymal origin. 
The histological diagnosis may be missed and the tumor may be 
misdiagnosed as hemangiopericytoma, or schwanomma (Polito et al 2002). 
The differential diagnosis between SFT and a special form of angiomatous 
tumor called giant cell angiofibroma is still under discussion. Some authors 
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suggest that giant cell angiofibroma be a morphologic variant of SFT (Gouillou 
et al 2000, Gouillou et al 2002). The differential diagnosis also includes 
fibrous histiocytoma, menigioma and spindle cell melanoma. A misdiagnosis 
occurred initially in our case, as well; the tumor was initially diagnosed as a 
hemangiopericytoma or a giant cell angiofibroma. Immunohistology plays a 
very important role in the differential diagnosis; SFT are intensely positive for 
CD34 and negative for S100, which helps differentiate them from tumors 
mentioned above (Westra et al 1994, Heathcote et al 1997). Orbital MRI can 
also provide characteristic features suggesting the diagnosis of a SFT. The 
tumor is isointens in T1-weighed and more frequently hypointense in T2-
weighed images to grey matter, as was observed in our case, as well. This 
helps distinguish SFT from the T2-hyperintensity found in other spindle-cell 
neoplasms, such as fibrous histiocytoma and hemangiopericytoma (Gigantelli 
et al 2001). SFT are well circumscribed tumors (Gigantelli et al 2001, Polito et 
al 2002, O’ Donovan et al 2002, Romer et al 2005). This differentiates them 
from other collagen containing lesions, which share a similar T1 and T2 
pattern in MRI, such as sclerosing non-specific inflammations or scirrhous 
carcinoma metastases, which are lesions of infiltrative nature. Clinically the 
tumor can occur at any age, even in children (Alexandrakis et al 1998, Lucci 
et al 2001). Proptosis and eyelid swelling are the prevailing symptoms in the 
cases described in the literature. SFT are in their majority tumors with benign 
behavior, but cases of aggressive lesions have been also documented 
(Dorfman et al 1994, Ing et al1998, Carrera et al 2001, Polito et al 2002). As 
to the prediction of clinical behavior, although worrisome histological features 
of malignancy have been described (hypercellularity, cytologic atypia, tumor 
necrosis, and increase mitotic rate), there is no strict correlation between 
morphology and behavior. Histologically, atypical tumors with no evidence of 
recurrence or metastasis and recurrent tumors with benign histological 
profiles have been described (O’Donovan et al 2002). In our case, histology 
showed increased mitotic activity, and recurrence was observed 3 years after 
surgery. Radical surgery is the treatment of choice and is thought to be more 
advantageous for a good prognosis than histological signs of malignity, and 
this applies to pleural and orbital sites of involvement (Briselli M et al 1981, 
Gigantelli et al 2001). Recurrence of the tumor in our patient was 
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accompanied by more aggressive clinical and histological characteristics than 
the initial lesion, as sarcomatous transformation of the entire lesion and 
infiltrative growth were noticed. The same has been reported by other 
authors, as well (Carrera et al 2001 Bernardini et al 2003). Recurrence can 
occur many years after initial treatment; therefore, long term follow up is 
recommended. In our patient recurrence could not be treated with radical 
surgery as this would lead to total blindness (the other eye was enucleated in 
childhood). We performed subtotal excision in combination with radiotherapy, 
and the patient was free of disease one year after. A number of pleural 
malignant SFT have been successfully treated with postsurgical radiotherapy 
(Hayashi et al 2001). However, the efficacy of radiotherapy and chemotherapy 
remains overall unclear. Nevertheless, radiotherapy could be applied in 
exceptional cases like ours, in which radical surgery would lead to blindness.   
 
Rhabdomyosarcoma 
Rhabdomyosarcoma (RMS) is a rare tumor with an annual incidence of 4.3 
cases per million children (Gurney et al 1999). The orbit is the primary site in 
approximately 10% of these tumors. From the ophthalmologist’s standpoint, 
however, RMS is the most common malignant orbital tumor of childhood 
(Maurer et al 1993, Crist et al 1995). The histopathologic types of RMS 
include embryonal, alveolar, and pleomorphic. The embryonal form is the 
most common; the alveolar variety is less common and carries the worst 
prognosis. In a large series, 264 patients with orbital RMS were studied 
(Kodet et al 1997). Embryonal RMS was diagnosed in 221 patients (84%). 
The 5-year survival rate for these patients is approximately 95%. In contrast, 
the 5-year survival rate for the 24 children with alveolar RMS was 
approximately 75%.The pleomorphic type rarely occurs in the orbit (Newton et 
al 1995, Shields et al 2001). The most characteristic clinical presentation is 
the rapid onset and progression of exophthalmos and displacement of the 
globe. RMS should be suspected whenever the clinical presentation of a 
rapidly progressive unilateral exophthalmos is observed in a child. The clinical 
differential diagnosis includes most causes of proptosis in childhood. Benign 
and malignant neoplasms need to be considered, along with inflammatory 
disease, vascular tumors, leukemia, Burkitt lymphoma, allergic sino-orbital 
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aspergillosis, non-specific orbital inflammation, orbital cellulitis, histiocytosis, 
and metastatic neuroblastoma (Mafee et al 1998, Cota et al 2000, Karcioglu 
et al 2004, Chung et al 2007). Although imaging, clinical signs and symptoms 
are helpful in delineating the differential diagnosis, the decisive diagnosis is 
based on histopathologic confirmation (Karcioglu et al 2004). In orbital CT 
bone destruction is common, as was also observed in our case (Scotti et al 
1982). Bone erosion and intracranial extension can occur, as well. 
Management of patients is based on tumor staging according to the 
classification system of the Intergroup Rhabdomyosarcoma Study (IRS) 
(Shields et al 2001, Karcioglu et al 2004). RMS is best managed with 
combination treatment of chemotherapy, external-beam radiation therapy, and 
surgery. At some centers, the therapeutical role of surgery is limited to 
excisional biopsy, while in other centers, extensive surgery is performed to 
remove or debulk the tumor (Wexler LH et al 1997, Lanzkowsky 2000, 
Karcioglu et al 2004). In case of recurrent refractory tumors, some authors 
advocate radical surgery, which usually means exenteration, with or without 
chemotherapy and radiotherapy (Mannor et al 1997). The prognosis for 
patients with orbital rhabdomyosarcoma has greatly improved in recent years. 
Overall survival rate of patients with orbital rhabdomyosarcoma is now 93%. 
Embryonal type, tumor size less than 5 cm, patient age of >1 year carry the 
best prognosis (Shields et al 2001, Chung et al 2007). Since radiotherapy and 
surgery may lead to undesirable side effects, such as bony hypolplasia, facial 
asymmetry, cataract, dry eye, keratopathy, retinopathy and visual acuity 
deterioration (Raney et al 2000), it seems that the challenge of the future is to 
identify patients who can be safely treated only with chemotherapy and 
reserve radiotherapy and surgery for patients at risk of recurrence (Ducrey et 
al 2002). 
In our case, we preferred wide local excision in combination with 
brachytherapy for tumor recurrence, despite unfavourable histology, in an 
attempt to preserve ocular function and reduce the radiation dose. The clinical 
effect is unfortunately not known to us.  
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4.2.1.3. Tumors of the lacrimal gland 
 
Adenoid cystic carcinoma of the lacrimal gland is a rare malignant tumor 
generally associated with a grim prognosis. The difficulty in achieving a cure 
is due to the aggressive infiltrative behavior of the tumor though bone, distinct 
propensity for perineural infiltration with retrograde intracranial extension and 
hematogenous or lymphatic invasion. Although conventional therapy (surgery 
and radiation) may achieve local control in many patients, it is possible that 
occult metastases have already developed at the time of presentation (Forrest 
1971, Bertley et al 2002). Subsequently frequently death results from 
intracranial tumor extension or metastatic disease (Lee et al 1985). This also 
explains local recurrences in sites remote from the primary excision bed, such 
as ethmoid sinus mucosa, skull base and dura in many published series 
(Wright et al 1992, Font et al 1998, Esmaeli et al 2004). By anatomic 
definition, finding of tumor cells in the ethmoid sinus mucosa suggests that 
intracranial expansion and perineural extension to the trigeminal ganglion has 
already occurred. One such patient, who was included in our series, died 14 
months after initial diagnosis. The tumor affects relatively young subjects 
between 35 and 50 years of age, but the 2 of the totally 3 patients in our study 
were older than 60 years of age. It is believed that adenoid cystic carcinoma 
of the lacrimal gland in childhood and adolescence has a better survival 
(Tellado et al 1997). Radiographically, the tumor can be relatively well 
circumscribed resembling a pleomorphic adenoma (Tse et al 2005). Suspicion 
of malignancy should be raised if bone erosion, infiltration of the orbital 
muscles and fat or calcifications is observed. Pain in the lateral orbital region, 
which is reported to be present at 35-70% of the cases according to various 
authors, and relatively short time history of symptoms (less than a year), may 
also imply malignancy. In MRI scans the tumor becomes hyperintense with 
gadolinium injection. The 2 of our patients had a relatively well-circumscribed 
lesion, but in both of them extraocular muscle infiltration in orbital imaging was 
shown, with one of them having additional tumor calcification. In all cases the 
tumor enhanced contrast medium intensely. In 2 patients bone erosion was 
observed. None of our patients had pain.  
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Controversy exists regarding the appropriate therapy. Some authors advocate 
conservative surgical resection of tumor followed by external beam radiation 
therapy or proton-beam therapy. The alternative use of brachytherapy has 
also been proposed (Shields et al 2003). Others advocate an aggressive 
surgical approach with or without radiotherapy. Wright et al (1992) reported a 
series of 50 patients who had malignant lacrimal gland tumors, 38 of whom 
had adenoid cystic carcinoma; 12 patients (32%) died, all but one within 4 
years of treatment. Moreover, only 6 (35%) out of the other 17 patients 
described as disease-free had a follow-up of more than 4 years. Cranioorbital 
resection did not decrease the rate of tumor recurrence or improve the rate of 
disease free survival. The patients who underwent an aggressive surgical 
approach however constituted a greater proportion of those who lived for 
more than 10 years after treatment than those treated more conservatively. In 
a series of 7 patients (Esmaeli et al 2006), all of them with locally advanced 
adenoid cystic carcinoma of the lacrimal gland, the survival outcome was 
poor, with 5 of 7 patients dying of metastasis in a mean of 21 months after 
diagnosis, although radical orbital and skull base surgery followed by radiation 
therapy had initially achieved good local control. In one patient metastasis 
was known before surgery, however in the rest of the patients metastasis 
developed after surgery. All of the patients had perineural invasion and 6 of 
them had basaloid (solid) pattern, both of which are considered as bad 
prognostic factors (Tellado et al 1997, Font et al 1998). It seems that patients 
with advanced local disease are more likely to develop metastasis or to have 
occult metastasis at the time of diagnosis; therefore, radical surgery usually 
performed in these patients will not improve survival. Moreover, other studies 
found that disease free survival may not be improved by aggressive surgery 
(Esmaeli et al 2004, Lee et al 1985). Nevertheless, keeping with basic 
principles of oncology most authorities would agree that it is desirable to 
achieve local control of the disease and eradicate the clinically and 
radiographically apparent tumor even by means of radical surgery. Another 
potential option for local therapy of adenoid cystic carcinoma of the lacrimal 
gland is the preoperative intra-arterial chemotherapy followed by tumor 
excision (Meldrum et al 1998, Tse et al 2006). Since the tumor may have 
already escaped the orbital confines by perineural dissemination by the time 
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of presentation, the introduced intra-arterial administration of chemotherapy 
could constitute a rational therapeutical option. This approach intends to 
decrease systemic side effects and simultaneously increase the dose in the 
tumor region. This sort of treatment is not intended to replace but to augment 
surgical and radiation therapy and to achieve a higher survival rate reducing 
the possibility of distant disease relapse. Intra-arterial chemotherapy may also 
permit surgical resection of a formerly considered unresectable tumor with 
intracranial invasion, by shrinking the tumor and bringing its margins to within 
the orbit. In the study of Tse et al (2006), in 2 patients with extensive 
intracranial infiltration, shrinking of the tumor was achieved with this method 
and subsequent radical surgery with radiotherapy followed. Both patients 
remained free of disease 16,5 and 5 years after treatment. In the same study 
the cumulative 5-year carcinoma cause specific death rate in the treated 
group was 16,7% compared to 57,1% in the conventional treatment group. 
The cumulative 5-year recurrence rate was 23,8% in the treated group 
compared to 71,4% in the conventional treatment group.  
In our series, 1 patient had advanced disease with intracranial dural 
involvement at first presentation. We performed orbital exenteration with 
treatment of suspicious bone foci with CO2-laser and postoperative 
radiotherapy. The tumor relapsed with involvement of frontal sinus, ethmoid 
sinus, skull base and optic chiasm 10 months later and the patient died 14 
months after initial diagnosis. 1 of our patients had a tumor extending close to 
the apex, without obvious bone infiltration (radiographically and intraoperative) 
or intracranial invasion. Exenteration without bone removal with postoperative 
radiotherapy was performed. This patient was free of relapse and metastasis 
in MRI 4,5 years after treatment. The third patient in our series had also no 
intracranial involvement. Bone erosion could not be definitively excluded. We 
performed orbital exenteration with subsequent radiotherapy. Histological 
examination showed tumor cells in all excision margins and perineural 
infiltration. The clinical course in this patient is not known to us. All of our 
patients had solid (basaloid) type of adenoid cystic carcinoma which is 
considered as bad prognostic factor. In a review of 94 adult patients from 4 
major centers a distant metastasis rate of 50% (47 of 94) at 5 years is 
reported (Lee et al 1985, Wright et al 1992, Font et al 1998, Esmaeli et al 
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2004). The prevention of metastasis is a major challenge and could improve 
the prognosis in patients with adenoid cystic carcinoma of the lacrimal gland. 
Future efforts that will concentrate on targeted biological therapies may alter 
the generally bad prognosis of this malignancy.  
 
4.2.1.4. Metastasis 
 
This study included 3 patients with orbital metastases: 1 from breast 
carcinoma, 1 from prostate adenocarcinoma and 1 from neuroendocrine heart 
tumor. Only the first patient had symptoms in form of ptosis and lid swelling. 
The diagnosis of the orbital disease was made 5 years, 3 months and 7 years 
respectively after diagnosis of the primary tumor. The patient with the breast 
carcinoma and the patient with neuroendocrine tumor had already been 
operated due to their primary tumor. In the third patient the tumor was found 
in scintigraphy performed for staging of a newly diagnosed prostate 
adenocarcinoma. In the patient with the neuroendocrine tumor, the orbital 
tumor was a coincidental finding in MRI performed for other reason.  
The patient with prostate adenocarcinoma had an osteoplastic metastasis in 
the sphenoid bone; chemotherapy followed and the patient was free of orbital 
disease 1 year after. The further course is not known to us.  
The patient with breast carcinoma died of metastatic disease 2 years after 
diagnosis of the metastasis.  
The patient with neuroendocrine tumor had no residual disease after tumor 
extirpation, but follow-up was for a short period of time (4 months).  
According to various authors metastatic tumors account for 2-9% of orbital 
neoplasia. Breast carcinoma has been reported to be the most frequent cause 
of orbital metastasis (Henderson 1980, Shields et al 1988, Goldberg et al 
1990). Orbit is a crowded area and therefore expansion of a mass will cause 
symptoms earlier than in other sites. Therefore orbital symptoms can precede 
symptoms caused by the primary tumor in as many as 14-42% of the cases 
(Font et al 1976, Henderson 1980, Shields et al 1988, Goldberg et al 1990). 
The mean interval between the diagnosis of the primary tumor and metastasis 
also varies between 2,5 and 5 years (Goldberg et al 1990, Tijl et al 1992, 
Moreiras 2004). The longer mean interval is that of breast carcinoma 
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compared to all other tumors (mean interval 6 years, Moreiras 2004). This is 
in agreement with our case of metastatic breast carcinoma. According to 
Rootman (1988) bilaterality occurs in 14% of cases. Histopathologic 
examination is adequate in diagnosing most tumors but in some instances of 
undifferentiated tumors electron microscopy (Jakobiec et al 1978, Riddle et al 
1982) and immunohistochemistry (Winkler et al 1981, Tell et al 1985) are 
necessary. The treatment of patients with orbital metastasis is almost always 
palliative and depends on primary tumor. Orbital surgery is indicated only in 
cases where the tumor is small, well circumscribed and easily accessible, or 
when it threatens vision or causes extreme proptosis and pain (Tijl et al 1992). 
Mean survival varies in different studies from 10,2 to 25 months (Shields et al 
1988, Goldberg et al 1990, Tijl et al 1992). It is obvious that survival depends 
on primary tumor. Breast carcinoma has a mean survival of 22 months in the 
larger series and this was also observed in our case (24 months).   
 
4.2.2. Benign tumors 
 
4.2.2.1. Vascular tumors 
 
Cavernous hemangiomas are the most common benign tumors of the orbit in 
adults (Henderson 1994, Rodgers et al 2000). Yet cavernous hemangioma is 
an uncommon finding; the incidence is between 0,6-2 per year (Wright 1974, 
Jakobiec 1978). Orbital cavernous hemangiomas are seen more frequently in 
females with a peak incidence in the fifth decade of life (Gloor et al 1992, 
Gunalp et al 1995). However, in our series we noticed no sex predilection and 
this has been reported by other authors, as well (Thorn-Kany 1999). All our 
patients had unilateral single lesions, but bilateral or multiple lesions in the 
same orbit have also been described (McNab et al 1989, Wolin et al 1990, 
Sullivan et al 1992, Paonessa et al 2008). The most common symptom is 
exophthalmos of slow evolution with subsequent globe displacement. Ocular 
motility is usually normal, even in cases of large tumors. Unlike many other 
vascular orbital lesions, acute symptoms due to tumor hemorrhage are 
exceedingly rare. In a large series of 162 cavernous hemangiomas (Selva et 
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al 2001) an acute or subacute hemorrhagic episode was never documented. 
Therefore, acute hemorrhage in an orbital tumor makes the diagnosis of a 
cavernous hemangioma extremely unlikely. The vast majority of these tumors 
are intraconal (93% in our series, 80-82% in the literature). In CT and MRI, 
cavernous hemangiomas present as well circumscribed oval tumors (Acciari 
et al 1993, De Potter et al 1995, Wilms et al 1995). In T1-weighed images in 
MRI the tumor typically shows a homogenous isointense signal with respect to 
the extraocular muscles and a hypointense signal relative to orbital fat. In T2-
weighed images the tumor has homogenous signal intensity with respect to 
fat and muscles. Calcified phleboliths are occasionally seen in CT (De Potter 
et al 1995). The CT appearance and MRI signal in T1-weighed and T2-
weighed images are however of no value for differential diagnosis, because 
many other orbital lesions may show similar signal characteristics and present 
as well-circumscribed oval masses, such as: neurofibroma, 
hemangiopericytoma, schwannoma, fibrous histiocytoma. MRI can specify the 
diagnosis of orbital cavernous hemangioma after administration of gadolinium, 
especially if delayed sequences are repeated after contrast medium 
administration. An initial heterogenous patchy enhancement of the lesion 
which increases on delayed scans and becomes homogenous, is highly 
suggestive for cavernous hemangioma as reported by some authors (De 
Potter et al 1995, Wilms et al 1995, Thorn-Kany et al 1999). However others 
suggest that similar characteristics can be observed in other orbital lesions, as 
well, such as schwannomas, and not the enhancement gradient but the 
enhancement spread pattern on dynamic MRI be more useful for the 
differential diagnosis (Tanaka et al 2004). The differential diagnosis of orbital 
vascular lesions, which include cavernous hemangiomas, varices, 
lymphangiomas, hemangiopericytomas and arteriovenous malformations, can 
be difficult, since some orbital vascular lesions exist on a continuum and only 
subtle differences may be noticed on conventional CT and MRI. A 
classification of these lesions according to their hemodynamic characteristics 
has been proposed (Harris 1999). On this basis, determining blood flow 
characteristics alongside high-resolution soft tissue images can be very 
important for the right diagnosis and treatment in certain cases. For these 
purpose 3 alternatives exist: combining separate soft tissue imaging with 
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invasive angiography, dynamic CT-angiography and dynamic contrast 
enhanced magnetic resonance angiography (MRA) (Kahana et al 2007). 
Although conventional angiography has been considered as the gold standard 
method for the study of orbital vascular pathology for many years, this 
technique is invasive and it is associated with minimal but definite risk of 
complications, such as cerebral infraction or ophthalmic artery thrombosis or 
embolization.  Computed tomography angiography and dynamic MRA with 
different system modalities (TRICKS, Syngo TWIST, 4D-TRAK) can provide 
extremely useful information when difficulties in the differential diagnosis are 
encountered (Kahana et al 2007). It is however true that in the majority of 
patients with cavernous hemangioma diagnosis can be made on the basis of 
clinical findings and conventional MRI (Scheuerle et al 2004, Yan et al 2004). 
We suggest that more detailed investigation should be spared for untypical 
cases or lesions whose anatomical site of involvement makes surgical 
excision problematic and is associated with high risk of complications. In case 
of such lesions simple observation may be more beneficial than surgery; 
exclusion of lesions with the potential for malignant transformation, such as 
hemangiopericytoma or solitary fibrous tumor, is then of great importance. 
Surgical treatment is indicated in symptomatic patients. For patients with 
small lesions without any symptoms simple observation may be sufficient. 
Total excision is not mandatory, especially when it is difficult due to tumor 
location, because recurrences are extremely rare and growth is very slow 
(Orcutt et al 1991, Gloor et al 1992, Gunalp et al 1995).  Removal can be 
performed through several surgical approaches such as lateral, medial, 
anterior or transconjuctival, dependent on the tumor location. In case of 
tumors located in the anterior orbit, extraconally or intraconally, a 
transconjuctical approach can be chosen (Yan et al 2004, Cheng et al 2008). 
In case of lesions located deeper in the orbit close to the apex or lesions 
combined with large draining veins, standard lateral orbitotomy should be 
considered. Some authors advocate a transcranial approach for large lesions 
superior and medial to the optic nerve, which involve the orbital apex 
(Scheuerle et al 2004).  
We performed 11 lateral, 2 medial and 1 anterior orbitotomy. Lateral 
orbitotomy offered a very good tumor exposure in the majority of intraconal 
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lesions. The surgical approach chosen depends not only on tumor location but 
also on experience and personal preference of the surgeon. Independent of 
surgical approach, the majority of patients obtain benefit from surgery 
particularly in their exophthalmos and motility impairment (McNab et al 1989, 
Hassler et al 1994, Acciari et al 1995, Scheuerle et al 2004, Yan et al 2004, 
Cheng et al 2008). In 12 of our 14 patients, complete tumor excision without 
any postoperative complications was achieved. In 1 patient with large 
cavernous hemangioma surrounding the optic nerve, partial tumor excision 
led to reduction of exophthalmos (14 mm difference preoperatively, 9 mm 
difference postoperatively in Hertel exophthalmometry). Since visual acuity 
was normal, no other treatment followed. Only in 1 out of 14 patients visual 
acuity loss occurred after partial excision of a tumor in close proximity to the 
optic nerve due to retinal central artery occlusion; visual acuity failed to 
recover in this patient.  
Orbital lymphangiomas are defined as abortive, non-functional vascular 
systems that arborize through variable portions of the orbit (Harris et al 1990). 
Contrary to Wright, who considered them as primary orbital varices (1974), 
many orbitologists and finally the Orbital Society in its annual meeting in 1998, 
classified them as distinct vascular malformations (Harris 1999). This 
classification was based on the hemodynamic characteristics of orbital 
vascular malformations, and lymphangiomas were separated from orbital 
varices due to their isolation from the systemic circulation. Mixed forms, 
including venous and lymphatic (no flow) components were classified as 
venous flow malformations, in order to emphasize the clinical importance of 
the venous relationship. Although hemodynamically isolated from the 
systemic circulation, nutritient vessels within their flimsy walls may be the 
source of hemorrhage in their lumens, which transforms microscopic channels 
and cysts to large macrocysts. These lesions are present at birth but they can 
be hidden for years, becoming manifest after trauma and intralesional 
hemorrhage. It must be emphasized that vascular malformations are 
considered as a continuum that runs the gamut from purely arterial to purely 
venous, lymphatic or capillary vascular lesions, and as such this continuum 
includes a potential combination of lesions that have elements of one, two, 
three or four of the various types of vessels (Mulliken et al 1988, Harris et al 
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1990, Rootman 1998). In fact many lesions display a spectrum of mixed 
lymphatic and venous characteristics based on the clinical, radiological, 
hemodynamic and histological evidence (Rootman et al 1986, Katz et al 
1998). Predominantly lymphatic lesions with foci of irregularly shaped cystic 
spaces showing direct filling from tiny branches of the ophthalmic artery in 
selective arteriograms have been recently described. These lesions have 
been termed as arteriolymphatic communications (Bisdorff et al 2007).  
Lymphangiomas are rare tumors accounting for less than 2% of orbital tumors 
in large series (Shields et al 1984, Henderson et al 1994). Clinical 
presentations are slowly progressive proptosis, globe displacement, ptosis, 
and restriction of eye movements, spontaneous intraorbital hemorrhage with 
acute exophthalmos or optic neuropathy and even loss of vision. In children 
with marked ptosis deprivation amblyopia may develop. Lymphangiomas 
usually present in the first two decades of life (Tunc et al 1999, Selva et al 
2001). However, lesions becoming clinical evident over the age of 50 years 
have been described; some of them had been initially diagnosed as 
cavernous hemangiomas (Selva et al 2001). In order to establish the right 
diagnosis, orbital imaging with CT or preferably with MRI is of utmost 
importance. MRI better delineates the heterogenous and often multiloculated 
nature of the lesion, and is certainly the definite method for imaging any 
hemorrhagic cysts (Bond et al 1992, Moreiras 2004). Imaging findings have 
been reported to correlate with the surgical outcome (Gunduz et al 2006). 
From a clinical point of view, lesions are classified as superficial, deep or 
mixed.  
In general, treatment of lymphangiomas may be challenging and many of 
them may require multiple operations for visual preservation and cosmesis 
(Tunc et al 1999 Gunduz et al 2005).  Total excision of the lesion is in most 
cases impossible due to its infiltrating nature. Excision of relatively well 
circumscribed lesions situated in the anterior orbit mainly extraconally or 
excision of the anterior part of a lesion with extra- and intraconal component is 
not generally considered to be combined with high risk or recurrence (Selva et 
al 2001, Moreiras 2004, Gunduz et al 2006). However, when moving 
posteriorly, there are dense fibrous adhesions, and aggressive surgical 
excision can lead to postoperative hemorrhage with optic nerve compression 
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or forming of new blood cysts. Moreover, excision of apical components 
carries a high risk of vision loss due to central retinal artery occlusion. This 
also held true in cases of very well delineated intraconal lymphangiomas, 
which had been initially misdiagnosed as cavernous hemangiomas in 
preoperative orbital imaging techniques (Selva et al 2001).  This emphasizes 
the value of meticulous pre-operative MRI study for the right planning of the 
operative procedure. When surgery is performed and difficulty in posterior 
dissection is encountered, it is advisable to consider leaving a small residual 
component. This also prevents trauma to unexpanded parts of the anomaly, 
reducing new blood cyst formation (Harris et al 1990, Moreiras 2004). In some 
of these cases the carbon dioxide laser can be used during surgery, as it can 
facilitate surgical debulking and shrinkage of unresectable parts of the tumor 
(Kennerdell et al 1986, Harris et al 1990). Interestingly, subtotaly excised 
lymphangiomas have not recurred in a long period of follow-up (Selva et al 
2001, Gunduz et al 2006). In the study of Tunc et al (1999), which included 24 
operated patients, a recurrence rate of 58,3% was reported. A similar rate 
(52%) was reported in the study of Harris et al (1990) including 23 operated 
patients. Tunc et al (1999) found that presence of definite chocolate cyst 
appearance at initial MRI was significantly correlated with multiple 
recurrences. The same authors failed to disclose any relationship between 
histological findings and risk of recurrence. Many orbitologists advocate 
conservatism in surgical case selection and surgical dissection (Haris et al 
1990, Moreiras 2004).  In that sense, other treatment modalities which include 
administration of systemic steroids (Muallem et al 2000, Sires et al 2001) or 
intralesional injection of various sclerosing agents (Suzuki et al 2000, Larrane 
et al 2002, Schwarcz et al 2006) have been proposed with various results.  
In our single case the lymphangioma recurred three times in a period of 6,5 
years. For patients presenting in the second decade, like our patient, multiple 
recurrences have been reported by other authors, as well (Tunc et al 1999). 
However, no association between age at presentation and recurrence risk has 
been observed by others (Wright 1974, Illif et al 1979, Graeb et al 1990). 
Since multiple surgeries correlate with higher risk to vision and motility 
(Hemmer et al 1988, Wilson 1989), we advised the patient against a new 
operation due to the presence of a large intraconal tumor with close contact to 
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the optic nerve. The patient, however, demanded a re-operation due to 
cosmetic disfigurement caused by marked exophthalmos, and unfortunately 
suffered vision loss from apical hemorrhage with optic nerve compression.   
 
4.2.2.2. Tumors of the lacrimal gland 
 
Pleomorphic adenoma of the lacrimal gland accounts for approximately 12-
25% of lacrimal gland tumors (Reese 1971, Shield et al 1989). The most 
important differential diagnosis includes malignant lacrimal gland tumors. A 
clinical algorithm taking into account duration of acute symptoms, persistent 
pain, sensory loss and radiological findings has been proposed by Wright et al 
(1979 and 1992) to assess the possibility of malignity of a lacrimal gland 
tumor. With the use of this algorithm these authors claimed to have correctly 
diagnosed preoperatively 55 of 63 (87%) patients with pleomorphic adenomas 
of the orbital portion of the lacrimal gland (Rose et al 1992). Preoperative 
diagnosis is crucial since incisional or fine needle biopsy is traditionally 
thought to increase the risk of recurrence (Font et al 1978, Wright et al 1979, 
Auran et al 1988) and it should be ideally avoided. However a recent review of 
the literature on biopsy of both lacrimal gland pleomorphic adenoma and 
pleomorphic adenoma of the salivary gland, questions whether preoperative 
biopsy correlates with high recurrence rate, if it is followed by total excision of 
the tumor including the biopsy tract. Rootman (2003) has also suggested that 
difficult cases should be biopsied. In a published series of 15 patients who 
had incisional biopsy (Rose et al 1992), 10 underwent total 
dacryoadenectomy with excision of the biopsy tract and none recurred in a 
mean follow-up of 6 years. As to the other 5 patients, 4 of them had 
incomplete excision, with 2 of them developing recurrence attributed to 
incomplete excision rather than biopsy. Only 1 patient developed malignant 
transformation, but he was initially operated 4 decades before his first 
presentation to the authors and no details were provided regarding surgical 
technique and radicality of excision. Incomplete resection is surely the main 
risk factor for recurrence, and the importance of initial complete excision of 
the tumor is emphasized by many authors (Font et al 1978, Rose et al 1992, 
Henderson 1994, Tang et al 1997). In the series of Font (1978), about 10% of 
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adenomas underwent malignant change by 20 years after first treatment and 
20% by 30 years. In our study, 4 patients with newly diagnosed lacrimal gland 
adenoma underwent lateral orbitotomy, with 3 of them having total and 1 of 
them partial tumor excision; in a mean follow-up of 1,4 years only 1 of them 
recurred. Additionally, 2 other patients presented with tumor relapse; the first 
of them had had partial tumor excision 5 years before reference to us. We 
performed lateral orbitotomy and excision of a multinodular tumor. Malignancy 
was excluded histologically. A small rest was left after surgery and no 
increase was shown in MRI three years after. The second patient had been 
operated 23 years before reference to us. No details about the first operation 
are known. We performed total excision of tumor relapse. Histological 
examination again excluded malignancy. Since, however, pleomorphic 
adenomas have the tendency to late recurrence it is obvious that a true 
assessment of “cure rate” for our patients is precluded until many years have 
passed. 
 
4.2.2.3. Neurogenic tumors 
 
Schwannomas are uncommon orbital tumors that arise from the Schwann- 
cell sheaths of peripheral nerves. About 2% of space-occupying orbital lesions 
have been reported to be peripheral nerve tumors, with approximately 1% 
schwannomas (neurinomas) (Shields et al 2002). Schwannomas are almost 
always benign tumors, but extremely rare malignant varieties have been 
reported (Capps et al 1990, Miliaras et al 2008). Clinical symptoms evolve 
insidiously and include exophthalmos, diplopia, optic neuropathy and sinusitis 
(Rootman et al 1982). Histologically, these tumors are characterized by two 
distinct cellular patterns: Antoni A and Antoni B. Antoni type B pattern areas 
have undergone extensive cystic and mucinous degeneration, whereas Antoni 
type A pattern is more cellular. This reflects to the MRI findings of 
neurinomas, which may present as heterogenous tumors composing of a solid 
and a cystic component (Rawlings et al 2007, Kiratli 2007). Both patients with 
neurinoma included in our study, displayed these MRI characteristics. This 
MRI pattern and the non-specific clinical picture of a space occupying lesion 
of slow evolution makes differential diagnosis from other orbital lesions with 
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cavitary change, such as cavernous hemangioma and lymphangioma, 
problematic (Gunduz et al 2003). Both cases in our series had been initially 
misdiagnosed as cavernous lymphangioma (mixed venous-lymphatic 
malformation) by radiologists. Dynamic MRI can be helpful for the differential 
diagnosis from vascular neoplasms, especially from cavernous hemangiomas 
as already mentioned above. In a recent review of MRI findings of 62 patients 
with orbital schwannomas, an intense peripheral ring shaped contrast uptake 
seen in 25% of the cases has been considered as a specific characteristic of 
these tumors (Wang et al 2008). The surgical approach can be through 
anterior, lateral, or combined lateral-orbitotomy and frontal-craniotomy 
(Rootman et al 1982, Kiratli et al 2007) and it is dictated by the location of the 
lesion. Surgical removal may be total or subtotal, in piecemeal fashion, or by 
evacuation of the tumor from within its capsule. The type of removal is 
dictated by the location and attachments to adjacent structures. Due to their 
peripheral outpouching characteristic, schwannomas may be successfully 
stripped of the nerve of origin by microscopic techniques (Rootman et al 
1982). We performed lateral orbitotomy in both cases with total and subtotal 
tumor excision respectively. In both patients the clinical course was uneventful 
and no other treatment followed.  
 
4.3. Vascular lesions 
 
4.3.1. Arteriovenous fistulas 
 
Dural (indirect) arteriovenous fistulas (AF) are separated anatomically into 
three types: 1) shunts between meningeal branches of the internal carotid 
artery (ICA) and the cavernous sinus (CS), 2) shunts between meningeal 
branches of the external carotid artery (ECA) and the CS, and 3) shunts 
between meningeal branches of both ICA and ECA and the CS (Barrow et al 
1985). Their pathogenesis remains controversial. The theory supported by 
most investigators assumes that most of these lesions develop in response to 
spontaneous venous thrombosis in the cavernous sinus and represent an 
attempt to provide a pathway for collateral venous outflow. In a study (Mironov 
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1994) residual angiographic findings implying past CS thrombosis were found 
in 62% of patients. Predisposing factors include pregnancy, systemic 
hypertension, atherosclerotic vascular disease, connective tissue disease 
(such as Ehlers–Danlos- syndrome), and minor trauma (Taki et al 1994, 
Mironov 1995). The symptoms and signs produced by these lesions are 
influenced by the size of the fistula, the rate of blood flow, and drainage route, 
especially if the drainage route is posterior, anterior, or both (Stiebel et al 
2002). Some authors postulate that in most cases the initial drainage route of 
the fistula is posterior into the inferior petrosal sinus, basilar plexus or both, 
and when this pathway becomes thrombosed the fistula begins to drain 
anteriorly producing visual signs and symptoms (Grove 1984). These patients 
are usually initially asymptomatic or they may present with an acute, isolated 
cranial nerve paresis such as trigeminal neuropathy (Rizzo et al 1982), facial 
nerve paresis (Moster et al 1988) or an ocular motor nerve paresis 
(Eggenberger 2000) without any signs of orbital congestion. Further 
evaluation with cerebral angiography will reveal a posteriorly draining fistula. 
Shortly thereafter ocular symptoms will evolve. Ocular symptoms may be 
subtle or more severe mimicking a direct fistula. In some cases, redness of 
one, or rarely, both eyes, caused by dilation and arterialization of conjuctival 
and episcleral vessels may be the only sign, which can be misdiagnosed as 
episcleritis, conjunctivitis or thyroid orbitopathy. In more advanced cases with 
high flow-rate, however, proptosis, chemosis, diplopia resulting from 
ophthalmoplegia or orbital congestion or both mechanisms, and retroocular 
discomfort or pain, are present suggesting an inflammatory process or even 
the Tolosa–Hunt syndrome (Brazis et al 1994). Increased intraocular pressure 
can evolve due to multiple mechanisms, such as increased episcleral venous 
pressure (Keltner et al 1987), secondary angle–closure resulting from 
choroidal effusion and forward displacement of the iris–lens diaphragm (Talks 
et al 1997), or angle vascularisation resulting from retinal ischemia (Barke et 
al 1991, Moreiras 2004). Ophthalmoscopic abnormalities include venous 
stasis retinopathy, central retinal vein occlusion, proliferative retinopathy, 
retinal detachment, vitreous hemorrhage, choroidal folds, choroidal 
detachment, or optic disc swelling (Jorgensen and Guthoff 1988, Gonshor et 
al 1991, Barke et al 1991, Moldovan et al 1997). Visual loss, although less 
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frequent than in patients with direct fistulas, may be caused by ischemic optic 
neuropathy, retinal compications, or uncontrolled glaucoma. The ocular 
manifestations of unilateral dural fistulas are almost always ipsilateral to the 
fistula, but they may be solely contralateral or bilateral (Stiebel-Kalish et al 
2002). Our series included 1 patient with dural fistula between the ICA and the 
CS with drainage by the contralateral superior ophthalmic vein. When 
unilateral fistulas cause bilateral manifestations, there is a high probability that 
the fistula is draining into cortical veins and this is combined with a high risk of 
intracranial hemorrhage (Stiebel-Kalish et al 2002). In these cases, absolute 
indication for therapy exists (Solymosi 2004). None of our patients had 
bilateral symptoms. Direct fistulas between the ICA and CS are usually of 
traumatic origin and cause the signs and symptoms mentioned above. 
Differential diagnosis includes conjunctivitis, dysthyroid orbitopathy, non 
specific orbital inflammation, orbital cellulitis, episcleritis, sphenoorbital 
meningioma, or Tolosa–Hunt syndrome (Grove 1984, Brazis et al 1994, 
Procope et al 1994, Oestreicher et al 1995). The correct diagnosis in some 
cases may not be able to be made until symptoms and signs worsen, new 
symptoms and signs develop and appropriate diagnostic studies are 
performed. When a dural carotis cavernous fistula is suspected, CT scanning, 
CT angiography, MR imaging, MR angiography, orbital ultrasonography, 
transorbital and transcranial color Doppler imaging, or a combination of these 
tests may be beneficial in confirming the diagnosis (Coskun et al 2000, Kilic et 
al 2001, Kawaguchi et al 2002, Rucker et al 2003). The gold standard 
diagnostic test, however, is a catheter angiogram, as in the case of the direct 
carotid cavernous fistula (Debrun 1995). Because many dural fistulas are fed 
either by meningeal branches of the ECA or by meningeal branches of both 
the ICA and ECA and others are fed by arteries from both sides or are fed by 
unilateral arteries but produce bilateral symptoms and signs, selective 
angiography of both the ICA and ECA on both sides should always be 
performed (Debrun 1995). When performed by an experienced 
neuroradiologist, catheter angiography has a morbidity rate of less than 1% 
and virtually no mortality rate, except in patients with connective tissue 
disorders such as Ehlers–Danlos syndrome, in whom the risks are much 
greater (because of excessive fragility of the extracranial and intracranial 
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vessels). Regardless of whether they drain anteriorly or posteriorly, 20–50% 
of dural fistulas close spontaneously or after angiography (Liu et al 2001). For 
this reason, patients with mild symptoms can be initially observed. In general, 
however, endovascular embolization is the optimum treatment for high flow 
dural fistulas or direct fistulas that produce progressive or unacceptable 
symptoms and signs including visual loss, diplopia, intolerable bruit, severe 
exophthalmos, and, most importantly, cortical venous drainage. Direct fistulas 
can be embolized with balloons or platinum coils which are usually introduced 
though a catheter placed in the arteria femoralis. In some cases the wall of 
the ICA is severely injured, and the interventionalist cannot be sure if a device 
(balloon or platinum coils) used to close the fistula was either in or 
compromising the lumen of the ICA. In these cases, complete occlusion of the 
ICA (trapping) was previously the only choice (Solymosi 2004). However, 
significant advances in stent and catheter design nowadays make it possible 
in many instances to deploy either balloon-expandable or self-expanding 
stents in the cavernous and supraclinoid segments of the ICA. In this way, it is 
possible to reconstruct a severely injured artery, and trapping can be avoided 
(Ahn et al 2003, Men et al 2003, Moron et al 2005). Indirect dural fistulas can 
be best embolized with platinum coils introduced though a transvenous route 
(femoral vein or internal jugular vein) (Solymosi 2004). If this fails, a variety of 
other approaches may be applied, most of which involve cannulation of the 
superior ophthalmic vein via an eyelid crease incision (Spinelli et al 1994, 
Goldberg et al 1996) or even a lateral orbitotomy (Badilla et al 2007). 
Alternatively the embolization material can be introduced via a microcatheter 
placed in the ECA and passed into the specific branch or branches that feed 
the fistula (Liu et al 2000). The ICA is not usually embolized unless the 
interventionalist can successfully catheterize the meningohypophyseal trunk 
or other meningeal feeders from the artery (Borden et al 2001). When a dural 
fistula is fed by branches from both the ECA and ICA, embolization of the 
feeders from the ECA may reduce the blood flow in the fistula sufficiently so 
that non-embolized feeders from the ICA will thrombose spontaneously (Liu et 
al 2001). This was observed in one of our patients with a complex fistula fed 
by both ECA and ICA. Embolization of feeders of the ECA only led to closure 
of feeders from the ICA and full recovery of symptoms. Embolization of 
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feeders from the ICA is in many cases inappropriate because of the significant 
potential neurological morbidity from distal embolization (Kupersmith et al 
1988). The intravenous route is then the route of choice (Badilla et al 2007). 
With endovascular therapy the healing rate for patients with carotid cavernous 
fistulas is overall > 90% (Solymosi 2004). After successful closure, however, 
recanalisation of the fistula can occur in some cases. The decision to perform 
further treatment depends on the severity of symptoms.  
5 patients with carotid cavernous fistulas and 1 patient with fistula between 
the ECA and SOV, included in this study, underwent endovascular 
embolization. In 2 patients recanalisation occurred; 1 of them underwent 
second treatment, whereas the second one received no further treatment, as 
symptoms resolved. In all 5 patients the postoperative course was uneventful 
and symptoms completely regressed.  
 
4.3.2. Orbital Venous malformation (OVM)-Thrombosis of the superior 
ophthalmic vein (SOV) 
 
As already mentioned, in 1999 a consensus statement on terminology of the 
orbital vascular disorders was published by the members of the Orbital 
society. The classification, which was proposed, was based on hemodynamic 
characteristics of orbital vascular malformations. Venous flow lesions or 
orbital venous malformations (orbital varices) were divided in distensible and 
non-distensible varieties (Harris 1999). Distensible lesions are those with rich 
and direct communication to the orbital vascular system, which is obvious 
clinically (enlargement with Valsalva maneuers or in dependent positions) or 
radiographically (enlargement with increased venous pressure-dynamic CT). 
Non-distensible OVM have minimal connection to the orbital vascular system 
and these lesions either produce a mass effect or can lead to acute symptoms 
due to hemorrhage or thrombosis. These symptoms include acute pain, 
exophthalmos, diplopia or even optic nerve compression. Episodes of 
thrombosis or hemorrhage may be recurrent. The non-distensible variety is 
often difficult to separate from lymphangiomas, which are considered as no-
flow lesions (Rootman 1988). Non-distensible OVM have demonstrable 
connections to the orbital venous system by venography or direct intralesional 
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injections, whereas lymphangiomas do not (Rootman 1986, Harris 1990). 
Mixed lesions with lymphatic and venous component are classified as venous 
flow malformation, in order to emphasize the clinical importance of the venous 
relationship (Harris 1999). Episodes of thrombosis and/or hemorrhage may 
complicate distensible OVM, as well, but they are much less common (Lacey 
et al 1999). In a review of 22 cases of OVM, of whom 18 were distensible and 
4 non-distensible, thrombosis or hemorrhage were observed in 17,6% in the 
distensible and 100% in the non-distensible group (Arat et al 2004). In our 
series, 2 out of 4 patients (50%) with non-distensible OVM had a histologically 
proven thrombosis. In the distensible group no thrombosis was evident in 
orbital imaging, but since these lesions were not biopsied we cannot exclude 
the presence of minimal thrombi in them. Non-distensible OVM tend to occur 
in older patients (Moreiras 2004, Arat et al 2004), and some authors postulate 
that many of them have been distensible and have remained clinically quiet 
for many years before diagnosis (Moreiras 2004). In our series of 6 patients 
with OVM no age predilection for both varieties was noticed. 
Histopathologically, in 2 of them with non-distensible OVM, intravascular 
benign endothelial hyperplasia was present. This unusual condition is 
reported by other authors as well, and it is considered as a reactive response 
developing secondary to a thrombus in vascular malformations or 
hemangiomas (Shields et al 1999, Arat et al 2004). Orbital CT and especially 
dynamic orbital spiral CT with contrast medium can be very useful for the 
diagnosis of OVM (Rubin et al 1995, Moreiras 2004). OVM are well 
circumscribed lesions and may show either an intense homogenous or an 
inhomogenous (partial thrombosis) contrast medium uptake. In cases of 
thrombosis phleboliths may be present in CT scans. An interesting finding of 
orbital wall defects has also been described in some patients with orbital 
varices (Islam et al 2004). In MRI the lesions are isointens in T1-weighed and 
iso-hyperintens in T2-weighed images. Signal intensity rises if intralesional 
blood flow decreases, as in cases of thrombosis. Heterogenous signal in MRI 
is seen in the presence of hemorrhage in various lytic stages (Moreiras 2004). 
Orbital varix thrombosis must be differentiated from other manifestations of 
orbital venous thrombosis: cavernous sinus thrombosis or thrombosis of the 
SOV (Takahashi et al 1984). The findings of a superior ophthalmic vein 
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thrombosis include: increased intraocular pressure, retinal venous congestion, 
and conjunctival chemosis, eyelid oedema, optic compression neuropathy 
retinal venous dilation and tortuosity or even macular oedema. 2 cases in our 
series involved a thrombosis of the superior ophthalmic vein; one of them was 
idiopathic and one due to factor Leyden mutation. The clinical signs above are 
secondary to thrombosis of a functional orbital vein and represent an acute 
compromise to the orbital venous drainage system. Such symptoms are not 
characteristic of OVM, since these anomalies do not replace a normally 
functioning venous drainage system. The main differential diagnostic 
possibilities for OVM are the cavernous hemangioma and the lymphangioma 
of the orbit (Bullock 1989). Orbital MRI can be valuable in some problematic 
cases (Moreiras 2004). Indications for therapy are intractable pain, 
hemorrhage leading to visual deterioration, severe exophthalmos and 
cosmetic disfigurement (Guigon-Souquet et al 2002). Lesions causing minimal 
symptoms should be initially observed. Thrombosed non-distensible OVM are 
best treated with surgical exposure and evacuation of clot followed by subtotal 
or total excision (Bullock et al 1990). Distensible lesions can be treated 
dependent on their location. In general, surgery can be extremely difficult in 
many cases, as OVM are very friable and intimately intermixed with normal 
orbital structures; the risk of visual loss as a result of hemorrhage or optic 
nerve damage especially in deep OVM, must always be taken into account. 
Superficial distensible lesions can be surgically excised if they are well-
circumscribed or treated by carbon-dioxide laser ablation, either 
trancutaneously of after surgical exposure if they are diffuse. Both methods 
can be combined. For deep lesions surgical exposure, partial excision (total 
excision is rarely possible) and carbon-dioxide ablation can be performed 
(Moreiras 2004). Surgical excision can be facilitated by the use of clips (Beyer 
et al 1985, Lacey et al 1999) or by previous embolization with cyanoacrylate 
glue after surgical exposure (Lacey et al 1999). If a distensible deep lesion is 
not complicated by thrombosis and/or hemorrhage, endovascular 
embolization with platinum coils either via percutaneous transfemoral venous 
catheterization (Takechi et al 1994) or after surgical exposure (Weill et al 
1998) can be chosen as less invasive treatment. Embolization is probably 
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more useful in case of saccular or segmental venous dilatations than in 
tangled plexus of venous channels (Weill et al 1998).  
We treated 4 patients with non-distensible OVM, 2 of whom had extraconal 
lesions situated in the anterior orbit and 2 others had intraconal lesions. 
Tumor excision was performed via anterior orbitotomy (2 cases) and lateral 
orbitotomy (2 cases). In the 2 patients with intraconal lesions, both of whom 
had preoperative diplopia, diplopia persisted after the operation. 1 of them 
underwent strabismus surgery and was free of symptoms thereafter, whereas 
the clinical course of the second patient is not known. All patients had an 
uneventful postoperative course without any complications.  
2 additional patients with minimal intermittent exophthalmos caused by 
distensible OVM, were simply observed.  
 
4.3.3. Orbital hematic cyst 
 
Numerous terms, including hematoma, hematocele, blood cyst, hematic cyst, 
cholesteatoma and cholesterol granuloma, have been used to describe orbital 
cystic collections of blood and its breakdown products. The term orbital 
hematoma should be reserved for an acute traumatic or spontaneous 
collection of blood which is absorbed in a matter of days to weeks (Henderson 
1994). In most instances orbital hematomas break down and are absorbed 
without sequelae. However the degradation of blood to its breakdown 
products can occasionally lead to a granulomatous reaction, appearance of 
hemosiderin and hematoidin and cholesterol clefts in a fibrous background 
(Milne et al 1987, Henderson 1994). This procedure results in the formation of 
a hematic cyst. Hemorrhage into a preexisting lesion such as lymphangioma, 
dermoid or cavernous hemangioma (the latter is very rare) is usually referred 
to as chocolate or blood cyst. This lesion has an endothelial or epithelial 
lining. A hematic cyst has, in contrast, no epithelial or endothelial lining but 
rather a fibrous pseudocapsule.  Orbital cholosteatomas and orbital dermoids 
are synonyms which describe lesions with epithelial elements, keratin, 
cholesterol clefts, lipid laden histiocytes, fibrous stroma and in some cases 
hemorrhage. As already mentioned, the main feature used to distinguish an 
orbital hematic cyst from these lesions is the absence of epithelial or 
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endothelial lining. Histopathologically, cholesterol granulomas and orbital 
hematic cysts are identical. Hematic cysts can be further classified into acute 
or chronic. Acute hematic cysts lack a thick capsule and present typically with 
posttraumatic ptoptosis, conjuctival chemosis and restricted ocular motility 
(Amrith et al 1990). Chronic hematic cysts may produce erosion of bone and 
consist of cholesterol clefts, hemosiderin, hematoidin and a fibrous 
pseudocapsule. Painless unilateral proptosis is the main clinical symptom. 
These benign lesions may increase in size (Amrith et al 1990). A proposed 
mechanism of growth is rebleeding into the cyst secondary to fibrinolytic 
activity (Shapiro et al 1986, Henderson 1994). Most of orbital hematic cysts 
are located in the superior orbit subperiostaly or in close contact to the 
periosteum, but intraconal lesions have also been described (Akira et al 
2000). MRI shows a well circumscribed lesion and signal intensity is 
dependent on the age of the cyst, as shown in the table below. Only the 
pseudocapsule enhances with gadolinium (Moreiras 2004). Surgical excision 
is the typical treatment, although some authors contend that incomplete 
removal (Mund 1981, Akira et al 2000) or needle aspiration is adequate 
(Wolter et al 1976, Siegel et al 1982).  
We operated 1 patient with the typical clinical and histological characteristics 
of an intraconal orbital hematic cyst. The postoperative course was 
uneventful. An additional patient with typical clinical and MRI findings of an 
acute subperiostal orbital hematic cyst after an episode of intense nausea and 
vomiting, refused an operation and was only observed.  
Table 8. Signal intensity of hemorrhage in MRI (Moreiras 2004, modified) 
 T1 T2 
Very acute hemorrhage 
(hours-3 days) 
hypointens 
hyperintens (the first 
hours) , hypointens 
Acute-subacute 
hemorrhage (4-7 days) 
hyperintens hypointens 
Subacute hemorrhage 
(7-20 days) 
hyperintens hyperintens 
Chronic hemorrhage (> 
20 days) 
hypointens hypointens 
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4.4. Structural lesions 
 
Dermoid cysts are developmental choristomas comprising 3 to 9% of all 
orbital masses (Grove 1981).10% of all head and neck dermoids are orbital 
and the superior temporal orbital quadrant is the most frequent location 
(Meenakshi et al 2009). From a clinical point of view, Grove (1981) divided 
them in superficial and deep. The natural history of dermoids is slow 
expansion and, depending on their site, displacement ofadjacent structures. 
Anterior or superficial dermoids are generally easily recognised and treated 
early.  Deeper seated lesions frequently present later as 'giant' dermoids and 
may be misleading in terms of clinical size (Sherman et al 1984). Deep 
dermoids may have a palpable anterior margin but not easily palpable 
posterior margin and presence of oculomotor or visual disturbance should 
raise a suspicion for a deeper location. In cases where a deep located lesion 
is clinically suspected CT scan is the preferred method for the evaluation of 
the size, shape, extension and demonstrationo of the relation to bone 
(Moreiras 2004). Bone changes are usual especially in deep dermoids and 
may include (Nugent et al 1987): focal thinning on a pattern of irregular 
scalloping of adjacent bone , full thickness defects with loss of a portion of the 
orbital wall, linear defects through bone which represent widening of a suture 
line or sclerosis with thickening of adjacent bone. The lesion may display rim 
calcification (Nugent et al 1987, Moreiras 2004). In cases of location in the 
lacrimal fossa region with presence of bone erosion and/or of calcification 
difficulty in making the differential diagnosis from malignant lacrimal gland 
neoplasms exists; the presence of low signal density similar to fat is virtually 
pathognomonic of a dermoid in these cases (especially since orbital lipomas 
and hiposarcomas are extremely rare) (Hammerschlag et al 1983).  However 
dermoids of muscle density also exist (Nugent et al 1987).  Enhancement with 
intravenously administered contrast material may be then very useful for the 
differential diagnosis since dermoids show no or only rim enhancement 
whereas lacrimal gland tumors tend to enhance homogeneously (Nugent et al 
1987). Rupture of the cyst capsule either traumatic or spontaneous leads to 
granulomatous reaction with granulomatous reaction, fibrosis and 
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attachement of the lesion to adjacent soft tissues; symptoms of acute 
inflammation may evolve or alternatively capsule rupture may display no 
clinical symptoms (Sherman et al 1984). If acute symptoms evolve, fat density 
and absence of contrast capture inside the cyst along with evidence of 
sclerosis and hyperostosis of the adjacent bony wall are valuable for the 
differential diagnosis from cellulitis and non-specific inflammation (Moreiras 
2004). Complete surgical excision with intact capsule is the treatment of 
choice in order to prevent surgical dissemination of the contents which can 
induce an acute inflammation. This also helps avoid deposistion of cells which 
could lead to reccurence (Sherman et al 1984). However, some deep 
dermoids cannot be excised in this way due to their large size; dissection 
along the orbital side of the lesion and subsequent evacuation followed by 
microdissection of the remaining lining is then necessary (Rootman 1988). As 
long as the complete linings and contents of the dermoid cyst are removed in 
these cases intraoperative rupture does not appear to lead to late or early 
postoperative morbidity (Rootman 1988). 
In this series 4 patients with dermoids located in the anterior orbit were 
operated with total tumor excision. No reccurences or postoperative 
complications occurred.  
 
4.5. General considerations regarding the therapeutic 
approaches to orbital lesions 
 
It can be generally said that the therapeutic procedure chosen in cases of 
orbital pathology should be based on the evaluation of 3 parameters: a. the 
pathophysiology of the lesion (expansive, infiltrative, vascular or myopathic).  
b. the anatomical site of involvement in the orbit c. the histology (malignant or 
benign lesion). Two lesions displaying the same pathophysiological and 
anatomical characteristics may require different treatments if the first of them 
is benign and the second of them malignant. In cases of malignant lesions 
every effort should be made to reduce the risk of mortality related to 
malignancy, even if this implies sacrifice of visual function. In this sense, 
which therapeutic procedure will be chosen is mainly determined by the 
histological nature of the lesion and secondarily by pathophysiology or 
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anatomical site of involvement. For example an infiltrative localized orbital 
malignant lymphoma of low malignity is to be treated with orbital radiotherapy 
with high success rate, as mentioned above. On contrary an infiltrative 
malignant lymphoma of high malignity will require chemotherapy with or 
without subsequent radiotherapy. A high malignant mesenchymal tumor will 
generally require wide excision, which usually implies exenteration if bone 
involvement is present, irrelevant if the tumor is expansive or infiltrative in 
orbital imaging techniques. A low malignant mesenchymal tumor can in 
contrast be treated with total excision if it is of expansive nature and close 
follow-up will be performed. As example the two patients with malignant 
expansive mesenchymal tumors of the orbit included in this study can be 
mentioned: the first of them had a well-differentiated expansive liposarcoma of 
low malignancy situated in the anterior orbit, and was successfully treated 
with total excision without any other therapy; the second patient had an 
expansive intraconal high malignant fibrous hystiocytoma which required 
exenteration.  The decision to perform adjuvant chemotherapy or radiotherapy 
will again be made according to histology.  
Perhaps in the category of vascular lesions more than any other, the whole 
spectrum of orbital imaging techniques may be necessary in order to 
determine the exact nature of the lesion. Since many clinical and radiological 
characteristics of such lesions overlap and, as already mentioned, mixed 
forms (for instance mixed venous-lymphatic malformations) are common, 
careful preoperative evaluation based on history, clinical examination and 
imaging findings is mandatory; it is for instance very important for a lesion 
situated deep in the orbit, to differentiate between a haemangioma and a 
lymphangioma (mixed venous lymphatic malformation) since attempt of total 
excision for the latter carries high risk of postoperative complications or even 
visual loss. One more example can be mentioned: a hemangiopericytoma 
may be associated with malignancy or high recurrence rate if total excision is 
not performed, and can be in many cases distinguished from a cavernous 
hemangioma preoperatively, if meticulous study of CT or MRI scans is 
performed by an experienced radiologist (Moreiras 2003). The same applies 
to distensible and non-distensible venous malformations, where indications for 
surgical treatment and treatment approaches are quite different. From the 
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examples mentioned above it is clear that the orbital surgeon should not be 
mislead by the expansive nature of most vascular “tumors”, something that 
per se would in most cases mean that total excision and healing will be 
possible. If he underestimates the value of accurate preoperative diagnostic, 
he may be confronted with unexpected difficulties in surgical field.  In cases of 
vascular pathology, the anatomical site of involvement is of high importance 
for the therapeutic procedure which will be chosen. If decreased visual 
function is present (for instance cavernous haemangioma or non-distensible 
venous malformation of the apex causing visual field defects or intraconal 
cavernous haemangioma causing choroidal and retinal folds) surgery is the 
therapy of choice. For the same lesions situated elsewhere in the orbit and 
causing minimal symptoms, however, observation only can be justified. In 
cases of acute vision threatening complications which are relatively common 
in this category, it is clear that prompt surgery should be performed. 
Myopathic lesions are almost always to be treated conservatively. In this 
category, however, careful diagnostic evaluation is mandatory, since 
increased muscle volume can have various causes: idiopathic non-specific 
inflammation, endocrine orbitopathy, lymphoproliferative lesions like 
lymphomas, rhabdomyosarcoma, metastatic disease, specific inflammation 
like Wegener’s granulomatosis or even arteriovenous dural fistulas. The 
signal characteristic in T2- weighed MRI images can be helpful for the 
differential diagnosis in some cases, but many times signal features overlap. 
High dose steroid treatment can be justified, at least at the beginning of 
disease, as non-specific myositis has a good and quick response to this 
therapy. The question for the clinician is when to perform biopsy in such 
cases, or in other words how long should be waited for steroid treatment to 
prove its efficacy. It is also true, that lymphoproliferative lesions such as 
lymphomas, may show an initial good response to steroids. All cases of 
idiopathic non-specific myositis of this study responded very well in a period to 
1-3 days to steroid treatment. It can be assumed, that orbital biopsy is to be 
performed if no improvement in the clinical symptoms is observed after the 
first days of therapy.  
For benign pathology treatment should be clearly based on pathophysiology 
and anatomical site of involvement. Location in the orbital apex causing 
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oculomotor, sensory or visual deficits in the presence or an expansive lesion 
is an indication for surgery. If the lesion is expansive total excision should be 
attempted, provided that meticulous care is taken not to injure vital structures. 
If an infiltrative lesion involves the apex and causes functional visual deficit 
the treatment approach is more complicated. Taking into account, that 
location in the orbital apex may have minimal inflammatory signs from the 
anterior orbit, diagnosis of non-specific inflammation cannot be easily made 
and presence of malignancy cannot be excluded, at least clinically. It is also 
well documented (Rootman 1994) that sclerosing idiopathic inflammation 
most commonly involves the anterior and superior lateral orbit also the apex; 
moreover 20% of sclerosing idiopathic inflammations (SNSI) are 
predominantly apical (Rootman 1994). Differential diagnosis between SNSI 
and other lesions causing desmoplasia and presenting with pain, proptosis 
and mild or no inflammation, such as Wegener’ s granulomatosis, sinus 
disease, primary and secondary neoplasia or direct extension of sinus 
carcinomas can be problematic. In such cases early orbital biopsy with or 
without surgical debulking or orbital decompression should be considered for 
the following reasons: a. high risk of misdiagnosis, as mentioned above. b. in 
cases of SNSI steroid treatment or even radiotherapy have very often 
unsatisfactory results, as shown in this study and also reported in the 
literature. If diagnosis of SNSI is missed and response to steroids and/or 
radiotherapy is long awaited, irreversible visual deficits may evolve, which 
could have been avoided, if other treatment modalities, such as 
immunosuppressant therapy (Rootman 1994), surgical debulking or orbital 
decompression were promptly performed. Other authors state, as well, that in 
cases of SNSI quick identification and prompt surgical treatment is crucial to 
minimize residual functional deficits (Kennerdell 1991) c. cases of acute or 
subacute non-specific inflammations can also be steroid tolerant. In summary, 
location in the apex with functional deficit is indication for prompt surgery in 
both expansive and infiltrative lesions, aiming to preserve as much function as 
possible. For expansive lesions total excision should be attempted, whereas 
for infiltrative lesions surgical debulking or orbital decompression is to be 
performed. If the inflammatory nature of the lesion is confirmed by biopsy, 
adjuvant anti-inflammatory therapy or radiation therapy can also be performed 
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postoperatively on the basis of histology (specific or non-specific 
inflammation).   
Lacrimal involvement is also an indication for prompt surgery for the same 
reasons as in apical involvement with the difference that in this case direct 
threat to vision is not present at the beginning of disease. Moreover, the 
lacrimal gland lesions are likely to be associated with a systemic disorder 
more than any other location in the orbit (Rootman 1998) and this is another 
reason why routine biopsy should be part of the treatment protocol. Diagnosis 
of non-specific inflammation is to be made extremely cautiously in this 
location.  
For lesions of the anterior orbit presence of acute inflammatory signs can 
justify conservative anti-inflammatory treatment without need of early biopsy. 
Given however the fact that the majority of lymphoproliferative lesions are 
located in this site, failure of response or initial response with multiple 
recurrences should raise the suspicion of lymphoma and biopsy should be 
performed to exclude malignancy.  
The intraconal space is a relatively rare site of involvement for non-specific 
inflammation. In this study only 5 of 32 intraconal lesions were inflammatory; 
in contrast 22 were neoplastic. Given the fact that neoplasia is very common 
in intraconal space, chronic presentations in this part of the orbit are almost 
always to be explored surgically.  
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Summary 
1. The clinical and radiological characteristics along with the results of 
treatment of 132 cases of patients with orbital disease, who were 
treated from the year 1993 to the year 2008 in the University Clinic of 
Ophthalmology Rostock were studied.  
2. Data was collected from patient’s archives of the University Clinic of 
Ophthalmology Rostock. Postoperative follow-up examinations have 
taken place mainly in the University Clinic of Ophthalmology Rostock. 
Some patients were examined postoperatively by ophthalmologists in 
private practices. Information about the postoperative course for these 
patients was collected by questionnaires which were sent to and filled 
out by private ophthalmologists. 
3. 48 patients (36 %) had inflammatory, 59 patients (45%) had neoplastic, 
19 patients (14%) had vascular (tumors excluded) and 6 patients (5%) 
had structural lesions. Diagnosis was confirmed histologically in 103 
cases. 
4. In the age groups of 0-20 years inflammatory lesions were the most 
common. In the age group of > 60 years neoplasia dominated. In the 
age group of 20-60 years inflammatory lesions and neoplasia had the 
same frequency. 
5. A pathophysiological classification based on clinical and radiological 
characteristics was made in the following categories: expansive 43 
cases), infilrative (60 cases), vascular (tumors excluded) (19 cases) 
and myopathic (10 cases). 
6. Anatomically, the intraconal space along with the lacrimal gland region 
were the most common sites of involvement for expansive and 
infiltrative lesions (103 cases): 32 intraconal (31%) and 32 lacrimal 
(32%) lesions were encountered. The anterior orbit was the third most 
common site with 27 cases (26%). 7 lesions (7%) were diffuse, 3 
lesions (3%) affected the orbit by continuity (periorbital) and 2 lesions 
(2%) were apical.  
7. The most common infiltrative lesions were non-specific inflammations 
and malignancy with domination of lymphomas. The differential 
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diagnosis between them is in many cases very difficult and the 
question whether to perform biopsy emerges. If acute symptoms, such 
as pain, erythema and proptosis dominate the clinical picture, the 
presence of an acute non-specific inflammation is highly likely and in 
that case, an initial treatment with steroids without first performing a 
biopsy could be considered.  
8. Several CT and MRI features have been described to differentiate 
between non-specific inflammation and lymphoma in the orbit. 
However clinical and radiological findings overlap in many cases and 
biopsy is recommended for prompt diagnosis of a potential malignancy 
and subsequent treatment.   
9. In cases of non specific inflammation of the orbit surgical debulking 
with additional steroids is the treatment of choice for relatively small 
and well circumscribed lesions, especially if the lacrimal gland involved. 
For diffuse lesions steroid therapy is the therapy of choice. If steroids 
fail or are contraindicated, radiotherapy is the next therapeutic option. 
10. Surgical debulking or orbital decompression should not be delayed if 
the apex is involved and visual deficits are present, especially if 
sclerosing inflammation is diagnosed of if diagnosis remains clear. 
11. Sclerosing inflammation of the orbit may be considered as a distinct 
clinicopathologic entity characterized by primary, chronic, and 
immunologically mediated fibrosis. Since poor response to steroids and 
radiotherapy is common, surgical removal is recommended for 
relatively well delineated lesions especially in the lacrimal gland region. 
For more diffuse lesions surgical debulking with additional steroids 
and/or radiotherapy should be tried. In cases of failure the 
administration of immunosuppressants can be discussed on case to 
case basis. 
12. Orbital lymphomas were in their majority localized and of low-malignity. 
Radiotherapy was the treatment of choice with very good results. With 
dose of <40Gy serious complications were rarely seen.  In cases of 
disseminated disease or lymphomas of high-malignity chemotherapy 
must be performed. 
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13. Malignant orbital mesenchymal tumors are rare and may be initially 
misdiagnosed. The differential diagnosis among them and vascular 
tumors such as hemangiopericytomas is often challenging in biopsy 
specimens. Surgical treatment in the form of total excision or 
exenteration was performed (rhabdomyosarcoma excluded). The 
efficacy of radiotherapy and chemotherapy (rhabdomyosarcoma 
excluded) is controversial and the decision to perform them additionally 
to surgery is to be made on case to case basis.  
14. Tumefactions in the lacrimal gland region may be lymphoproliferative, 
inflammatory or malignant. Distinguishing between pleomorphic 
adenoma and lacrimal gland carcinoma is crucial and is guided by 
clinical and radiological features; however difficult cases may require 
biopsy. Lacrimal gland adenomas are managed by total excision of the 
tumor with its capsule. If meticulous surgery is performed recurrence 
drops virtually to zero. The adenoid cystic carcinoma of the lacrimal 
gland is a tumor with grim prognosis, due to early occult metastasis or 
intracranial extension at the time of diagnosis. Nevertheless, radical 
surgery with radiotherapy should be performed to achieve local control 
of the disease.  
15. Vascular lesions of the orbit, including cavernous hemangiomas, 
lymphangiomas and venous malformations must be viewed in respect 
to their hemodynamic characteristics. Mixed clinical forms are often 
encountered and diagnosis presents a challenge to the orbital 
specialist. In this category of lesions the total spectrum of radiological 
examination methods including CT, MRI, MR-angiography, transorbital 
color Doppler imaging, invasive angiography may be needed for the 
establishment of the diagnosis. Differentiating between these lesions is 
crucial for treatment. Cavernous hemangiomas are surgically managed 
with very good results overall. For lymphangiomas, conservatism is 
generally recommended, especially for lesions situated deep in the 
orbit or in the apex, due to high risk or complications and recurrence. 
Anteriorly located lesions are much more easily managed with low 
complication rates.  
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16. Venous malformations are classified in distensible and non-distensible 
ones. Distensible malformations should be observed if they cause 
minimal symptoms. In cases of complications or cosmetic 
disfigurement, treatment is based on location and includes surgical 
excision, ablation or embolisation by neuroradiologists. Non-distensible 
venous malformations are treated by surgical excision. 
17. Arteriovenous fistulas may cause multiple ocular symptoms from the 
anterior and posterior segment. Cases of therapy-resistant 
“conjunctivitis” or refractory, usually unilateral “glaucoma” or palsies of 
oculomotor nerves should raise suspicion of such a lesion. After 
confirmation of diagnosis therapy is undertaken by interventional 
radiologists. 
18. Patients with orbital disease will need in many cases an 
interdisciplinary approach for their diagnosis and treatment. The 
ophthalmologist is in most cases the first reference specialist and the 
one who will organize the management of these patients.  
19. When confronted with a patient suspected of having orbital disease the 
clinician may feel confused, since the symptomatic of orbital disease 
(endocrine orbitopathy excluded) is non-specific. A pathophysiological 
categorization of all orbital lesions in 4 groups, namely expansive, 
infiltrative, myopathic and vascular in combination with the anatomical 
site of involvement in the orbit provides a useful framework for 
analyzing each case.  
20. The clinical analysis includes the complete spectrum of 
ophthalmological and neuroophthalmological examination methods and 
is supported by a considerable amount of information provided by 
modern diagnostic imaging methods. Since “good answers can be 
given only to good questions”, the clinical analysis remains a valuable 
tool. 
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Theses 
 
1. Non-specific inflammation of the orbit (NSI) is one of the most common 
diagnoses in cases of orbital lesions.  Steroid treatment is generally 
considered as the treatment of choice, but as already mentioned some 
authors question this. Some patients respond well, others show a partial 
response with recurrence and others show no response. The question which 
arises is how long should be waited before other treatment options are 
considered. Additionaly, if diagnosis has been made only on the basis of 
clinical and radiological findings without any biopsy confirmation the situation 
becomes more complicated: in this case suspicion of misdiagnosis also exists 
and biopsy is to be considered.  
 
2. If muscle involvement dominates, it can be assumed that if no improvement 
is observed after the first days of treatment, biopsy should be performed 
because misdiagnosis is likely. In cases of other orbital involvement the right 
time for biopsy to be performed is a question for the clinician. If diagnosis has 
already been confirmed histologically but steroids are not effective or are 
contraindicated, radiotherapy could be another option. Controversy however 
exists if correlation between steroid and radiotherapy response exists and if 
failure of steroids is a negative prognostic factor for the results of 
radiotherapy.  
     
3. Even if systemic steroid administration (intravenous or oral) is most 
commonly performed, local injection with good results and practically no 
systemic side effects is reported in the literature. These reports however 
include a relatively small number of patients. Periocular injection of steroids 
carries a very low risk for systemic complications, but local complications, 
which can be very serious, have been observed. Since the dose equivalent 
between local and systemic dose is not known and as mentioned only few 
reports on intralesional steroid administration exist, it is difficult to compare 
the efficacy of these methods.  
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4. For apical lesions or lacrimal gland lesions the diagnosis of NSI is to be 
made with caution. In these cases biopsy may be performed as soon as 
possible, in order to avoid misdiagnosis and (in cases of apical involvement) 
to preserve as much function as possible. It can be argued that surgery 
carries a risk of complications and these patients should be given the chance 
of steroid therapy before surgery is suggested. Since the exact time to wait for 
steroids to act is not known and may also be variable, it could be assumed 
that the risks of an operation should be taken into account and thus referral to 
an orbital centre is surely justified, at least in cases of visual dysfunction. 
 
5. Controversy exists regarding the appropriate management of sclerosing 
orbital inflammation (SNSI). If SNSI is considered as a unique 
clinicopathological entity, where dysfunction of the immune regulation plays a 
significant role, early and aggressive immunosuppressant treatment may be 
considered; this sort of treatment however, caries the risk of systemic side 
effects. Anecdotal cases of treatment with immunosuppressant medicaments 
are reported in the literature: some patients responded well whereas others 
did not. On the other hand steroids and radiotherapy have high failure rates. 
Thus, it seems that surgery should be considered as the treatment of choice, 
at least in cases of relatively well circumscribed lesions or in case of lacrimal 
gland involvement. For more diffuse lesions treatment could be surgical 
debulking alone or in combination with steroids, immunossuppressants or 
radiotherapy on case-to-case basis. 
 
6. For orbital lymphomas treatment approach is clear: radiotherapy for 
localized low-malignity tumors and chemotherapy for high-malignity tumors or 
disseminated disease alone or in combination with radiotherapy. Controversy 
exists regarding the appropriate dose: the dose should be sufficient for 
treatment but very high dose carries the risk of serious complications such as 
radiation retinopathy or cataract formation. It can be assumed that with dose 
of <40 Gy complication rate is very low. 
 
7. For lacrimal lesions many reasons biopsy is often an essential part of the 
diagnostic protocol. In cases of neoplasia distinguishing between malignant 
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and benign lesion is of vital importance: careful evaluation of clinical and 
radiological findings, may be extremely helpful for this reason, however 
difficult cases requiring biopsy also exist. Traditionally biopsy in cases of 
benign pleomorphic adenoma is considered to carry high risk of reccurence; 
many authors though have questioned this and suggest that biopsy should be 
performed for difficult cases and if then diagnosis of benign pleomorphic 
adenoma is made, excision of the biopsy route practically minimizes 
reccurence to zero.  
 
8. Controversy exists regarding treatment of lacrimal gland carcinoma. 
Surgery either radical in form of exenteration with or without removal of bone 
or primary resection of the tumor mass with radiotherapy is the conventional 
treatment. The overall prognosis is bad due to early perineural and 
hematogenic metastases which may initially be occult. Locally advanced 
disease is correlated with high rate of development of metastasis at the time 
of diagnosis; in these cases radical and aggressive surgery has not proven to 
improve disease free survival. Reports of higher survival rates after 
intraarterial chemotherapy followed by surgery and/or radiotherapy exist in the 
literature. Intraarterial chemotherapy however carries the risk of complications 
of endovascular catheterization and systemic toxicity of chemotherapeutic 
drugs. Questions arising in the management of these patients are: a. which 
patient will benefit from aggressive surgery and in which cases more 
conservative surgery with adjuvant radiotherapy or even intraarterial 
chemotherapy is should be preferred for a better quality of life? b. in which 
cases intraarterial chemotherapy is likely to improve local disease control and 
overall disease free survival? Generally, the prevention of metastasis and 
control of local disease is a major challenge for the clinician and treatment 
decisions are generally to be made on case to case basis. 
 
9. Malignant mesenchymal tumors (rhabdomyosarcoma excluded) are 
generally to be treated surgically with total excision, even if this frequently 
implies exenteration. The efficacy of radiotherapy is for most of them unclear 
and decision to perform it is generally to be based on the radicality of surgical 
excision. 
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10. The differential diagnosis of vascular lesions of the orbit is in many cases 
very difficult since clinical manifestations and imaging characteristics overlap; 
moreover mixed forms are not unusual. In this category of lesions, perhaps 
more than any other, extensive preoperative diagnosis is very important and 
justifies the use of the whole spectrum of orbital imaging techniques (invasive 
and non-invasive). An example supporting this is the following: treating a 
lymphangioma as a cavernous haemangioma may cause serious 
complications; however distinguishing preoperatively between them may be 
extremely difficult. Taking into account that vascular lesions are in their 
majority benign, the question arising is in which cases surgical treatment is to 
be performed (especially if diagnosis is not clear) and on the contrary, which 
lesions should be initially observed. The absence of symptoms or presence of 
minimal symptoms is surely a main criterion. Since however some of these 
lesions, which initially cause minimal symptoms, carry the risk of acute and 
even vision threatening complications (acute hemorrhage of a non-distensible 
venous malformation spontaneously or posttraumatic is an example) it is 
obvious that other parameters must also be considered (socioeconomic, age, 
way of life, occupation). 
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